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SUMMARY
This study has analysed some of the mechanisms involved in the transcriptional 
activation of the human immunodeficiency virus type 1 (HIV-1) by transcriptional 
modulator proteins of the NF-KB/rel family.
Initial attempts to purify a single NF-kB (p50-p65) heterodimer species from 
HeLa cells suggested that a family of proteins might contribute to kB motif DNA 
binding activity, HeLa cell kB motif DNA binding proteins were shown to be 
modified by glycosylation. Using circularly pemiuted DNA probes carrying a kB 
motif, it was shown that kB binding proteins induced significant DNA bending 
upon binding, while studies of the effects of the poly amine spermidine on purified 
HeLa cell kB motif DNA binding proteins showed it greatly stimulated their DNA 
binding activity.
Tlie DNA binding activity of native kB motif DNA binding proteins was also 
greatly stimulated by the reducing agent dithiothreitol. Using a cDNA encoding 
the p i05 precursor to the NF-kB p50 subunit, the wild type DNA binding and 
dimérisation region (aa35-381) of p50, and three cysteine to serine mutants at 
cysteine residues (aa62,119, and 273) conserved throughout the NF-KB/rel/dorsal 
family, were expressed in bacteria. The dissociation constant of the aa62 p50 
mutant for the kB motif was 10-fold higher than that of the wild type p50. Also, 
dissociation rate constants for the aa62 mutant-KB motif complex in both the 
presence and absence of speimidine were anomalously high. The above changes 
suggested a different DNA binding specificity for the aa62 mutant - this was 
confirmed by oligonucleotide competition studies. Oligonucleotide protection 
experiments suggested the presence of a cysteine residue in the p50 DNA binding
site - substrate protection experiments showed that this was cysteine 62, and that 
tliis residue is involved in redox regulation of p50 DNA binding activity. 
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INTRODUCTION,
1. Natural history of human immunodeficiency virus type 1.
Tlie causative agents of the acquired immunodeficiency syndrome (AIDS) have 
been identified as the human immunodeficiency vimses types 1 and 2 (HIV-1 and 
HIV-2) (reviewed in Vaishnav and Wong-Staal, 1991; Haseltine, 1991) - these are 
retroviruses - RNA-containing viruses which replicate via a DNA inteimediate by 
use of a virally-encoded RNA-dependent DNA polymerase, also known as reverse 
transcriptase. Tlie retrovims family can be divided into three subfamilies:- 
oncoviridae including all oncogenic retrovimses and many closely related 
non-oncogenic vimses; lentiviridae including the "slow" viruses such as 
visna-maedi virus, equine infectious anaemia vims (EIAV), and the various 
immunodeficiency viruses; and the spumaviridae comprising the "foamy " vimses 
which induce persistent infections with vacuolisation of cultured cells but without 
causing clinical disease.
This short survey will concentrate on the better characterised and more 
pathogenic human immunodeficiency virus type 1 (HIV-1). This is a complex 
retrovims - in addition to genes encoding the virus particle and replicative 
enzymes common to all retroviruses, HIV-1 encodes at least six additional proteins 
which regulate the viral life cycle. Tlie virus particle contains an inner core which 
contains the diploid, single-stranded RNA genome, as well as viral enzymes and 
other factors needed for early replication events. Tliis inner core is, in turn, 
surrounded by capsid proteins, and the capsid is surrounded by a lipid bilayer 
envelope. A viral matrix protein is inserted into the inner surface of the lipid 
bilayer envelope, and a viral integral membrane protein, the envelope
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glycoprotein, protrudes through the membrane and forms the outer surface of the 
virion.
Infection begins when an HIV-1 vims particle or a cell producing vims particles 
encounters a cell with a high affinity receptor for the virus - a specific high 
affinity binding reaction occurs between the viral envelope glycoprotein and a 
target cell CD4 molecule (Dalgleish et al., 1984). Tlie CD4 surface glycoprotein 
molecule is found at low concentration on monocytes, macrophages, and 
antigen-presenting dendritic cells, but is present at high levels on the surface of 
immature T-cells, as well as mature CD4"  ^T helper cells.* There have been 
suggestions that HIV-1 may enter cells which lack the CD4 molecule via a low 
efficiency membrane fusion reaction (Clapham et al., 1989).
After the high affinity binding reaction, viral entry to the cell occurs by fusion 
of viral and cell membranes. Tlie fusion reaction is mediated by the viral envelope 
glycoprotein, the external subunit of which specifies binding to CD4, while the 
transmembrane subunit is responsible for the membrane fusion event. Viral 
envelope glycoprotein-mediated reactions are cytopathic for cells carrying large 
numbers of CD4 molecules - by fusion reactions beween budding virus and cell 
surface CD4 which destroy the integrity of the plasma membrane (Popovich et al., 
1984), and by fusion reactions with uninfected CD4’^  cells to generate non-viable, 
giant multinucleated cells.
The HIV-1 viral genomic RNA is converted into DNA by the action of 
virally-encoded RNA-dependent DNA polymerase and ribonuclease H activities 
present within the viral core. Tliis results in the conversion of the diploid 
single-stranded RNA viral genome into a double-stranded DNA copy within the
first six hours of infection (Famet and Haseltine, 1990), this reverse transcription 
process occurring in the cell cytoplasm. The next event in the viral life cycle is the 
insertion of tlie linear double-stranded viral DNA into the host genome, tliis is 
mediated by a virally-encoded integrase - also packaged within die virus particle. 
Preintegration complexes of double-stranded viral DNA and integrase protein can 
be detected in the cytoplasm. The viral integrase protein has three activities:- it 
trims die ends of die linear double-stranded DNA provirus prior to the 
recombination reaction; it cleaves the host cell chromosomal DNA; finally the 
integrase covalently joins the freshly cut ends of die viral and host DNA, followed 
by repair of the site of insertion by host cell enzymes (Bushman and Craigie,
1991). All the above integration reactions occur in the nucleus, leading to the 
generation of a proviral DNA which resembles a cellular gene.
Once integrated, the proviral HIV-1 DNA seems to remain permanently 
associated with the host cell genetic material, where it remains quiescent until the 
host cell is activated in some way (see Introduction section 2.1). Upon host cell 
activation, HIV-1 viral expression begins with the synthesis of a full-length RNA 
copy of the proviral DNA, transcription initiates widiin the 5’ terminally 
redundant long teiminal repeat (LTR) flanking the coding sequences of the 
provirus.
Tlie initial rate of transcription initiation from the HIV-1 proviral DNA is 
determined by the activity of a large range of host cell transcription modulatory 
proteins - including importantly, host cell proteins of the NF-icB/rel family 
binding to two kB motifs located between nucleotides 80 and 105 upstream of the 
transcriptional start site (see Results section). The same range of host cell
transcription modulatory proteins is also involved in the transcriptional control of 
host cell genes - some of these transcription modulator proteins such as the 
NF-KB/rel family seem to be inactive in most cell types until the cell receives 
some sort of activation signal (Tong-Starksen et al., 1987).
Tlius, proviral DNA is not transcribed into RNA in resting T-cells and as a 
consequence little HIV-1 virus is produced by this population of infected ceUs. 
However, specific or non-specific mitogenic stimulation of the CD4+ T-cell 
population results in active transcription from the HIV-1 LTR and virus 
replication. Tliis ability of the HIV-1 provirus to persist in the host cell without 
viral replication is in part responsible for the long latent period of HIV-1 
infections. In addition to the cell-specified transcription modulators giving rise to 
transcriptional activation from the HIV-1 LTR upon host cell activation, a 
virally-encoded transactivator (tat) protein can, by binding to a stem-loop 
stmcture (the TAR region) at the 5' end of the nascent RNA increase the 
steady-state level of full-length viral RNA (Laspia et al., 1989) - however this 
process is dependent on the initial transcription from the LTR mediated by 
cellular factors, and translation to generate the tat protein.
The full-length viral RNA transcript can be multiply spliced to generate niRNAs 
whose translation products include the tat protein, and two regulatory proteins rev 
and nef. The rev protein profoundly affects the fate of primary RNA transcripts 
within the nucleus - in the absence of rev only small multiply spliced transcripts 
accumulate in the cytoplasm, whereas in the presence of rev, full-length and 
singly-spliced viral messenger RNAs (niRNAs) can accumulate in the cytoplasm 
(Malim et al., 1990). The action of rev is mediated by its binding to a rev
responsive element (RRE), tlius in the absence of rev only regulatory proteins 
made from multiply spliced transcripts are made, while in the presence of rev, 
unspliced and singly-spliced RNAs are exported and translated to yield the viral 
capsid protein and envelope glycoprotein (Heaphy et al., 1990).
Tlie full-length viral RNA is translated to yield a capsid polyprotein precursor 
and a fusion protein of capsid polyprotein precursor with the replicative enzymes, 
different but overlapping reading frames specify the capsid precursor and 
replicative enzymes. A ribosomal frameshift event occurs near the 3' end of the 
capsid genes to allow at low frequency (approximately 5%) the generation of the 
capsid replication enzyme fusion protein (Jacks et al., 1988).
Tlie capsid precursor polyprotein and the capsid replication enzyme fusion 
protein assemble at the inner surface of the plasma membrane and bind to the 
plasma membrane by virtue of the myristylated amino tenninal residue of the 
capsid precursor protein (Veronese et al., 1988). Tlie capsid precursor also binds 
to a specific packaging sequence near the 5’ end of the viral genomic RNA. A 
complex of capsid precursor protein, capsid precursor replication enzyme fusion 
protein, and viral RNA then assembles into a closed spherical particle which buds 
through the plasma membrane (Gelderblom et al., 1987) incoiporating the viral 
envelope glycoprotein as it does so. Interestingly, the newly-budded particle seems 
to remain attached to the cell surface by a tether before release.
The viral envelope protein is translated from the singly spliced viral mRNA and 
is cotranslationally translocated at the rough endoplasmic reticulum, where it 
assembles as a dimer, and where the lumenal part of the envelope protein is 
heavily modified by approximately twenty complex oligosaccharide chains. The
envelope glycoprotein then enters the Golgi apparatus where it is cleaved into two 
subunits - the amino terminal region destined to become the external gpl20 
component, and the carboxyl terminal region which becomes the integral 
membrane protein gp41 (Allen et al., 1985). The complex carbohydrates are 
modified during passage through the Golgi apparatus before transport of the 
gpl20/gp41 complex to the cell surface and concentration in the plasma membrane 
regions of virus budding.
Other virally-encoded regulatory proteins include the vif protein (which may 
act as a protease to clip the carboxyl terminus of gp41) - the lack of vif function 
results in progeny HIV-1 being only poorly infectious (Strebel et al., 1987). Tlie 
vpu protein which facilitates the export of virus particles from the cell (Klimkait 
et al., 1990), the vpr protein which is packaged within the virus itself and may 
function in transactivation of viral and cellular promoters (Ogawa et al., 1989), 
and finally, the nef protein which is expressed soon after viral infection but whose 
role is unclear (Kim et al., 1989). Tlie late maturation events for the HIV-1 virion 
include activation of the viral pro tease to cleave the capsid polyprotein precursors 
into their mature forms, and the release by an unknown mechanism of the mature 
HIV-1 virus particle from its tether to the plasma membrane.
2. The NF-KB/rel/dorsal transcription factor family.
2.1. NF-kB as an inducible transcriptional activator
The sequence-specific DNA binding activity termed NF-kB was first identified 
as a protein which bound to a sequence in the immunoglobulin k light chain gene 
major (J-C) intron transcriptional enhancer (Sen and Baltimore, 1986a). Tliis 
factor initially appeared to be not only tissue-specific and limited to cells of the B
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lymphoid lineage, but also seemed to be stage-specific within that lineage - its 
DNA binding activity could not be detected in several standard pre-B-cell lines, 
but was detectable in several mouse and human B-cell and myeloma cell lines. The 
nuclear factor bound around an 1 Ibp sequence - GGGGACTTTCC, termed the B 
site, in the k chain gene major intron enhancer - and hence was named NF-kB. In 
the cell lines examined, there was a striking correlation between the apparent 
presence of this NF-kB activity and immunoglobulin k light chain gene 
expression.
Such behaviour tended to suggest that the NF-kB factor was only expressed in 
mature B-cells and plasma cells, however one discrepancy in this scheme was 
noted in tlie above study - that in a pre-B-cell line PD which undergoes k chain 
gene rearrangement in culture did show nuclear NF-kB activity. The behaviour of 
the PD cell line could be rationalised following reports tliat NF-kB DNA binding 
activity could be induced in the 70Z/3 pre-B-cell line by treatment with bacterial 
lipopolysaccharide (LPS), with evidence tliat induction might involve a 
posttranslational activation - the combination of LPS and the protein translation 
inliibitor cycloheximide caused a superinduction of NF-kB activity (Sen and 
Baltimore, 1986b). Most interestingly, the use of either cycloheximide or the 
translation inhibitor anisomycin alone resulted in significant induction of NF-kB 
DNA binding activity - indicating that protein synthesis was not required for 
induction of NF-kB DNA binding activity, and hence implying that NF-kB existed 
in some inactive, possibly labile, precursor form in pre-B-cells.
Evidence for such an inhibited foim of NF-kB already existed - studies of the 
70Z/3 pre-B-cell line had indicated that after treating cells with cycloheximide or
anisomycin, K gene transcription still occurred following LPS stimulation (Nelson
et al., 1985; Wall et al., 1986). Wall et al. also reported that k  gene expression
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could be induced in the presence of cycloheximide alone - leading them to propose 
tliat K gene expression in 70Z/3 cells was inhibited by one or more labile 
regulatory proteins that blocked transcription.
Further interesting points to emerge from the study by Sen and Baltimore 
(1986b) were that the active phorbol ester phorbol 12-myristyl 13-acetate (PMA) 
caused the induction of NF-kB activity in the 70Z/3 pre-B-cell line, and that PMA 
treatment also caused tlie induction of NF-kB in the Jurkat T-cell line and in the 
HeLa epithelial cell line. The obseiwation that PMA caused a much more rapid 
induction of NF-kB activity than did LPS was consistent with previous models that 
LPS binding to a receptor results in activation of phosphatidylinositol-specific 
phospholipase C with the concomitant generation of inositol 1,4,5-trisphosphate 
and diacylglycerol - the latter being the physiological activator of protein kinase C 
(Wightman and Raetz, 1984). As PMA can activate protein kinase C directly, 
NF-kB activation by this route is much more rapid. The involvement of protein 
kinase C in tliis activation process led to suggestions that the critical event might 
be a phosphorylation of the pre-NF-KB. In such a model, a labile repressor 
protein could be either a phosphatase or a molecule which blocked the site of 
phosphorylation by directly binding to the pre-NF-KB, alternatively protein kinase 
C could phosphorylate the inliibitor, releasing it from its interaction in the 
pre-NF-KB complex (Sen and Baltimore, 1986b). The other most significant 
observation from the above study was that neidier the NF-kB factor, nor the 
inliibitor protein, was confined to the B-cell lineage since NF-kB activity could be
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induced in T-cell and epithelial cell lines - thus forcing a reformulation of the 
tissue and stage-specific regulatory problem as one of activating NF-kB from its 
seemingly ubiquitous precursor.
Altliough the correlation between the constitutive and inducible activity of 
NF-kB and the transcription of the k light chain gene was suggestive of a link, 
more direct evidence confirming a causal link came from genomic méthylation 
protection studies of the (NF-kB binding) kB site of the K chain gene large intron 
enhancer - studies of die 70Z/3 cell line before and after induction of K chain 
transcription by LPS treatment gave direct evidence for protein interaction witii 
the kB site in tiiose cells expressing the k chain gene, similarly in two fully 
differentiated K chain expressing lines the protein interaction with the kB site was 
maintained (Hronias et aL, 1988). Another line of evidence indicating a direct 
causal link between the induction of kB DNA-binding activity and the activation 
of K gene transcription emerged from studies of three mutant lines of the 70Z/3 
pre-B-cell line (Briskin et aL, 1990). All three mutant 70Z/3 lines failed to 
activate NF-kB after treatment with LPS or PMA, however by 
deoxycholate/NP40 detergent treatment of cytoplasmic extracts, all three mutants 
were shown to possess functional NF-kB. Further, cycloheximide treatment of 
two of the mutants induced activation of NF-kB binding and k gene transcription 
to levels comparable to those induced in wild type 70Z/3 cells - confinning that 
activation of NF-icB binding is a late and critical event in activating k gene 
transcription.
The functional role of NF-kB was demonstated by a mutational analysis of the k 
gene large intron enliancer (Lenardo et al., 1987) where the B motif, the binding
site for NF-kB, seemed to be the key site as its mutation resulted in little or no 
enhancer activity in transfected S I94 myeloma cells, and abolished inducibility by 
LPS treatment in transfected PD31 pre-B-cells. Subsequent studies demonstrated 
directly that oligonucleotides bearing the kB motif when inserted into test 
plasmids carrying the chloramphenicol acetyltransferase (CAT) reporter gene 
could act independently as enliancer elements (Pierce et al., 1988). In transient 
transfection studies of lymphoid and non-lymphoid cells, insertion of a single copy 
of the kB motif (at -7 Ibp relative to the transcriptional start site) could act as a 
tissue-specific upstream activating element - giving 24-fold higher levels of CAT 
transcription in S I94 myeloma cells compared to a 3-fold increase in 3T3 cells 
(which may have had a low level of endogenous active NF-kB). Interestingly, 
insertion of a dimer of the kB motif at the same upstream site gave a further 
10-fold increase in CAT activity and it was also demonstrated that the dimer of 
the kB site could act as an enliancer element when located 2.5kbp downstream of 
the transcriptional start site. Tlie inducibility of this enliancer element was 
confirmed by transfection of the pre-B-cell line 38B9 and induction with LPS - in 
fact tlie kB motif dimer proved more active than the entire k gene enliancer while 
plasmid constructs bearing a dimer of a mutant non-binding kB motif at the 2.5kb 
downstream position showed no increase in CAT activity over the parental 
plasmid. A most interesting observation from the above study was that the 
presence of two widely separated kB motifs (-7Ibp and +2.5kbp) was not enough 
to generate enhancer activity, although the precise spacing requirement for the 
functional interaction of the two sites was not determined. Tlie reciprocal 
experiment - that the kB motif enhancer element could also function as a
1 0
promoter element was demonstrated via transfection studies using a mouse 
B-globin gene and TATA-box with and without the insertion of a kB site 26bp 
upstream of the TATA-box : transfection into tlie S I94 mouse myeloma and 3T3 
fibroblast cell lines revealed that the globin gene was transcribed only in lymphoid 
cells and was dependent on tlie presence of the kB site (Wirth and Baltimore, 
1988). Moving the site of insertion of the kB motif to approximately 200bp 
upstream of the TATA-box resulted in transcription levels falling to baseline 
values - suggesting that the kB site positioned 26bp upstream of the TATA-box 
was supplying promoter rather than enhancer function.
The implication of these early results was that the induction of NF-kB activity 
might be the key event for the activation of immunoglobulin light chain gene 
expression. However more recent studies have suggested a more complex picture. 
Firstly, more recent studies identifying ininiunglobulin X light chain gene 
enhancer regions (Hagman et al., 1990) have suggested that in the mouse X locus 
there are two active transcriptional enhancers, 90% similar, both lacking 
functional kB sites.
Other studies of k light chain gene expression demonstrated that while the 
activation and binding of NF-KB to kB sites was necessary for LPS induced K 
gene transcription it was not sufficient as treatment of 70Z/3 pre-B-cells with 
transforming growth factor-B (TGF-B), a potent inhibitor of B-cell 
lymphopoiesis, inhibited LPS-induced k gene transcription but not the activation 
and in vitro binding activity of NF-kB (Briskin et al., 1988). Most interestingly, 
tlie induction of 70Z/3 cell k gene transcription by interferon-y (IFN-y) was not 
inhibited by TGF-B, nor was NF-kB activated during interferon-y induction -
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results which were confirmed by another group who noted that while IFN-y was 
completely inactive in mobilising NF-kB activity, it was a potent activator of 
protein kinase C in 70Z/3 pre-B-cells (Bomsztyk et aL, 1991).
Furtlier evidence indicating the complexity of the control of k light chain gene 
transcription was tlie obseiwation that the endogenous K light chain gene could still 
be expressed at high levels in certain myeloma cell lines which posessed little 
active NF-kB (Atchison and Perry, 1987). Thus the K gene large intron enhancer 
was found to be inoperative (and NF-kB activity absent) in both the plasmacytoma 
S I07 cell line and the pre-B-cell line 3-1 - whereas the S I07 plasmacytoma 
produced normal levels of k gene mRNA, despite its inactive enliancer. Another 
interesting obsei'vation from this study was tliat transfection and stable integration 
of exogenous k genes into the plasmacytoma cell lines S I94 (which shows high 
levels of NF-kB activity) and S 107 (which shows little or no active NF-kB) 
showed that these exogenous k genes were expressed only in the S I94 cells. These 
results led to suggestions that while establisliment of k gene large intron enhancer 
activity was absolutely dependent on the presence of active NF-kB, the 
requirement was only transient - either k gene large intron enhancer function was 
only required transiently for establishment of k gene transcription, or that the 
enliancer continued to function but with no requirement for NF-kB activity.
Tliese rather peiplexing results were supported by studies of a cell line which 
continued to produce immunoglobulin transcripts after a spontaneous deletion of 
the heavy chain enhancer (Klein et aL, 1985), leading to two possible explanations 
- either an as yet unidentified enhancer element substituted for the deleted heavy 
chain enliancer, or that the enliancer somehow organised the DNA into a stable
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transcription complex, after which it was no longer required - the authors 
favouring the latter choice. The mechanisms by which this transcriptionally active 
state might be maintained were unclear but might involve possibilities such as the 
déméthylation of 5-methylcytosine bases or the establishment of a more open 
chromatin configuration.
However, there were several pieces of evidence against this postulated transient 
requirement for the enhancer - for example NF-kB activity was only rarely absent 
in mature B-cells (Sen and Baltimore, 1986a). Further, a study of [i heavy chain 
immunoglobulin gene transcription (Grosschedl and Marx, 1988) demonstrated 
that the p heavy chain gene enliancer (normally located in the intron between the 
rearranged VDJ variable and Cp constant region) was necessary for the 
establisliment of an active transcriptional state during normal B-cell 
differentiation. However, a p gene construct containing this enhancer, flanked by 
D and Jh recombination signals, when transfected and stably integrated at various 
chromosomal locations in the murine pre-B-cell line PD31, then allowed to 
undergo site-specific deletion of the p  enhancer showed that those cell clones 
which had deleted the enhancer from the p gene constmct no longer transcribed 
the p  gene construct. Further, the deletion inactivation occurred even though the p 
gene had undergone hypomethylation before enhancer deletion - leading to the 
conclusion that the enhancer did not confer any sort of memory to the p gene of 
its previously transcriptionally active state. Hence for the p heavy chain gene this 
enliancer sequence was necessary both for the establishment and maintenance of p 
gene transcription.
The above confusion about the roles of the immunoglobulin k light chain and p
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heavy chain gene enhancers was at least partially resolved by the discovery that 
both the K light chain and p  heavy chain genes had additional enhancer elements at 
large distances downstream of the constant regions. Thus the k light chain gene 
was shown to have a second enliancer region, located approximately 4kbp 3’ of the 
previously characterised enliancer in the large (Jk-Ck) intron. Further, this 
enhancer element was significantly more active than the relatively weak k gene 
intronic enhancer - 7-fold stronger in transient transfection assays of MPCl 1 
myeloma cells (Meyer and Neuberger, 1989).
Tlie omission of this 3' enhancer led to 20-40-fold lower expression of k 
transgenes, while transfection experiments showed that the 3' enhancer, like the k 
intronic enhancer, could be induced by treating the 70Z/3 pre-B-cell line with 
LPS. While LPS induction of intronic enhancer activity was mediated via the 
induction of NF-kB activity, deletion mapping studies of the LPS-responsive 
region in the 3' enliancer identified a 50bp region lacking any kB sites - 
supporting the obsei'vation that the 3' enhancer allowed K gene transcription in the 
absence of active NF-kB (Meyer et al., 1990). It follows that both the k intronic 
and 3' enliancers can be induced by the same agent, in cells at the same stage of 
differentiation, but by distinct pathways. A similar situation was demonstrated in 
the rat immunoglobulin heavy chain (IgH) locus - this led to the identification of a 
strong B-cell-specific enliancer at the 3' end of the rat IgH locus (Pettersson et al., 
1990).
Although NF-kB was initially characterised as being constitutively present in 
the B-cell nucleus, there may be variations in the degree of activation of the 
factor. Thus, in studies of human B-interferon promoter regulation (Visvanathan
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and Goodboum, 1989) whole cell extracts of the Daudi B-cell line (which 
transcribe the k light chain gene) contained detectable NF-kB DNA binding 
activity as would be expected, however, deoxycholate/NP40 detergent treatment of 
tliese extracts resulted in the release of significantly greater amounts of NF-kB 
activity. Similarly, in a study of resting murine primary B-cells (Liu et al., 1991) 
it was shown that although nuclear extracts contained significant amounts of 
KB-binding activity, the treatment of cytosolic fractions with deoxycholate/NP40 
revealed tlie presence of comparable amounts of KB-binding activity. Most 
interestingly, kB binding activity was induced after the cross-linking of surface 
immunoglobulin receptor, and this anti-Ig-induced activity was superinduced in 
the presence of cycloheximide - indicating tliat induction of NF-kB activity is a 
normal result of B-cell stimulation and may play a role in mature B-cell function 
in addition to its postulated role in k light chain gene expression in B-cell 
development.
Factors binding to KB-like motifs have been implicated in the transcriptional 
activation of a variety of other genes - including :- MHC class I and B2 
microglobulin genes (Yano et al., 1987; Baldwin and Sharp, 1988), genes 
encoding MHC class II and its invariant chain li (Blanar et al., 1989; Pessara and 
Koch, 1990; Zhu and Jones, 1990). Such obsei'vations suggest that the role of 
NF-kB in B-cells may be as a wide-ranging activator of gene transcription 
responding to a range of extracellular signals. However, two major questions are 
posed by the study of NF-kB in B-cells - firstly, if NF-kB can induce the 
transcription of many different genes in different cell lineages, what mechanism 
restricts its transcriptional activation to only a subset of those genes in B-cells,
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secondly, what mechanism allows the constitutive activity of NF-kB in mature 
B-cells, but not in (most) other cell types.
One potential mechanism to restrict the response of certain genes to NF-KB to 
B-cells only was revealed by a study of the immunoglobulin k light chain gene 
intronic enhancer (Pierce et al., 1991) this suggested that part of this specificity 
for the K chain gene to be expressed only in B-cells lay in an orientation and 
distance-independent silencer element located in a 232bp restriction fragment 5’ of 
the intronic enliancer kB site. Tlie addition of this silencer element upstream of an 
active kB site in reporter plasmids transfected into activated Jurkat T-cells caused 
a 10-fold decrease in transcription relative to a construct with a kB site alone, 
whereas the presence of this sequence had no effect on levels of transcription in 
the S I94 myeloma cell line.
Tlie idea that constitutive NF-kB activity is found in mature B-cells but not in 
other cell types may not be entirely tme as some evidence exists that NF-KB 
activity is constitutively present in some T-cell lines (Baeuerle et al., 1988; 
Bôlinlein et al., 1988; Leung and Nabel, 1988; Cross et al., 1989; Lin et al., 1990) 
and also seems to be present constitutively in mature monocytes and macrophages 
(Griffin et al,, 1989). The mechanism giving rise to constitutive NF-kB activity in 
any particular cell lineage is still uncertain. However, one obvious possibility for 
ensuring constitutive NF-kB activity would be a modulation of the activity of a 
labile inhibitor protein, either by control of the level of its expression, or by 
control of the rate of its inactivation.
H ie versatility of the role of NF-kB in inducible gene transcription is illustrated 
by the peiplexingly large number of agents which can upregulate levels of NF-kB
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DNA binding activity in the nucleus. Unlike transcription factors such as steroid 
receptors which respond to a limited number of inducers, NF-kB DNA binding 
activity can be activated by agents such as bacterial lipopolysaccharide (Sen and 
Baltimore, 1986b), protein synthesis inhibitors such as cycloheximide and 
anisomycin (Sen and Baltimore, 1986b; Liu et al., 1991), active phorbol esters 
(Sen and Baltimore, 1986b; Liu et al., 1991; Griffin et al., 1989), anti-IgM 
antibodies (Liu et al., 1991), the Human T-cell Leukaemia Virus Type-I (HTLV-I) 
tax protein (Mauxion et al., 1991; Leung and Nabel, 1988) and by double stranded 
RNA (Visvanathan and Goodboum, 1989).
Other agents which can induce active NF-kB include tumour necrosis factor-a 
(Griffin et al., 1989; Pessara and Koch, 1990; Osborn et al., 1989), tumour 
necrosis factor-B (lymphotoxin) (Hohmann et al., 1990), interleukin-1 (Osborn et 
al., 1989; Zhang et al., 1990), the mitogenic lectin phytohaemagglutinin (Sen and 
Baltimore, 1986b; Libermann and Baltimore, 1990), anti-CD3 antibody (Jamieson 
et al., 1991), antigen (Kang et al., 1992; Jamieson et al., 1991), cyclic adenosine 
5'-3' monophosphate (Shirakawa et al., 1989), ultraviolet light (Stein et al., 1989), 
hydrogen peroxide (Schreck et al., 1991), semm (Baldwin et a l, 1991), okadaic 
acid (Thevenin et a l, 1990), hepatitis B virus (Faktor and Shaul, 1990), and 
human heipes virus-6 (Ensoli et a l, 1989) - the above list of NF-kB-inducing 
agents is by no means exhaustive.
The number of different signals and the different sites of their action in the cell 
suggests that the induction of NF-kB DNA binding activity may play some central 
integrating role in deteimining the state of cellular activation. While all of the 
above inducing agents cause the appearance of NF-kB DNA binding activity, there
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are significant differences in the time courses of the inductions - thus early studies 
demonstrated that induction of 70Z/3 cells by PM A caused maximum xB-binding 
activity to appear by 30 minutes (Sen and Baltimore, 1986b) with significant 
induction being present much earlier, and the xB-binding activity decaying 
relatively quickly after 2-3 hours. In contrast, induction of 70Z/3 cells by LPS 
caused maximum activity to appear at 2 hours post-treatment, and significant 
activity still to be present 8 hours after LPS addition. Later studies of induction of 
NF-kB DNA binding activity by tumour necrosis factors-a and -B (TNF-a, -B) 
showed NF-kB activity detectable within 2 minutes and maximal after 10-15 
minutes (Hohmann et al., 1990). Further, studies of 70Z/3 cells demonstrated that 
NF-kB activity could be detected in nuclear extracts within 15 minutes after 
treatment with IL-1 (Shirakawa et al., 1989).
The rapid response to stimuli mediated by NF-icB seems to be due to the lack of 
any requirement for new protein synthesis in the generation of the active 
transcription factor, coupled with the probable involvement of cellular kinases in 
inactivating labile inhibitor proteins. However, it should be noted that these 
control features may not be unique to NF-KB (and related) proteins - for example 
a labile inliibitor protein is responsible for the cytoplasmic retention of the c-fos 
(and possibly the c-jun) protein in serum-starved fibroblasts (Roux et al., 1990) - 
a situation with intriguing parallels to NF-kB activation.
Although the actual mechanisms involved in the activation of NF-kB by the 
large number of inducers listed previously are uncertain, it seems possible that 
many, or all of them, may act through a common mechanism involving the 
generation of reactive oxygen species such as hydrogen peroxide, superoxide
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anion, and hydroxyl radicals. Such a possibility was initially raised by 
obseiTations that the treatment of cells with the antioxidant scavenger molecule 
N-acetyl-L-cysteine (NAC) resulted in potent inhibition of PMA- and 
TNF-a-induced transcriptional activation from the HIV-1 long terminal repeat 
(LTR) (Roederer et al., 1990), further, that this effect was mediated specifically 
through blocking the activation of NF-kB (Staal et al., 1990).
Subsequent studies demonstrated that micromolar concentrations of hydrogen 
peroxide could induce transcriptional activation of the HIV-1 LTR in the human 
Jurkat T-cell line (Schreck et al., 1991) - this effect being mediated by NF-kB 
induction. It was further shown that by pre-incubating several cell lines with 
30mM NAC, the activation of NF-kB by a wide range of inducers (such as 
hydrogen peroxide, tumour necrosis factor a , interleukin-1, double-stranded 
RNA, LPS, PMA, cycloheximide, and calcium ionophore) could be blocked. 
These studies were recently extended to the activation of NF-kB by truncated 
forms of the hepatitis B virus middle surface antigen and the hepatitis B virus X 
protein - both of these protein species were shown to mobilise NF-icB and induce 
kB -directed gene expression by a mechanism which depended on the prooxidant 
state of the cell. In both cases this activation process could be blocked by 
antioxidant species such as NAC and pyrrolidine dithiocarbamate (Meyer et al.,
1992).
As the hepatitis B virus X protein is known to transactivate genes via cis-acting 
elements binding inducible transcription factors such as NF-kB, AP-1, AP-2, 
CREB/ATF and C/EBP it is tempting to speculate that some or all of these 
inducible factors may be regulated in a similar manner to NF-KB. Some evidence
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in favour of such a scheme is provided by obsewations from HeLa cells that the 
activity of factors binding to kB and AP-1 sites is inducible by ultraviolet 
irradiation (Stein et al., 1989). Although it should be noted that the study by 
Schreck et al. (1991) did not detect any induction of AP-1-specific DNA binding 
activity in Jurkat T-cells treated with hydrogen peroxide, in contrast to the clear 
induction obsei'ved for kB-specific DNA binding activity - whether this reflects 
some cell-type specific difference is as yet unclear. Wliile nothing is known about 
tlie nature of the steps following the generation of the prooxidant state by the 
various inducers of kB -specific DNA binding activity, one attractive proposal 
(Schreck et al., 1991) was the stimulation of protease activity by reactive oxygen 
species resulting in the release of NF-kB from its labile inhibitor protein.
Another interesting recent development is of the possibility that protein 
modifications such as méthylation and isoprenylation may prove to be important 
events in the induction of NF-kB DNA-binding activity by LPS but not for 
induction by PMA (Law et al., 1992). This study demonstrated that treatment of 
70Z/3 pre-B-cells with the S-adenosylmethionine-dependent méthylation inhibitor 
5‘-methylthioadenosine blocked the LPS induced activation of kB DNA binding 
activity and immunoglobulin k light chain gene expression. The same two events 
were also blocked by treatment with the protein isoprenylation inhibitor 
mevinolin - while neitlier of these treatments significantly inhibited activation of 
kB DNA binding activity by PMA.
The implication that carboxyl methylated and/or isoprenylated proteins play 
some essential role in the LPS-mediated NF-kB activation pathway is paralleled by 
a number of other examples of proteins involved in cellular responses to
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extracellular signals being modified by lipidation and methyl estérification. Thus, 
tlie protooncogene product p2U^^ and other low molecular weight guanosine 5' 
triphosphate (GTP)-binding proteins, the nuclear lamins, and the y  subunit of the 
heterotrimeric G proteins are all known to be prenylated species (Reviewed in 
Sinensky and Lutz, 1992). Interestingly, kB DNA-binding activity in crude 
nuclear extracts of murine pre-B and human T-cells has been shown to be 
dramatically stimulated by the addition of GTP to 3mM (ATP addition was much 
less effective as a stimulant) (Lenardo et al., 1988), a similar but much less 
dramatic stimulation was seen with GTP addition to affinity purified xB-binding 
species isolated from HeLa cells (Clark et al., 1990). Tlie meaning of the above 
obseivations is unclear at the moment but one possibility might be association at, 
or close to, the plasma membrane of a prenylated protein with NF-kB - all known 
prenylated proteins are at least partially localised to cell membranes.
Tlie preceding sections have concentrated on the activation of NF-kB and 
subsequent transcriptional activation - however, some mechanisms for attenuating 
the response of NF-kB -induced gene transcription must exist. Such mechanisms 
include purely passive events such as dissociation of NF-kB from its cognate 
binding site due to the inherent "off-rate" of the DNA-protein complex. However, 
even events such as this may be under some degree of control - although the 
preformed complex of native, affinity purified NF-kB and its cognate kB site has 
been shown to be relatively stable towards challenge with unlabelled kB motif 
oligonucleotide, with a half-life of approximately 45 minutes (Zabel and Baeuerle, 
1990) it is clear that dissociation rate constants for the DNA-protein complex are 
much larger in the presence of the naturally-occurring polyamine spermidine
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(Results, Chapter 3). As the concentration of spermidine and other cellular 
polyamines are tightly regulated to the eukaryotic cell cycle (Reviewed in Tabor 
and Tabor, 1984), this mechanism offers obvious possibilities for the control of 
binding of transcription factors. Once NF-xB is no longer bound to its recognition 
site, it is possible that intranuclear inhibitor proteins could form complexes with 
tlie NF-kB to prevent it re-binding to kB motifs. A more active role for inhibitor 
proteins has been suggested by studies demonstrating that two forms of the NF-kB 
inliibitor protein IkB (Baeuerle and Baltimore, 1988a,b) (IxB-a, and -13) could 
reduce the half-life of native (p50-p65) NF-kB-kB motif DNA complex with 
respect to dissociation to 3 and 7 minutes respectively, by a mechanism involving 
more that one IkB molecule (Zabel and Baeuerle, 1990).
2.2. Cellular genes activated by NF-kB
The target cellular genes which NF-kB activates seem to share one property in 
that they are all quickly transcriptionally induced in response to extracellular 
stimuli. As discussed before, a very wide range of agents can cause the induction 
of NF-kB DNA-binding activity, hence the role of NF-kB may simply be to 
transmit a rapid signal to the nucleus that the cell is undergoing some 
inflammatory, immune, or acute phase challenge. Although NF-kB seems to be 
ubiquitously present in all cell types its behaviour has been most thoroughly 
characterised in the cells of the immune system - notably lymphocytes, 
macrophages and monocytes. The majority of the target genes for NF-kB 
transcriptional activation can be divided into three classes (i) genes encoding 
immunomodulatory cytokines such as TNF-a, J3-interferon, and interleukin-6
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(IL-6); (ii) genes encoding immunoregulatory cell surface receptors such as MHC 
class I antigens, the interleukin-2 (IL-2) cytokine receptor, and the 
non-polymoiphic MHC subunits; (iii) genes encoding acute phase proteins such as 
angiotensin and semm amyloid A precursor.
One very important subset within the large range of genes which are 
transcriptionally controlled by NF-kB are those induced during the T-cell 
activation process. Over 70 genes are transcribed in T lymphocytes upon 
interaction of the T lymphocyte antigen receptor with antigen in the proper 
histocompatibility context (Reviewed in Crabtree, 1989). NF-kB in cooperation 
with other transcriptional regulator proteins (both activators and repressors) 
seems to be involved in the expression of many genes - especially those induced 
during the early phases of the response to T-cell receptor stimulation (Jamieson et 
al., 1991; Lenardo and Baltimore, 1989). Thus for example, virtually all of the 
cytokine genes whose expression is induced by T-cell activation are detected in 
early stages of activation - i.e. requiring protein synthesis, but being expressed 
before cellular DNA replication and cell division (Crabtree, 1989).
Cytokine gene expression can provide an easily assay able model system for 
studies of the role of NF-kB in early T-cell activation processes. The most 
thoroughly studied examples of T-cell cytokine gene regulation, the genes 
encoding IL-2 and the a  chain of the IL-2 receptor demonstrates that NF-kB plays 
only one part in the transcriptional activation process.
In the case of tlie IL-2 gene, the 300bp promoter/enliancer region immediately 
upstream of the transcriptional start site has a strong response towards T-cell 
activation signals (Fujita et al., 1986; Novak et a l, 1990). This promoter/enhancer
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region contains binding sites for NF-kB, and other transcription factors such as 
NF-AT, the octamer proteins, the fos-jun AP-1 complex, and in human cells, a 
CD-28-responsive complex (Lenardo et ah, 1988; Hoyos et ah, 1989; Durand et 
ah, 1988). Deletion studies have suggested that several of the trans-acting factor 
binding sites must be occupied to allow the full activity of the IL-2 gene 
promoter/enhancer (Durand et ah, 1988; Hoyos et ah, 1989) - thus mutation of the 
kB motif in the IL-2 promoter (located at positions -206 to -195) resulted in only 
a partial inhibition of mitogen and HTLV-1 tax protein-mediated transcriptional 
activation. While certain of the trans-acting factors involved in binding to the IL-2 
promoter/enhancer are tissue-specific (NF-AT), others such as NF-kB and AP-1 
are not - hence it seems likely that a variety of transcription factors are 
simultaneously necessary for transcriptional activation of the IL-2 gene.
Some studies have suggested rather paradoxically that in certain cell lines the 
IL-2 promoter/enhancer kB motif may function in a tissue-specific manner 
(Radler-Pohl et ah, 1990; Briegel et ah, 1991), As has been hinted up to this point 
the p50-p65 heterodimeric NF-kB is but one member of a family of proteins - 
these all share a highly consei^ved N-temiinal region which is responsible for 
DNA-binding and dimérisation functions (Kieran et ah, 1990; Ghosh et al 1990; 
Nolan et ah, 1991) - as will be discussed later, this presents a wide range of 
possibilities for transcriptional control by binding to kB motifs. An interesting 
recent study of non-transformed murine T-cell clones has suggested that more 
than one protein species of the NF-icB family is important in binding to the IL-2 
gene kB site (Kang et ah, 1992). The authors proposed that DNA-protein 
complexes involving a p50 subunit homodimer with tlie IL-2 gene kB site were
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present in unstimulated, nontransformed CD4+ T-cells, and that this p50 
homodimer bound more tightly to the IL-2 gene kB motif than to the 
immunoglobulin/liuman immunodeficiency virus type-1 enhancer type of kB 
motif. Interestingly, although the amount of DNA-protein complex in 
nontransformed CD4+ T-cells involving the NF-kB p50-p65 heterodimer was 
increased by the addition of antigen presenting cells (APC), by antigen plus APC, 
or the immunosuppressant cyclosporin A, the amount of DNA-protein complex 
involving tlie p50 homodimer was only decreased after full antigenic stimulation. 
Further, those activation signals which led to the loss of the p50 honiodimer 
complex resulted in IL-2 gene transcription, whereas treatments which resulted in 
increases in the activities of the p50-p65 NF-kB heterodimer or NF-AT in the 
nucleus but did not result in loss of the p50 honiodimer-IL-2 gene kB motif 
complex failed to induce IL-2 gene expression.
It was proposed that this loss of DNA-protein complex corresponding to the p50 
honiodimer might be due to the formation of a complex of p50 honiodimer within 
the nucleus with a newly synthesised inhibitory protein whose synthesis was tightly 
linked to the process of antigen stimulation, and whose synthesis was blocked by 
cyclosporin A treatment (Kang et al., 1992). These proposals allow a satisfying 
explanation of some puzzling aspects of T-cell activation - in this scheme the 
p50-p65 NF-kB heterodimer can be activated in nontransfomied T-cells in 
response to a variety of signals such as APC, antigen plus APC, cyclosporin A, the 
protein synthesis inhibitor anisomycin, iononiycin, and ionomycin plus PMA - but 
not by PMA alone. In contrast the amount of p50 honiodinier-IL-2 gene kB motif 
complex can only be decreased after full antigenic stimulation of the
25
nontransformed T-cell.
The above model can thus account for the fact that stimulation of 
nontransfonned T-cells with anti-CD3e antibody does not activate transcription 
via the IL-2 kB motif (Jain et al., 1992). Wliile the induction of NF-kB 
DNA-binding activity is only weakly blocked by cyclosporin A at physiological 
doses, it is possible that other mitogen-induced complexes binding to kB sites may 
be sensitive to this drug (Randak et al., 1990; Schmidt et al., 1990).
Studies of the transcriptional activation of the gene encoding the a  chain of the 
IL-2 receptor (IL-2R) have revealed the importance of a kB motif in its promoter 
also. The inducible cell surface expression of the 55kD a  chain is critical for the 
formation (as a complex with the constitutively expressed 13 chain) of the high 
affinity form of the IL-2 receptor - allowing T-cells to respond to this growth 
factor during their response to antigen.
Several groups have demonstrated that the p50-p65 NF-kB heterodimer or a 
closely related species is responsible for transducing T-cell activation signals into 
increased transcriptional activity from die IL-2R promoter (Leung and Nabel, 
1988; Bohnlein et al., 1988; Cross et al., 1989; Lin et al., 1990). The activation of 
the IL2R promoter by the tax trans activator protein of HTLV-I or TNF-a has 
also been shown to be mediated via NF-kB (Cross et al., 1989; Siekevitz et al., 
1987a; Ruben et al., 1988; Lowenthal et al., 1989). In contrast, phorbol ester 
inducibility of the IL-2R promoter is mediated by another sequence which does 
not involve the kB binding site (Ballard et al., 1989; Lin et al., 1990). The kB site 
in the IL-2R promoter is a relatively low affinity one, and shows a poorer 
response in transactivation experiments than do other kB motifs (Shibuya et al.,
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1989). However, recent observations that tlie activity of the kB motif in T-cells is 
mediated by cooperation between NF-kB and serum response factor (SRF) and 
other trans-acting factors such as Spl (Ballard et al., 1989; Pomerantz et al.,
1989; Roman et al., 1990) may well compensate for the lower affinity of NF-kB 
for the IL-2R kB motif.
In addition to the above two examples, a variety of cytokines produced by 
activated T cells appear to involve NF-kB in their transcriptional control :- 
interleukin-6 (IL-6) - which stimulates B cells to proliferate, differentiate, and 
secrete antibody (Libermann and Baltimore, 1990); granulocyte-macrophage 
colony stimulating factor (GM-CSF) - which sustains the proliferation of bone 
marrow precursor cells for macrophages and granulocytes (Schreck and Baeuerle,
1990); the inflammatory mediators tumour necrosis factors-a and -B (TNF-a and 
-B) (Collart et al., 1990; Drouet et al., 1991), and the neuropeptide precursor 
proenkephalin (Rattner et al., 1991). In the case of TNF-a and -B these cytokines 
are also potent inducers of NF-kB DNA binding activity - leading to proposals 
that some type of feedback amplification might be initiated in response to antigen.
As indicated before, KB-binding trans-acting factors are also involved in the 
transcriptional activation of a number of genes expressed in inflammatory and 
acute phase processes. Certain cytokines which are primarily derived from 
non-lymphocytic leukocytes are also transcriptionally controlled by NF-kB - these 
include TNF-a and IL-6 which are expressed primarily in monocytes but also by 
T-cells (Collart et al., 1990; Libermann and Baltimore, 1990) and the chemotactic 
factor EL-8 which is responsible for neutrophil recruitment into inflammatory 
sites (Mukaida et al., 1990). Tlie involvement of NF-kB in B-inteiferon gene
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expression was initially reported by Visvanathan and Goodboum (1989), with the 
obseiTation that transfection of cell lines with double stranded RNA could induce 
a DNA-binding activity with identical characteristics to those of NF-kB - tliis 
raised tlie possibility that multiple protein kinases, including the double stranded 
RNA stimulated Dl-kinase might release NF-kB from IkB and iKB-like inliibitor 
proteins. As the B-interferon gene can be induced in virtually all cell types, it may 
be tliat the involvement of NF-kB in gene transcription regulation is more 
widespread than previously suspected.
It seems that another inflammatory response involving NF-kB -mediated gene 
transcription is the acute phase of hepatocytes (Edbrooke et ah, 1989). During this 
process, various cytokines (IL-1, IL-6 and TNF-a) acting at the liver cell 
membrane and steroid homiones result in changes in the expression of particular 
genes - NF-kB is the mediator for the elevated expression of the genes encoding 
semm amyloids A2B and A1 - serum amyloid A2B being a precursor to the 
amyloid A subunits of amyloid fibrils. Other acute phase genes such as those 
encoding angiotensinogen - a precursor to the hormone angiotensin II - and 
a 1-acid glycoprotein - a non-specific immunosuppressant - are also 
transcriptionally controlled by NF-kB or a related KB-binding species (Ron et ah, 
1990; Brasier et al., 1990). Further hepatocyte genes apparently regulated by 
NF-kB, and which can be loosely grouped with immune/inflammatory genes, are 
those for complement factor 4 (Yu et al., 1989) and the factor B protease (Nonaka 
and Huang, 1990),
Although only peripheral to the above discussion, evidence is accumulating of a 
direct involvement of NF-kB in the control of cell growth - it has been proposed
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that by binding to a site in the first exon of the c-myc gene transcript, NF-kB 
could relieve a transcriptional block by interrupting a stable stem-loop structure 
in tliis region of the transcript which seems to halt transcriptional elongation by 
RNA polymerase II (Duyao et al., 1990). Another example is the induction of a 
binding complex resembling NF-kB in BALB/c 3T3 cells following serum 
stimulation (Baldwin et al., 1991). Taken together, these reports suggest that 
NF-kB may play some central regulatoiy role in genes involved in cell growth in 
both lymphocytes and non-lymphoid cells.
2.3. NF-kB and viruses
In addition to the important role KB-binding proteins play in regulating the 
transcription of cellular genes, they also have important roles in the 
transcriptional regulation of many viruses. Most attention has been focused on two 
retroviruses which can infect human T-cells - the human immunodeficiency 
viruses (HIV-1, HIV-2) and human T-cell leukaemia virus type I (HTLV-I), 
However, NF-kB is also important for the transcriptional control of a number of 
other virus types;- adenovimses, simian virus 40 (SV40), herpesvirus types 1 and 
6, cytomegalovinis, and hepatitis B virus.
The role of NF-kB in controlling transcription from the long terminal repeat 
(LTR) of the integrated, proviral form of human immunodeficiency virus type 1 
(HFV-l) was intially established by Nabel and Baltimore (1987) with the 
demonstration of a correlation between increases in NF-kB DNA-binding activity 
and the transcriptional activity of the HIV-1 LTR in transient transfection 
experiments following T-cell activation. Deletion analysis of the HIV-1 LTR 
suggested that a strong transcriptional enliancer within the LTR was localised at a
29
nucleotide sequence containing two direct repeats of the immunoglobulin k chain 
gene kB site (Muesing et al., 1987). Most isolates of HIV-1 have two functional 
kB sites (as does simian immunodeficiency virus), in contrast in HIV-2 only one 
functional kB site remains in the LTR (Dewhurst et ah, 1990; Anderson and 
Clements, 1991).
One characteristic feature of infection by lentiviruses such as HIV-1 and -2 is 
the slow pattern of disease progression (Cullen and Greene, 1989) with symptoms 
appearing many months or even years after the initial infection. This delay in 
frank viral pathogenesis may be due to the infection of only a small population of 
T-cells, with the HIV provims remaining in a quiescent state. Upon activation of 
latently infected T-cells by full antigenic stimulation, the increased transcriptional 
activity of the LTR as a consequence of activation of NF-KB/rel family members 
(presumably the p50-p65 NF-kB heterodimer - Kang et al., 1992) could result in 
the generation of viral transcripts and production of progeny virus (Nabel and 
Baltimore, 1987; Tong-Starksen et al., 1989). Other inducers of active NF-kB, 
such as TNF-a and IL-1 may also be able to increase vims production (Folks et 
al., 1989; Osborn et al., 1989).
Tlie experimentally-observed correlation between the induction of NF-kB DNA 
binding activity and transcriptional activation from the LTR has received much 
support - many studies have shown that the induction of active NF-kB in T-cells 
or monocytes resulted in increased transcriptional activity from the LTR (Nabel 
and Baltimore, 1987; Garcia et al., 1987; Franza et al., 1987; Griffin et al., 1989; 
Berkliout and Jeang, 1992). Further, the ability to activate transcription from the 
LTR is not restricted to cell types such as CD4'*' T-cells and monocytes which
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normally exhibit productive infection but seems to be dependent on the availability 
of NF-KB or NF-KB-like transcriptional activators (Toyama et al., 1992). Thus if 
the LTR is tested in B-cells, NF-kB activity results in strong transcriptional 
activation, and B-cells artificially expressing the CD4 viral receptor allow 
reasonably efficient viral replication (Caiman et al., 1988). In contrast, T-cells 
which do not express the NF-kB p50-p65 heterodimer have restricted HIV 
expression (Raziuddin et al., 1991).
Many of the above studies on transcriptional control of the HIV LTR were 
performed using transient transfections with reporter gene plasmid constructs - 
such systems may differ in their behaviour compared to the chromatin context of 
the integrated provirus. Hence it is also necessary to assay the replicative ability of 
HIV after mutation of various protein-binding motifs in the LTR to allow a tme 
assessment of their importance in the vims life cycle in vivo.
Studies of HIV replication in response to cytokine treatment have shown an 
association between the induction of NF-kB binding activity and transcriptional 
activation of the provims. One such in vivo study showed that vimses with 
deletions of both kB motifs were still able to replicate in MT-4 cells (Leonard et 
al., 1989). Further studies showed that the two NF-kB sites and three Spl sites 
were functionally redundant and not all required for viral infectivity, 
interestingly, mutation of these sites seemed to alter the cell types which were 
permissive for viral replication, as well as changing the replicative and cytopathic 
properties of HIV-1 (Ross et al., 1991; Englund et al., 1991; Parrott et al., 1991). 
Tliese functional redundancies contrast with the complete loss of viral replication 
activity seen with mutations of the TAR region (Leonard et al., 1989). The
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situation is further complicated by obsei'vations that some treatments which act as 
specific inducers of NF-kB activity can only induce viral replication in certain cell 
types - thus TNF-a can induce viral replication in some T-cell lines, but not in 
otliers. Wliile LPS treatment can stimulate HIV production in 
monocyte/macrophage cell lines but not in T-cells (Matsuyama et al., 1989; 
Pomerantz et al., 1990).
Recent studies of transcriptional control of the HIV LTR have identified 
transcriptional activation mechanisms which are independent of the NF-kB 
p50-p65 heterodimer. An 86kD protein (HIVEN 8 6A) has been identified as 
interacting strongly with the HIV enhancer - this species is now believed to be the 
c-rel member of the NF-KB/rel/dorsal transcriptional modulator family (Franza et 
al., 1987; Ballard et al., 1990,1992) - recent studies have suggested that the c-rel 
protein may transcriptionally activate the LTR (Muchardt et al., 1992). Further, 
transcription from the LTR also seems to depend on factors binding to sequences 
outside the -80 to -105 enliancer region - such as the three Spl sites and the 
NF-AT site (Jones et al., 1986). Enhancer-independent inducible transcription 
from the HIV LTR has recently been suggested to involve other proteins binding 
in close proximity to the TATA box (Jones, 1989; Sakaguchi et al., 1991).
Other recent findings tend to reinforce a primary role for NF-kB in 
determining whether HIV enters a latent state or becomes transcriptionally active 
upon infecting a host cell (Nabel, 1991). Recent studies have demonstrated that 
HIV infection causes tlie induction of NF-kB DNA binding activity in monocytic 
cell lines which typically only have very low levels of NF-kB activity (Bachelerie 
et al., 1991; Suzan et al., 1991; Roulston et al., 1992). Such results tend to suggest
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that NF-kB is involved in a positive feedback loop which may contribute to 
maintaining a productive infection. One potential mechanism for mediating such 
an amplification was revealed by studies showing that the virally encoded protease 
could cleave the 105kD p50 precursor to generate the active DNA-binding p50 
subunit of NF-kB (Riviere et al., 1991). Hence HIV infection, by causing the 
induction of NF-kB DNA binding activity, seems to be able to alter the cellular 
environment to make it more favourable for viral replication.
The other major intensively studied retrovirus capable of infecting human 
T-cells with a role for NF-kB in its transcriptional control is human T-cell 
leukaemia vims type I (HTLV-I) - the causative agent of adult T-cell leukaemia 
(Wong-Staal et al., 1983). Although the molecular basis of oncogenesis by 
HTLV-I is not completely understood, one of the three proteins encoded by the 
pX region of the viral genome - the viral Tax protein - has been strongly 
implicated in this process (Nerenberg et al., 1987; Pozzatti et al., 1990). Tlie 
HTLV-I Tax protein is a transcriptional trans-activator but it does not bind DNA 
or stimulate the activity of cis-acting regulatory motifs directly. The effects of 
Tax seem to be independent of new protein synthesis (Jeang et al., 1988), and its 
activation signals to be transmitted through other transcription factors including 
NF-kB (Ballard et al., 1988; Leung and Nabel, 1988; Ruben et ah, 1988; Mauxion 
et al., 1991).
The Tax protein seems to be the only component of HTLV-I needed to induce 
NF-kB DNA binding activity (Arima et al., 1991; Lacoste et al., 1991). Possibly 
by activating factors such as NF-kB to allow transcription of genes involved in 
T-cell proliferation, HTLV-I infected cells would be more likely to undergo
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mutational events eventually causing outright transformation (Yoshida and Seiki, 
1987). Consistent with this hypothesis, the Tax protein of HTLV-I (and the 
transactivator protein of HTLV-II) activates genes involved in T-cell growth 
(Greene et al., 1986; Wano et al., 1988). Thus the transcription of both tlie IL-2 
and IL-2 receptor a  chain genes are stimulated by Tax-induced NF-kB (Inoue et 
al., 1986; Ballard et al., 1988; Leung and Nabel, 1988; Hoyos et al, 1989). Other 
genes which are characteristically expressed in T-cells following antigen 
stimulation and which are also thought to be upregulated by Tax-induced NF-kB 
include c-fos (Fujii et al., 1988), GM-CSF (Schreck and Baeuerle, 1990), 
interleukin-3 (Miyatake et ah, 1988), B-interferon (Leblanc et al., 1990), and 
lymphotoxin (tumour necrosis factor-B) (Paul et al., 1990) - tliese products then 
being able to contribute to the progress of neoplasia.
As might be expected, the HTLV-I Tax protein is a potent trans activator of the 
HTLV-I LTR (Sodroski et al., 1984; Felber et al., 1985; Seiki et al., 1986), but it 
also strongly transactivates the HIV-1 and SV40 viral enliancers (Bohnlein et al., 
1988; Bôlinlein et al., 1989; Marriott et al., 1990; Miyatake et al., 1988; 
Zimmerman et al., 1991) - hence the importance of HTLV-I infection as a 
cofactor in accelerating the progression of HIV infections towards AIDS. 
Interestingly, Tax trans activation of the HTLV-I LTR is dependent on a promoter 
region which binds factors such as CREB and jun in addition to NF-kB 
(Yoshiniura et al., 1990; Xu et al., 1990; Numata et al., 1991).
Recent progress has been made in understanding the mechanism of action of tlie 
Tax protein (Meyer et al., 1992). Initial studies of Tax localisation showed tliat it 
was primarily a nuclear protein (Goh et al., 1985; Kiyokawa et al., 1985).
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Unexpectedly, soluble Tax protein can be taken up by tissue culture cells, such that 
the protein is found in both nuclear and cytoplasmic compartments, and can 
induce NF-kB DNA binding activity (Lindhohn et al., 1990; 1992), The 
mechanism by which Tax protein increases NF-kB activity is still unclear, but it 
seems likely to involve to involve a prooxidant state-mediated release of NF-kB 
from iKB/ankyrin repeat inhibitor proteins (Meyer et al., 1992). This in turn is 
presumably followed by NF-kB binding to and upregulating the transcription of 
the gene encoding the p i05 precursor to the p50 NF-kB subunit (Ten et al., 1992) 
and conceivably, the genes encoding other NF-KB/rel family proteins.
Other viruses making use of NF-KB for stimulating their own transcription 
include cytomegalovirus, the cytomegalovirus a  (immediate-early) 
promoter-enhancer NF-kB sites were found to be important for transcription of 
the viral immediate early gene 1 (IE 1) (Nelson and Groudine, 1986; Ghazal et 
al., 1988). Interestingly, the protein encoded by the IE 1 gene has been shown to 
activate the binding of NF-kB, and so raises the possibility of the IE 1 protein 
regulating the expression of its own gene (Sambucetti et al., 1989). Wliile the 
cytomegalovirus IE 1 protein shares certain similarities with the HTLV-I Tax 
protein, in that it is a nuclear phosphoprotein, it is unclear whether it activates 
NF-kB by the same route.
Other members of the heipes virus family such as heipes simplex virus type 1 
and human herpes virus 6 also seem to be able to induce NF-kB DNA binding 
activity through virally encoded trans-activator proteins, and may be 
transcriptionally regulated by NF-kB (Gimble et ah, 1988; Ensoli et al., 1989; 
Martin et al., 1991). Again, coinfection with these viruses is likely to result in an
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acceleration of HIV infections towards AIDS through their ability to mobilise 
NF-kB.
Several other viral types employ activation of NF-kB to activate their 
transcriptional units - thus adenovirus type 5 transfoimed cells have high levels of 
nuclear NF-kB and show high levels of expression of B-interferon and MHC class 
I genes (Nielsch et al., 1991), further, binding of NF-kB has been implicated in 
the lymphoid-specific transcription of the adenovirus E3 promoter (Williams et 
al., 1990). NF-kB has also been implicated in lymphoid-specific transcription of 
the simian virus 40 (SV40) core enhancer (Kanno et ah, 1989; Phares and Herr,
1991). Other NF-kB-like factors identified as binding to viral transcriptional 
regulatory sequences include the HeLa cell protein EBPl, this was initially 
identified as an activity binding to the 'core' region of the SV40 enhancer, affinity 
purification of this protein yielded a species of 60kD size (Clark et ah, 1988). 
Extensive analysis of the DNA contacts made by the purified EBPl protein 
indicated that it made base and backbone contacts over one complete turn of the 
DNA double helix (Clark et al., 1989). The EBPl méthylation interference 
pattern on its binding site in the SV40 enhancer was clearly distinct from that of 
other factors such as H2TF1 (Baldwin and Shaip, 1988) and KBFl (Israel et al., 
1987). KBFl is now known to be identical to the NF-kB p50 subunit (Kieran et 
al., 1990), while EBPl seems likely from its méthylation interference and 
binding site competition behaviour to represent the p50-p65 form of NF-kB 
(Clark et al., 1988).
A final most interesting example of viral NF-kB mobilisation, bearing in mind 
its known relationship to retroviruses (Miller and Robinson, 1986), is that by the
36
hepatitis B vims - the virally-encoded X protein transactivator has been shown to 
stimulate transcription of the HIV LTR, the SV40 enhancer, and cellular genes 
such as MHC class I (Siddiqui et al., 1989; Twu and Robinson, 1989; Faktor and 
Shaul, 1990; Lucito and Schneider, 1992). Most interestingly, truncated forms of 
hepatitis B virus surface antigen proteins have also been shown to be able to 
function as NF-kB mobilising trans-activators (Meyer et al., 1992).
2.4. Identification and characterisation of NF-kB as a member of a 
multiprotein family
The inducibility of NF-kB DNA binding activity detected in early studies after 
pre-B-cell treatment with agents such as active phorbol esters and mitogenic 
lectins, and the superinducibility in the presence of protein synthesis inhibitors has 
already been noted. The question of the nature of these different forms of NF-kB 
was clarified by the description of a protein species, termed IkB, which acted as a 
highly specific and reversible inhibitor of NF-kB DNA binding activity (Baeuerle 
and Baltimore, 1988a,b; Baeuerle et al., 1988). The noncovalent association of a 
possibly labile inhibitor protein witli NF-kB in a cytoplasmic complex which 
could be dissociated by treatment with agents such as deoxycholate or formamide 
fitted with the observations of a superinduction of DNA binding activity in the 
presence of protein synthesis inhibitors. The observation that PMA induction 
reduced the amount of the cytoplasmic inactive form of NF-kB, and increased the 
amount of the active nuclear form led to the concept that inactive NF-kB 
complexed with IkB in the cytoplasm was initially freed from the inhibitor, then 
transported into the nucleus (Baeuerle and Baltimore, 1988b).
The initial attempts at purifying NF-kB suggested that the DNA binding activity
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was associated with proteins in the size range of 40 to 60kD (Kawakami et al., 
1988; Lenardo et al., 1988). Tlie above studies also demonstrated that NF-kB was 
a positive regulator of in vitro transcription, and that its DNA binding activity 
could be stimulated by nucleoside triphosphates (with GTP showing the highest 
stimulatory activity). More definitive biochemical analysis revealed that the factor 
giving rise to the NF-kB gel mobility shift complex actually contained two distinct 
polypeptide subunits of 50kD and 65kD molecular weight - termed p50 and p65 
respectively (Baeueiie and Baltimore, 1989). The p50 NF-kB subunit was initially 
identified as being the DNA-binding subunit of the complex, with p65 lacking 
DNA-binding activity - leading to the proposal that NF-icB comprised a 
heterotetramer, with two p50 subunits contacting each half site of the kB motif, 
with the p65 subunits performing auxiliary roles.
However, later studies demonstrated that tlie p65 subunit did indeed possess 
DNA-binding activity, allowing the reformulation of NF-kB as a p50-p65 
heterodimer (Urban and Baeuerle, 1990; Nolan et al., 1991; Urban et al., 1991). 
These studies demonstrated the ability of the p65 subunit to influence the DNA 
binding specificity of the p50-p65 heterodimer such that it preferentially bound to 
the immunoglobulin/HIV enliancer kB motif rather than the more symmetrical 
types of kB motif such as found in the H2 gene.
Significantly, both the p65 and p50 subunits can interact with, and be inhibited 
by, different species of IicB/anlcyrin repeat proteins - allowing the possibility of 
differential regulation of the DNA binding activity of related kB motif binding 
complexes (Kerr et al., 1991; Inoue et a l, 1992). As the p50-p65 NF-kB complex 
obtained from the nuclei of stimulated cells seemed to be biochemically
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identical to the complex obtained from the cytoplasm of unstimulated cells 
(Baeuerle et al., 1988) - for example complexes from either source could have 
tlieir DNA-binding activity inliibited by partially purified IkB. Tliis last 
observation tended to suggest that the induction of NF-kB activity was the result 
of some change in the IkB protein(s). Evidence in favour of this came from 
studies showing that treatment of cytoplasmic extracts with a variety of purified 
protein kinases - such as the cyclic AMP-dependent protein kinase, protein kinase 
C, and the haem-regulated eIF-2 kinase - resulted in the induction of NF-kB 
DNA-binding activity (Shirakawa and Mizel, 1989; Ghosh and Baltimore, 1990). 
Further, the same studies showed that phosphorylation of purified IkB protein(s) 
with either protein kinase C or haem-regulated eIF-2 kinase resulted in the loss of 
aU NF-kB inhibitory activity. However, treatment of purified IkB with cyclic 
AMP-dependent protein kinase had no effect on its inliibitory activity - suggesting 
that this kinase exerted its effects through an indirect mechanism (Ghosh and 
Baltimore, 1990), hi any case it seems clear that no single kinase activity is 
responsible for the induction of NF-kB DNA binding activity (see Introduction 
Chapter 2, Section 1). Although studies quoted up to this point have suggested that 
the inactivation of IkB inliibitory activity is mediated by phosphorylation, recent 
studies have suggested that dephosphorylation of (the B-fomi of) IkB may also 
stimulate its release from NF-kB (Hohmann et al., 1992; Link et al., 1992). Such 
results need not necessarily invalidate the model of phosphorylation of IkB 
causing its release from NF-kB - for example such events could be mediated 
through different sites.
Tlie initial biochemical characterisation of IkB isolated from human placental
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cytoplasmic extracts suggested that NF-kB inhibitory activity existed in two 
chromatographically separable forms:- IkB a , a 35-37kD polypeptide (Ghosh and 
Baltimore, 1990; Zabel and Baeuerle, 1990), and a less abundant form IkBB, a 
43kD polypeptide (Zabel and Baeuerle, 1990), which both seemed to interact with 
the p65 rather than the p50 NF-kB subunit. Later studies demonstrated that the 
IkBB form could also bind to and inhibit the DNA binding activity of the related 
c-rel protein (Kerr et al., 1991), IkB a  and IkBB can interact with p65 and c-rel 
polypeptides (but not with p50 and hence cannot inhibit the binding of the p50 
homodimer).
While the inhibitory activity of both the IkB a and IkBB forms can be 
inactivated by phosphorylation, die IkBB foim can be inactivated by treatment 
with cyclic AMP-dependent protein kinase and also by protein kinase C, while 
IkB a  inhibitory activity seems only to be inactivated by protein kinase C 
treatment (Kerr et al., 1991). Studies have clearly demonstrated the ability of both 
iKBa and IkBB to dissociate prefoimed NF-kB-KB motif complexes (Zabel and 
Baeuerle, 1990) in vitro , however it is unclear whether these species can be 
translocated to the nucleus.
The recent purification of the p50 and p65 subunits of NF-kB and the 
subsequent molecular cloning of the corresponding cDNAs has allowed rapid 
progress in studies of these transcription factors (Kieran et al., 1990; Ghosh et al., 
1990; Bours et al., 1990,1991; Nolan et al., 1991; Meyer et al., 1991; Ruben et 
al., 1991). Comparison of the predicted protein sequences of these cDNAs has 
revealed that they share a highly conserved N-terminal DNA binding and 
dimérisation region with a number of other cellular and virally-encoded proteins.
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Figure 1.
Schematic diagram of some members of the NF-KB/rel/dorsal family 
of transcriptional modulator proteins, and of some members of the 
iKB/ankyrin repeat inhibitor protein family, (taken from Nolan and 
Baltimore, Current Opinion in Genetics and Development 2,211-220)
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Thus the p50 and p65 subunits are members of a family of proteins related to the 
protein product of the cellular rel protooncogene, the v-rel oncoprotein encoded 
by an avian erythroblastosis virus, and the Drosophila morphogen dorsal. Similar 
rapid progress has been made in characterising IkB-like proteins with inhibitory 
activity towards the NF-KB/rel family, following die identification of the 
inhibitory role of the p i05 C-terminal ankyrin repeat region on DNA binding 
activity (Figure 1).
The initial isolation of cDNAs encoding the NF-kB p50 subunit followed 
intensive efforts by several groups to purify sufficient protein to allow peptide 
microsequencing (Kieran et al., 1990; Ghosh et al., 1990; Bours et al., 1990; 
Meyer et al., 1991). Intriguingly, the p50 subunit is initially translated as a 105kD 
precursor which is unable to bind DNA, the generation of the mature p50 subunit 
requiring a proteolytic cleavage event near a glycine-rich hinge’ region in the 
centre of the pl05 sequence. Cleavage has been reported to involve an 
ATP-dependent process which leads to the generation of the (N-terminal) mature 
p50 subunit and the rapid degradation of the C-terminal ankyrin repeat region 
(Fan and Maniatis, 1991). Comparison of the predicted amino acid sequence of 
the p50 subunit revealed a region of approximately 360 amino acids located 
towards the N-terminus which was veiy similar to equivalent regions in the c-rel 
and \-rel gene products, and the Drosophila moiphogen dorsal - deletion studies 
with in vitro translated p50 derivatives demonstrated that this region was essential 
for DNA binding and dimérisation functions. The dimérisation function of this 
so-called rel homologous region allows the p50 subunit to form homodimers or to 
form heterodimers with other members of the NF-KB/rel/dorsal family (Kieran et
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a l, 1990; Ghosh et a l, 1990).
Initial characterisation of the DNA binding specificity of the p50 homodimer 
suggested that it was likely to be identical to the constitutively active nuclear 
factor KBF-1 which bound the more symmetrical type of kB motif found in the 
H2 gene (Israel et a l, 1987,1989a,b; Baldwin and Shaip, 1987; Kieran et a l,
1990). Initial transfection assays suggested that p50 homodimers could not act as 
transcriptional activators (Kieran et a l, 1990), however in in vitro transcription 
assays using baculovirus-expressed p50, the p50 NF-KB subunit proved capable of 
transcriptional activation (Fujita et a l, 1992). In contrast, recent studies of the 
activation of nontransformed primary T-cell clones have suggested that p50 
homodimer binding to kB motifs can suppress the transcriptional activation of 
those sites by p50-p65 heterodimers (Kang et a l, 1992) - the reason for these 
discrepancies is unclear but might reflect different transcriptional activation 
mechanisms. Recent studies from other groups have identified a novel method for 
the regulation of p50 homodimer binding activity - the Bcl-3 ankyrin repeat 
protein has been shown to inhibit the DNA binding activity of NF-kB p50 
homodimers in vitro (Hatada et a l, 1992) and also in vivo by transfection studies 
(Franzoso et a l, 1992). Tlie latter study also demonstrated that the occupancy of 
kB motifs changed from predominantly p50 homodimers to p50-p65 heterodimers 
upon activation of resting peripheral blood T-cells and U937 cells, and suggested a 
role for Bcl-3 in reducing the amount of DNA-protein complex containing NF-kB 
p50 homodimer.
The pl05 precursor to p50 is encoded by a 4.0kb mRNA which is transcribed in 
many tissues, the amount of this transcript can be increased by many of the
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treatments which promote the induction of NF-kB DNA-binding activity (Bours et 
al., 1990; Meyer et al., 1991) - this effect probably being mediated by a functional 
kB motif in tlie promoter of the gene encoding pl05 (Ten et al., 1992). Thus 
active phorbol ester treatment of HL60 or HeLa cells, or TNFa stimulation of 
HL60 cells greatly increased the level of pl05 mRNA, while in primary T-cells, 
treatments with agents such as PMA, phytohaemagglutinin, or calcium ionophore 
also increased the level of pl05 mRNA (Bours et al., 1990). Intriguingly, cell 
treatment with cyclosporin A inhibited p i05 niRNA induction by calcium 
ionophore, but had only a small effect on p i05 mRNA induction following PMA 
and phytohaemagglutinin/PMA treatment (Bours et al., 1990).
The C-terminal anlcyrin repeat region of p i05 may serve both to maintain the 
p50 region in a non DNA-binding form, and to prevent its translocation to the 
nucleus (Kieran et al., 1990; Ghosh et al., 1990; Bours et al., 1990; Meyer et al,, 
1991; Henkel et al., 1992). Recent studies have suggested tliat die separately 
expressed C-terminal ankyrin repeat region is a potent inliibitor of p50 DNA 
binding, but not of p65 homodimers (Liou et al., 1992). Immunofluorescence and 
immunoprécipitation experiments to determine the subcellular localisation of the 
p i05 protein suggested that the precursor is found only in the cytoplasm, whereas 
the mature p50 form is found in both nuclear and cytoplasmic compartments 
(Blank et al., 1991). Although the eight repeated ankyrin-like domains in the p i 05 
C-terminus are very similar to each other, they may not be functionally equivalent 
- thus the sixth ankyrin repeat and the adjacent acidic region of the pl05 
precursor were shown to be required for cytoplasmic localisation, while the loss 
of the seventh ankyrin repeat or the loss of the acidic region between ankyrin
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repeats six and seven results in a pl05 species able to bind DNA (Blanlc et al.,
1991). Intriguingly, recent transfection studies of Saccharomyces cerevisiae with 
Gal4-pl05 fusion protein constructs have suggested that the C-teitninal ankyrin 
repeat region of mouse and human p i05 contains a potent transcriptional 
activation region located around ankyrin repeat numbers six and seven (Morin and 
Gilmore, 1992).
The isolation of cDNAs encoding the p65 subunit of NF-kB (Nolan et al., 1991; 
Ruben et al., 1991) again revealed extensive similarities to the DNA binding and 
dimérisation region of the NF-KB/rel/dorsal protein family (with the p65 subunit 
being more closely related to the rel family than to the p50 NF-kB sunbunit), a 
2.6kb mRNA encoding p65 seemed to be widely expressed and was present in all 
tissues tested. In contrast to the situation with the p50 NF-icB subunit, p65 did not 
require cleavage from a larger precursor, and efficiently formed heterodimers 
with p50 to generate native NF-kB.
Wliile the p65 NF-kB subunit was initially characterised as a non-DNA-binding 
species (Baeuerle and Baltimore, 1989) on the basis of the inability of 
electrophoreticaUy gel purified and renatured p65 to bind DNA, this may simply 
have reflected inefficient renaturation of this subunit. It is now clear that p65 is a 
DNA-binding subunit in its own right which can also modulate the DNA binding 
specificity of the p50 subunit (Urban and Baeuerle, 1990; Urban et al., 1991; 
Zabel et al., 1991). The p65 subunit has also been shown to possess a C-teminal 
transcriptional activation region (Nolan et al., 1991; Ballard et al., 1990) which is 
likely to result in the p50-p65 NF-kB heterodimer being a much stronger 
transcriptional activator than the p50 homodimer. As might be expected, the p65
4 4
homodimer also has transcriptional activator properties (Nolan et al., 1991; 
Schmitz and Baeuerle, 1991).
Suggestions that the p65 subunit and c-rel proteins are closely related and the 
observation that p65 contained a C-terminal region corresponding to the putative 
transcriptional activation domain of c-rel (Nolan et al., 1991; Schmid et al., 1991; 
Sclimitz and Baeuerle, 1991; Ruben et al., 1991,1992a) led to the identification of 
a C-teiminal region of p65 running from amino acids 435 to 459 which was 
functionally important for transcriptional activation (Ruben et al., 1992a). Tliis 
activation domain contained a leucine zipper-like motif and an overall net negative 
charge - leading to the suggestion that the ability of p65 to activate transcription 
may occur through a leucine zipper type interaction with other regulatory factors. 
The above study also identified a naturally-occurring derivative of p65, lacking 
amino acid residues 222 to 231, which was unable to dimerise - suggesting a 
critical role of tliis region for dimérisation function.
A recent development has been the identification of cDNAs encoding an NF-kB 
subunit very closely related to p50 - this species has been termed p49 (Schmid et 
al., 1991) or p50B (Bours et al., 1992) and analogously to p50/pl05, represents 
tlie N-teminal half of a longer, non DNA-binding, (pl00/p97) protein containing 
ankyrin/cell cycle repeat domains. As with the p i05 precursor, the pl00/p97 
precursor must be cleaved to a species of approximately 50kD to be able to bind 
to kB motifs. The mature p49/p50B can form heterodimers with p65 and other rel 
family proteins to generate species with high affinity for kB motifs.
Cotransfection studies have demonstrated that the p49/p50B protein in 
combination with p65 can give efficient transcription from a kB site and from the
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HIV-1 LTR, however the relative amount of transcriptional stimulation compared 
to tliat obtained with the NF-kB p50-p65 heterodimer remains controversial 
(Sclimid et al., 1991; Bours et al., 1992).
Tlie cloning of cDNAs encoding the p50 subunit of NF-kB (Kieran et al., 1990; 
Ghosh et al., 1990; Bours et al., 1990; Meyer et al., 1991) allowed their 
identification as members of a family including the retroviral v-rel oncoprotein, 
its cellular counterpart c-rel and a Drosophila maternal effect moiphogen protein 
dorsal. The v-rel oncogene was isolated from a highly transforming defective 
avian retrovirus, Rev-T, which causes rapid and fatal lymphoma in young birds. 
The Rev-T genome encodes a 59kD phosphoprotein - pSgv-rei (Gilmore and 
Temin, 1986; Herzog and Bose, 1986; Garson et al., 1990) - whose intracellular 
location is mainly cytoplasmic in transformed spleen cells, but whose location is 
nuclear in non-transformed chick embryo fibroblasts (Gihnore and Temin, 1986).
The potential involvement of rel proteins in transcriptional control was 
suggested by early studies demonstrating that the v-rel protein could act as a 
transcriptional transactivator of the polyomavirus late promoter (Gélinas and 
Temin, 1988; Hannink and Temin, 1989). Later transfection studies with yeast and 
mammalian cells demonstrated that the c-rel protein possesses an N-teiminal 
regulatory domain and a C-teiminal transcriptional activation domain (Bull et al., 
1990). More recent studies have directly demonstrated that the v-rel oncoprotein 
is capable of binding to kB motifs, but is not capable of stimulating transcription 
of reporter genes through tliose motifs (Ballard et al., 1990; Inoue et al., 1991). 
While the protein encoded by the c-rel protooncogene, p85^" ’^®^, also binds with 
high affinity to kB sites, it in contrast has been shown to be a functional
4 6
transcriptional activator (Inoue et al., 1991). Tlie above obseiwations led to 
proposals tliat the transforming effect of the v-rel oncoprotein might be due to 
competition of v-rel and NF-kB factors for DNA binding sites, or a 
trans-dominant effect in which v-rel inhibited NF-kB via a protein-protein 
interaction sequestering one of the NF-kB subunits (Ballard et al., 1990; Inoue et 
al., 1991).
Tlie turkey v-rel cDNA (Wilhelnisen et al., 1984), chicken and turkey c-rel 
cDNAs (Hannink and Temin, 1989), mouse c-rel cDNA (Bull et al., 1990), human 
c-rel cDNA (Brownell et al., 1989) and a c-rgZ-related cDNA ïvomXenopus 
laevis (Kao and Hopwood, 1991) have been cloned. Although the chicken c-rel 
gene seems to be expressed at low levels in many cell types, high level expression 
occurs only in hematopoietic tissues (Moore and Bose, 1989).
Recent studies have demonstrated that the c-rel promoter contains a putative kB  
site and a binding site for the transcription factor HIP-1, and is a relatively weak 
promoter (Hannink and Temin, 1990). Co-transfection of the c-rel promoter with 
a retroviral vector expressing the c-rel protein resulted in a decrease in expression 
from tlie c-rel promoter - suggesting that the expression of the c-rel 
proto-oncogene is tightly regulated both at the level of basal promoter activity, 
and by autoregulation by the c-rel protein product.
The cloning of c-rel cDNAs has revealed that the v-rel cDNA encodes a 
truncated version of the c-rel protein p85^"^^  ^the v-rel p59''^ "^ ^^  protein has 
substituted the two amino terminal amino acids of c-rel with a sequence of amino 
acids derived from the REV-A viral env gene. Further, the v-rel protein has lost 
118 carboxyl terminal amino acids which may include the c-rel protein
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transcriptional activation domain (Bull et al., 1990; Inoue et al., 1991).
Strikingly, v-rel protein isolated from cellular extracts has been shown by 
several groups to be associated in a complex of over 400kD with at least five 
different cellular proteins in v-rel transformed cells (Moixison et al., 1989; Davis 
et ah, 1990; Kochel et al., 1991). The cellular proteins complexed with the v-rel 
protein have been shown to have apparent masses of 124,115,70, 68 and 40kD by 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis analysis. The 70, 68 , 
and 40kD proteins have been identified as a constitutive avian 70kD heat shock 
protein, the c-rel protein, and the B-foim of IkB respectively (Lim et al., 1990; 
Davis et al., 1991; Ken* et al., 1991). More recently, the 124kD protein has been 
identified as the pl05 precursor to the NF-kB p50 subunit (Capobianco et al.,
1992), with the proposal that the 115kD protein may represent the nonprocessed 
form of the related p49/pl00 protein.
The family of rel-related proteins has recently been extended with two further 
members Rel B, which cannot bind with high affinity to kB sites, but which can 
form high affinity heterodimers with the NF-kB p50 subunit and transcriptionally 
activate promoters containing kB sites (Ryseck et al., 1992); and the very closely 
related I-Rel protein which does not interact with DNA, and which does not have 
a carboxy terminal transcriptional activation domain but which can form 
heterodimers with p50 - which have greatly reduced DNA-binding activity (Ruben 
et al,, 1992b). Intriguingly, both the Rel B and I-Rel proteins contain leucine 
zipper-like motifs (Landschulz et al., 1988) in their extreme N-termini - between 
residues 22 and 51 and residues 40 and 68 respectively - hinting at the possibility 
of interactions with other leucine zipper motifs on proteins within the rel family
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and possibly outside the rel family.
A more distantly related member of this NF-KB/rel/dorsal protein family is the 
Drosophila maternal effect morphogen protein dorsal - one of a group of gene 
products required to establish normal dorsal-ventral polarity in the embryo. The 
dorsal gene was found to be highly similar to the turkey proto-oncogene c-rel, and 
the oncogene y-rel - with 47% identity in the amino-temiinal amino acid sequence 
(Steward, 1987). As might be expected the behaviour of the dorsal moiphogen as 
a transcriptional modulator shows many parallels with NF-kB and rel family 
proteins. Thus dorsal protein function is regulated initially by transport from the 
cytoplasm to the nucleus (Rushlow et al., 1989). The amino terminal region of 
dorsal which is highly conserved with rel and NF-kB proteins has been shown to 
be responsible for the NF-kB-like DNA binding specificity of dorsal (Ip et al., 
1991). Interestingly, dorsal seems to be able to behave as a transcriptional 
activator or repressor depending on the promoter context - thus dorsal binding in 
the context of the twi gene promoter acts as a transcriptional activator, while 
dorsal binding at the zen promoter results in transcriptional repression (Jiang et 
al., 1992). Analogously to the situation with NF-kB, nuclear uptake of dorsal is 
prevented by tlie product of an inliibitor gene (cactus) - further, a deletion of 80 
carboxy-terminal amino acids resulted in dorsal losing the ability to activate 
transcription of mesodermal genes, larger deletions affected the transcriptional 
repressor function of dorsal (Isoda et al., 1992).
An important mechanism for controlling tlie DNA binding activity of all 
members of the NF-KB/rel/dorsal transcriptional modulator family is their 
potential for interaction with various members of the iKB/ankyrin repeat protein
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family. As described previously, initial studies of the inliibitory IkB proteins 
isolated from the inactive cytoplasmic NF-icB-IkB complex (Baeuerle and 
Baltimore, 1988a,b; Baeuerle et al., 1988) suggested the existence of two forms of 
IkB:- a 36kD fomi denoted iKBa; and a less abundant 43kD IkBB form (Zabel 
and Baeuerle, 1990). Recent studies have identified a predominantly lymphoid 
IkB Y of 70kD which is identical to the C-terminal ankyrin repeat containing 
region of the pl05 precursor to the NF-kB p50 subunit (Inoue et al., 1992a).
Rapid progress in this area has been made possible by the identification of the 
ankyrin repeat structure in the C-terminus of the p i05 precursor to the NF-kB 
p50 subunit as having an inliibitory effect on DNA binding (Kieran et al., 1990; 
Ghosh et al., 1990). Isolation of a cDNA clone encoding five or six ankyrin 
repeats, termed MAD-3, from niRNAs induced upon monocyte adherence, and the 
observation that the encoded 36-38kD MAD-3 protein specifically inhibited the 
DNA binding activity of p50-p65 NF-kB, but not the p50 homodinier suggested 
tliat this was an iKB-like protein (Haskill et al., 1991). Comparison of tlie MAD-3 
predicted amino acid sequence witli tryptic peptide amino acid sequences from 
purified rabbit iKBa suggested that MAD-3 was identical to IicBa (Davis et al.,
1991).
Subsequent studies have demonstrated that the pp40 phosphoprotein associated 
with the c-rel protein can inliibit the DNA binding activity of p50-p65 NF-kB, 
p50-c-rel heterodiniers, and c-rel homodimers. Further, that pp40 was not related 
to iKBa (which has no effect on the DNA binding activity of the c-rel protein), 
but was likely to be identical to IkBB, intriguingly, only phosphorylated pp40 
could inhibit the DNA binding activity of c-rel, while botli unphosphorylated and
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hypeiphosphorylated pp40 forms were unable to inliibit c-rel binding (Kerr et a l, 
1991; Davis et al., 1991). The identification of pp40 as IicBB, together with 
previous observations of the presence of pp40 in both the nucleus and cytoplasm 
(Morrison et al., 1989; Davis et al., 1990; Kochel et al., 1991) gives rise to the 
possibility that the repression and activation of DNA binding activity of proteins 
of the NF-KB/rel/dorsal family may be able to take place in both the nuclear and 
cytoplasmic compartments.
A third form of IicB has recently been identified - the predominantly lymphoid 
IkBy which is identical to the ankyrin repeat-containing C-temiinus of the pl05 
precursor of the NF-KB p50 subunit (Inoue et al., 1992a). The product is 
generated by either alternative splicing of the pl05 gene transcript or different 
promoter usage to give a 2.6kb mRNA species distinct from the 4.0kb 
p i05-encoding mRNA. This 70kD IkBy protein can inhibit the DNA binding 
activity of the p50 homodimer, the p50-p65 NF-kB heterodimer, and c-rel 
proteins (Inoue et al., 1992a).
Tlie putative proto-oncogene product Bcl-3 has also been shown to be an 
anlcyrin repeat protein with the ability to act as a specific inliibitor of the DNA 
binding activity of the p50 homodinier. It was proposed that this might be due to 
the high similarity between the p i05 C-terminal anlcyrin repeat region and the 
anlcyrin repeat region of Bcl-3 - both contain seven or eight ankyrin repeats 
compared to the five or six ankyrin repeats of the MAD-3 protein (Hatada et al.,
1992). Intriguingly, the above study also demonstrated that the C-terminal ankyrin 
repeat region of p i05 could rapidly dissociate DNA-protein complexes involving 
either p50 honiodiniers or native NF-kB. However, other workers have suggested
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that while the p i05 C-terminal region can abolish the icB-specific DNA binding 
activity of p50 homodimers, it had only a minimal effect on the binding activity of 
NF-kB (and p65 homodimers) (Liou et al., 1992). Other studies have 
demonstrated that two Bcl-3 molecules bind per p50 dimer without dissociating 
tlie p50 dimer, and contact part of the p50 protein involved in dimérisation, and 
that Bcl-3 can act as a p50 subunit-specific inliibitor of p50-p65 NF-kB DNA 
binding activity (Wulczyn et al., 1992).
Tlie function of the ankyrin repeat region is not entirely clear, an early 
suggestion was that it might mask a nuclear localisation signal or in some way 
tether the rel family protein to some cytoskeletal or membrane component (Ghosh 
et al., 1990). However, the identification of the ankyrin repeat pp40 (IkBB) 
protein in both nuclear and cytoplasmic compartments tends to suggest that the 
primary function of the ankyrin repeat region may be to inhibit DNA binding 
activity, and that cytoplasmic localisation may occur secondarily, possibly via 
other domains of iKB/ankyrin repeat proteins.
Tlie general aim of this study was to make use of the initially available pl05/p50 
NF-kB subunit cDNA (kindly supplied by Dr.A.Israel) to study a minimal p50 
DNA binding and dimérisation region as a simplified system to try to identify 
amino acid residues important for DNA binding activity. And hence to try to gain 
some insights into the mechanisms used by NF-kB to bind to its kB motif 
recognition site.
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MATERIALS AND METHODS.
1. Cell lines and tissue culture procedures.
Suspension-adapted HeLa S3 cells were grown in Glasgow-modified minimal 
essential medium (Gibco-BRL) supplemented with 50 units/ml penicillin (Glaxo), 
50ug/ml streptomycin (Evans Medical), 2 .2g/l sodium bicarbonate, and 5% (v/v) 
new bom calf serum (Sera-lab). Jurkat T-cell lymphoma cells were grown in 
RPMI1640 medium (Gibco-BRL) supplemented as above with penicillin, 
streptomycin, and sodium bicarbonate - but with the addition of 10% foetal calf
serum (Sera-lab). Cell suspensions were grown in 5% CO2 , split in a 1 to 3 ratio
on average every 3-4 days, and harvested at a cell density of approximately 5x10^ 
to 10^ cells/1.
2. Bacterial strains.
All plasmid propagation and recombinant protein expression was carried out in
the E,coli K12 strain JMlOl {supE, thi, A(lac-proAB), [F\ traD36,proAB,
lacI^ZAMlS]), (Yanisch-Perron et al., 1985).
3. Bacterial culture.
Liquid bacterial cultures were grown in Luria broth (lOg/1 bacto-tryptone 
(Difco), 5g/l yeast extract (Difco), lOmM NaCl, pH 7.5), supplemented with 
lOOug/ml ampicillin (Sigma) when necessary. Solid media contained Luria broth
supplemented with 1.5% agar (Difco) and lOmM MgSOz]., and supplemented as
above with ampicillin (and tetracycline) when necessary.
4. Synthesis of synthetic oligonucleotides.
Synthetic oligonucleotides were made using an Applied Biosystems 381A DNA
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synthesiser and B-cyanoethyl phosphoramidite chemistry. In this system, the 
growing DNA chain remains covalently attached to an insoluble matrix - 
controlled pore glass (CPG). CPG is easily derivatised with adenosine, guanosine, 
thymidine, or cytosine phosphoramidites. An organic linker is attached to the 
surface of the CPG and the support is then derivatised by covalent attachment of a 
nucleoside 3’-hydroxyl to the linlcer via an ester bond. Following derivatisation, 
all free amino groups are capped.
To begin the synthesis, the DNA synthesiser is loaded with a column containing 
one of four support-bound nucleosides, DNA synthesis then proceeds in a 3' to 5’ 
direction. The first step in phosphoramidite oligonucleotide synthesis chemistry is 
the removal of the acid-labile dimethoxytrityl (DMTO) group by TCA treatment - 
this yields a reactive 5' hydroxyl which can react with a phosphoramidite during 
the following coupling or addition step. B-Cyanoethyl phosphoramidites are 
chemically modified nucleosides which contain a disopropylamine group on a 3 ' 
trivalent phosphorus moiety. A B-cyanoethyl protecting group is present on the 3' 
phosphorus group of the nucleoside with a DMTO protecting group on the 5' 
hydroxyl.
In the coupling step, tetrazole and the phosphoramidite are mixed as they enter 
the reaction chamber generating a highly reactive species which reacts with the 
free 5’ hydroxyl group of the support-bound nucleotide. Tetrazole protonates the 
nitrogen of the diisopropyl group on the 3' phosphorus which converts the amine 
into a good leaving group upon nucleophilic attack by the 5' hydroxyl group - 
thus leading to a 5' to 3' intemucleotide linkage.
During the coupling step, a small fraction of support bound oligonucleotides
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will fail to undergo addition, these truncated or failure sequences are chemically 
modified to prevent their participation in subsequent coupling steps. Acetic 
anliydride mixed with dimethylaminopyridine forms a powerful acetylating agent 
which terminates or caps any unreacted chains from the coupling step.
Immediately after capping, the labile trivalent phosphorus linkage foimed 
during the coupling step is oxidised to the stable pentavalent phosphorus linkage of 
natural DNA using iodine as a mild oxidant. Following oxidation, another cycle of 
nucleotide addition is initiated by the removal of the DMTO group at the 5’ 
terminus of the oligomer, the process being repeated until the desired length of 
oligonucleotide has been synthesised.
Upon completion of oligonucleotide synthesis, the chain is cleaved from the 
CPG support, and the B-cyanoethyl protecting groups on the phosphates removed 
by four 15 minute washes with concentrated ammonium hydroxide. Base
protecting groups are then removed by heating to 55’^ C in ammonium hydroxide 
for 15 hours.
Following the cleavage and deprotection steps, ammonia is removed by 
evaporation under vacuum, and the oligonucleotide DNA pellet dissolved in water 
and then ethanol precipitated, finally the DNA pellet is dried and taken up in 
water, and the DNA concentration detemiined by UV absorbance measurements at 
260nm (an absorbance of 1.0 at 260nm is taken to be equivalent to 40ug/ml).
5. Sequences of synthetic oligonucleotides used in these studies.
All double-stranded oligonucleotides used in this study are given in Table 1.
6. Preparation of plasmid DNA.
Small scale plasmid purifications employed a variant of the STET protocol :-
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TABLE 1
Oligo Nuclootldo Sequenco
16bp W T kB 5 ' CTG G G G A C T I T C C agg 3> 3 ' GAC C C C T G A A A G G T C C  5*
HIV-L 5 ' GATCTA G G G A C T T T C C  6CG 3 '3* AT c C C T G A A A G G cgcctag 5*
HIV-R s* G A TC TG G G G A CTTTCC  AGG 3 '3 ' a c C C C T G A A A G G T ccctag s *
IRE 5 ' GATCAAAGt G G G A A A T T C C  TCTG 3*3 ‘ t t t c a c C C T T T A A G G agacctag s *
H2TF1 5 • GATCT G G G G A T T C C C C  ag 3 •3 ' ACCCCTAAGGGGTCCTAG 5«
EBP'cons' 5* GATCATg G G G A A T T T C C C  CAG 3*3* t a c c C C T T A A A G G G  gtcctag 5 '
SVÜP 5* gatctgaggcG G A A A G A A C C agctg 3»3 ' a c t c c g c c T T T C T T G G T cgacctag s *
SVl-Ml 5* gatctagggtgtC C A T L A G T C C C  G 3*3 ' a tccc a ca gG T T T C A G G G  CCTAG 5 ‘
SVl-M2 5* gatctagggtgtG G A A T G T C C C g 3*3* atcccacaC C T T A C A G G G cctag 5 '
SV1-M3
<
5* gatctagggtgtG G A A A G T G G C cg 3*
3 ' a t ccc a ca cC T T T C A C C G  gcctag 5*
cells were harvested from 3ml of bacterial overnight culture by brief 
centrifugation in a microcentrifuge and the supernatant discarded. Bacterial pellets 
were resuspended in 350ul STET buffer (sucrose 8% w/v, Triton X-100 5% v/v, 
5mM EDTA,pH8.0, 50mM Tris.HCl,pH8.0), then 25ul of a lOmg/ml lysozyme 
(Sigma) in STET buffer solution added, and the mixture boiled immediately for 
45 seconds. Tlie lysed bacterial suspensions were then centrifuged at 13000 rpm in
a microcentrifuge at 4*^  C for 15 minutes and the pellets discarded. Next, 40ul of 
3M sodium acetate was added to the supernatants, followed by 400ul of 
isopropanol, and the mixtures centrifuged at 13000 ipm in a microcentrifuge at
4 ’^ C for 5 minutes. The supernatants were discarded, and the precipitates washed 
with 400ul of 70% ethanol, before being dried under vacuum, and resuspended in 
lOOul of sterile water.
Large scale plasmid preparations were by a variant of the alkali method 
500ml overnight cultures of bacterial transfonnants in Luria broth, lOOug/ml 
ampicillin were centrifuged using a Beckman JA14 rotor at 8000 ipm for 10
minutes at 4°C, the supernatant discarded, and the bacterial pellet resuspended in 
9ml of lysis buffer (50mM glucose, 25mM Tris.HCl, pH8.0, lOmM EDTA, 
pH8.0) and 1ml of a freshly prepared 20mg/ml lysozyme (Sigma), 0.2M Tris.HCl, 
pH8.0 solution added. The suspension was mixed and incubated at room 
temperature for 5 minutes before the addition of 20ml of a freshly made 0.2M 
NaOH, 1% SDS solution, the suspension was mixed again and placed on ice for 5 
minutes, followed by the addition of 10ml of an ice-cold solution 3M with respect 
to potassium and 5M with respect to acetate anion (pH4.8). Tliis mixture was then
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centrifuged in a JA14 rotor at 10000 rpm for 15 minutes at 4°C, the supernatant 
removed carefully, treated witli 16.5ml of isopropanol, mixed and allowed to
stand for 15 minutes at 20°C. Nucleic acids were recovered by centrifugation
using a Beckman JA20 rotor at 10000 ipm for 15 minutes at 20°C, the 
supernatant was discarded and the nucleic acid pellet washed with ice cold 70% 
ethanol before drying under vacuum.
The nucleic acid pellet was dissolved in 2ml of TE buffer (lOmM Tris.HCl, 
pH8.0, ImM EDTA, pH8.0), divided between two 1.5ml Eppendoif tubes, 1.15g 
CsCl added to each tube and dissolved, followed by addition of 50ul of lOmg/ml 
ethidium bromide (Bio-Rad). This mixture was allowed to stand at room 
temperature for 5 minutes then centrifuged at 13000 rpm for 3 minutes in a 
microcentrifuge, and the supernatant transfeixed to Beckman TLIOO 
ultracentrifuge quick-seal tubes.
Tlie sealed TLIOO tubes were then centrifuged at 80000 ipm overnight at 20°C, 
the plasmid band removed by syringe, passed over a 10ml Sepharose 4B column 
(Phamiacia) equilibrated with TENjqq buffer (lOmM Tris.HCl, pH7.5, ImM
EDTA, pH8.0, lOOmM NaCl), and tlie void volume collected. This fraction was 
then passed over a 0.5ml Dowex Dg-50WX8 column (Bio-Rad) equilibrated with
TENiqq, washed through with TEN^qo» fractions containing DNA
isopropanol precipitated. This DNA pellet was redissolved in 500ul of TE buffer, 
RNase A added to a concentration of 50ug/ml, and incubated for 30 minutes at
37°C. Tliis solution was extracted with an equal volume of fresh phenol, followed
by extraction with an equal volume of chlorofomi. The plasmid DNA in the
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aqueous phase was precipitated by the addition of 3 volumes (1.5ml) of ice-cold 
100% etlianol and 0.1 volume (50ul) of 3M sodium acetate (pH5.2), and collected
by centrifugation at 13000 rpm at 4°C for 5 minutes in a microcentrifuge. The 
precipitate was then washed briefly with 200ul of ice-cold 70% ethanol, dried
under vacuum, redissolved in sterile TE buffer and stored at -20°C.
7. Plasmid species used in these studies.
The plasmid species used for the bacterial expression of NF-kB p50 protein 
derivatives was the expression vector pGEX-2T (Smith and Johnson, 1988), while 
the parental plasmid used for the generation of the circularly peimuted kB 
binding site plasmid p2xAT/HIV-R was the pAT153 (Twigg and Sherratt, 1980) 
derivative of pBR322.
8. Generation of circularly permuted kB binding site plasmid.
The construction of the cicularly permuted kB binding site plasmid 
p2xAT/HIV-R is given in Figure 1.
9. Bacterial transformation procedure.
For the transformation of E,coli, a one-step method was used (Chung et al., 
1989) - generating competent E.coli in a transfoimation and storage solution
(TSS). A 100ml culture of E.coli strain JMlOl in Luria broth was grown at 37°C 
to a density equivalent to A^qq = 0.3-0.4, the culture was then centrifuged in a
Beckman JA14 rotor at 2500 ipm at 4°C for 10 minutes, the supernatant 
discarded, and the bacterial pellet resuspended in 10ml of ice cold TSS solution 
(Luria broth, pH 6.5,10% w/v polyethyleneglycol 6000 (BDH), 5% v/v
dimethylsulphoxide, 50mM MgCl2). Aliquots (0.1ml) of the suspension were
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transfeiTed to cold 1.5ml Eppendoif tubes, mixed with 5ul of plasmid DNA
solution, and incubated at 4°C for 30 minutes. Finally, 0.9ml of Luria broth,
20mM glucose was added to each tube, the cells shaken at 37°C for 1 hour, and 
0.1ml aliquots of bacterial suspension spread onto Luria-agar plates (supplemented
with the appropriate antibiotics) and incubated at 37°C overnight.
10. Preparation of oligonucleotide affinity resin.
The scheme for preparing the oligonucleotide affinity resin was based on that 
of Kadonaga and Tjian (Kadonaga and Tjian, 1986) - to generate the HIV 
enliancer oligonucleotide affinity resin, 4mg each of the single-stranded amino 
linked (witli a primary amine group coupled to its 5’ terminus) HIV-1 
oligonucleotide 5' GATCAAGGGACTTTCCGCTGGGGACTTTCCAGG 3’, and 
the single-stranded HIV-2 oligonucleotide 5'
GATCCCTGGAAAGTCCCCAGCGGAAAGTCCCTT 3' were hybridised in 
approximately 1.6ml oligonucleotide hybridisation buffer (lOmM Tris.HCl,pH8.0,
ImM BDTA,pH8.0, lOOmM NaCl) by heating to 100*^ C for approximately 2 
minutes, then allowing to cool to room temperature over 2-3 hours, the double
stranded HIV oligonucleotide was then stored at 4®C. In the following reactions 
coupling the hybridised HIV oligonucleotide to the Sepharose affinity matrix, all 
solutions used were ice cold. For the coupling reaction, 3g of CNBr-activated 
Sepharose 4B (Sigma) was swollen in 15ml of ImM HCl for 1-2 hours, then 
washed in a sintered glass funnel with 400ml of ImM HCl, followed by 500ml of 
ultrapure water. The resin slurry was then washed with 400ml of lOmM sodium 
phosphate buffer,pH8.0, virtually all of the slurry supernatant discarded, and the
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resin transferred to a 50ml tube. Tlie 8mg of double stranded HIV enliancer 
oligonucleotide was then adjusted to lOmM sodium phosphate,pH8.0, added to the 
Sepharose resin slurry, and allowed to react overnight at room temperature with 
rotation.
After tlie overnight coupling reaction, the Sepharose resin suspension was 
centrifuged at low speed, and the supernatant removed, the resin was then washed 
with 5ml of lOmM sodium phosphate,pH8.0, centrifuged briefly and the 
supernatant removed. Finally, unreacted sites remaining on the CNBr-activated 
Sepharose were blocked by washing the slurry with 100ml of IM 
ethanolamine,pH8.0 and rotating for 4 hours at room temperature, the resin was 
then washed with 100ml of lOmM sodium phosphate buffer,pH8.0,0.IM NaCl,
followed by washing with 100ml IM NaCl, and 100ml TEN3Q0 buffer 
supplemented with 0.02% NaNg (lOmM Tris.HCl,pH7.5, ImM EDTA,pH8.0, 
300mM NaCl, 0.02% NaNg). The HIV-Sepharose 4B affinity resin was then
stored as a slurry in TENgQQ,0.02% NaNg at 4 ‘^ C.
11. Preparation of calf thymus double stranded DNA affinity resin.
For the preparation of the calf thymus DNA affinity resin, essentially the same 
reaction procedure was followed using double stranded, sheared calf thymus DNA 
(Sigma) with CNBr-activated Sepharose 4B (Sigma).
12. Generation of cellular protein extracts.
Cellular protein extracts were prepared by different routes depending on the 
numbers of cells to be extracted. For small scale cell extractions of Jurkat T-cells, 
1ml aliquots of cell suspension (at approximately 5x10^ to 10^ cells/1) were
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centrifuged briefly at 6500 rpni in a microfuge, the cell pellet resuspended and 
washed in ice-cold PBS, the cells pelleted again, and the pellet freeze-thawed in 
50ul. of ice-cold lysis buffer (20mM Hepes,pH7.5, ImM DTT, ImM 
EDTA,pH8.0, ImM sodium metabisulphite, ImM PMSF (added just before use), 
0.5% NP40). After vortexing, the nuclei were collected by brief centrifugation 
and the supernatants snap-frozen in liquid nitrogen as cytoplasmic extracts. Tlie 
pelleted nuclei were then resuspended in 25ul of ice-cold extraction buffer (20mM 
Hepes,pH7.5, ImM DTT, ImM EDTA,pFI8,0, ImM sodium metabisulphite, ImM 
PMSF, 0.35M NaCl), allowed to stand on ice for 30 minutes, then clarified by 
centrifugation and the supernatants snap-frozen as nuclear extracts.
For large scale HeLa cell extractions, only nuclear extracts were prepared since 
tlie S3 HeLa cell line used has constitutive nuclear NF-icB activity, with virtually 
no active or IicB-shielded NF-kB DNA binding activity in cytoplasmic extracts. 
Tlie method used for preparing large scale nuclear extracts was a variant of tliat 
of Dignam (Dignani et al., 1983) - a 10ml pellet of liquid nitrogen snap-frozen 
HeLa S3 cells was thawed on ice, resuspended in 40ml of buffer A (lOmM
Hepes,pH7.5,1.5mM MgCl2 , lOmM KCl, 0.5niM DTT) and allowed to swell for
30 minutes on ice. The hypotonically swollen cells were then lysed in a Dounce 
homogeniser (10 strokes with a B-type pestle), a sample checked microscopically
for cell lysis, and the homogenate centrifuged at 2500 rpm at 4®C for 10 minutes 
in a benchtop centrifuge. Tlie supernatant was discarded, and the remaining 
sedimented crude nuclei (7ml) resuspended with 36ml of ice-cold buffer B (25mM
Hepes-NaOH, pH7.5, 5mM KCl, 0.5mM MgCl2 , 0.5mM DTT, 0.2M sucrose,
ImM PMSF (added just before use), 0.35M NaCl) by 10 strokes with a B-type
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pestle in a Dounce homogeniser (the resulting mixture being 0.25M with respect 
to NaCl), then stined gently on ice for 30 minutes. After this extraction stage, the 
suspension was centrifuged in a Beckman 42.1 rotor at 30000 ipm (lOOOOOG) at
4®C for 30 minutes. The supernatant was removed, then centrifuged again in a 
type 42.1 rotor under the same conditions as before, and the supernatant 
recovered as the nuclear extract - this was either aliquoted into smaller volumes,
snap-frozen in liquid nitrogen, and stored at -70®C, or used directly in attempts to 
affinity purify NF-kB.
13. Purification of kB binding proteins.
To purify NF-kB from HeLa cells, 50g of cells were fractionated into nuclei 
and cytoplasm and the nuclei extracted with 0.25M NaCl as described (Clark et
al., 1990). All operations were carried out at 4°C, and all buffer solutions kept on 
ice. 120ml of 0.25M NaCl HeLa cell nuclear extract was supplemented with 
spermidine (trihydrochloride - Sigma) to 3mM, EDTA,pH8.0 to 2mM, 0.5mg 
poly dAdT.dAdT/dGdC.dGdC carrier DNA (Pharmacia), and 
n-octylglucopyranoside (Sigma) to 3mM and applied to a 1.4ml HIV-Sepharose 
affinity column at a flow rate of 40ml per hour. The column was washed with 10 
column volumes of buffer C (25mM Hepes-NaOH,pH7.5, ImM DTT, 20% w/v 
glycerol, 0.01% NP-40 (BDH), lOmM EDTA,pH8.0, 3mM spermidine, 3mM 
n-octylglucopyranoside), supplemented with 0.25M NaCl and bound proteins 
eluted from the affinity matrix with 3.3ml of buffer C containing 0.6M NaCl: 1 
column volume of the high salt buffer C was allowed to pass through before the 
column was blocked off for 1 hour, and then the remaining eluant allowed to pass 
through - the whole process taking 1.5 hours.
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The sodium chloride concentration of the eluted protein solution was then 
reduced to 0.1 M by the addition of 16.5ml of 50mM Tris.HCl,pH7.5 buffer, the
mixture centrifuged in a Beckman 42.1 rotor at 30000 rpm at 4®C for 30 minutes, 
and the supernatant recovered. This supernatant was then applied to a Mono-Q 
FPLC chromatography column (Pharmacia-LKB) pre-equilibrated with 50mM 
Tris.HCl,pH7.5 buffer, and eluted fiom the Mono-Q column with a salt gradient 
using 50mM Tris.HCl,pH7.5 and 50mM Tris.HCl,pH7.5,5M NaCl. Those early 
eluting Mono-Q fractions (total volume 8.5ml) showing kB DNA binding activity 
were pooled, and their sodium chloride concentration adjusted to 0.35M by 
addition of buffer C, 0.5M NaCl prior to loading on a 2ml E.coli DNA-Sepharose 
column equilibrated with buffer C, 0.35M NaCl over approximately 1.5 hours.
The combination of 0.35M sodium chloride and non-specific E.coli DNA resulted 
in virtually aU of the kB site binding protein remaining in the flowthrough 
fraction, rather than binding to the column. In contrast, contaminating proteins 
with high affinity for non-specific DNA sequences bound to the E.coli DNA 
affinity resin under these conditions.
The flowthrough from the non-specific E.coli DNA column (29ml) was 
collected, the salt concentration reduced to 0.25M by addition of 11.6ml of buffer 
C, and 50ug of poly dAdT.dAdT/dGdC.dGdC carrier DNA added prior to loading 
onto the final 1ml HIV-Sepharose affinity column over approximately 1 hour. The 
column washed with 10ml of buffer C,0.25M NaCl over approximately 1 hour 
and bound proteins eluted with 4ml of buffer C,0.8M NaCl: 1 column volume of 
high salt buffer was allowed to flow through the column, then the column was 
blocked off and allowed to stand for 1 hour, before the remainder of the eluant
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passed through the column - the whole process taking 2 hours. The eluted protein 
and the other fractions were snap-frozen in liquid nitrogen before being stored at
- 70*^ 0 .
14. Lectin affinity resin purification of native kB binding proteins.
Following a report of the purification of the transcription factor Spl using 
wheat gemi agglutinin lectin - agarose (Jackson and Tjian, 1989), a similar 
purification scheme was attempted for NF-kB proteins from HeLa S3 cell line 
nuclear extracts. In this purification scheme, all operations were carried out at
4*^ C, and all buffer solutions kept on ice. Tlius, frozen HeLa cells(0.86g) were 
resuspended in 5 volumes (4.3ml) of ice-cold PBS, then centrifuged at 2000 ipm
at 4*^  C for 10 minutes in a bench top centrifuge, and the supernatant discarded. 
The pellet was then resuspended in 5 packed cell pellet volumes (4.3ml) of buffer
D (lOmM Hepes,pH7.9,1.5mM MgCl2 , lOniM KCl, 0.5mM DTT), then allowed
to stand 10 minutes, before centrifugation at 2000 ipm at 4*^0 for 10 minutes in a 
bench top centrifuge, and the supernatant discarded. Tliis cell pellet was 
resuspended in 2 packed cell pellet volumes (1.7ml) of buffer D, and then lysed in 
a Dounce homogeniser by 10 strokes with a B-type pestle. The homogenate was 
checked for cell lysis, then centrifuged at 4000 ipm in a Beckman 42.1 rotor at
4 for 10 minutes, and the supernatant discarded. Tlie pellet was then
recentrifuged in a 42.1 rotor at 15500 ipm at 4**C for 20 minutes and any residual 
cytoplasmic material removed. Tlie crude nuclear pellet was then resuspended in 
3.0ml of buffer E (50mM Tris.HCl,pH7.5,0.42M KCl, 20% v/v glycerol, 10%
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w/v sucrose, 5mM MgCl2 , O.lmM EDTA,pH8.0, ImM PMSF (added just before
use), ImM sodium metabisulphite, 2mM DTT) by 10 strokes with a B-type pestle 
in a Dounce homogeniser. The resulting suspension was tlien stined gently on ice
for 30 minutes before centrifugation in a 42.1 rotor at 28000 ipm at 4°C for 60 
minutes, and the supernatant (2.9ml) collected.
This nuclear extract was applied to a 2ml wheat germ agglutinin 
(WGA)-agarose (Vector) column (pre-equilibrated with buffer E) over 
approximately 1.5 hours and the column washed successively with 10ml of buffer
E, and 20ml of the buffer F (25mM Hepes-KOH, pH7.6,12.5mM MgCl2 , 20%
glycerol, 0.1% v/v NP40, lOuM Z11SO4 , ImM DTT, O.IM KCl). Finally, the 2ml
WGA-agarose column was eluted over 1 hour with 10ml of buffer F 
supplemented with 0.3M N-acetylglucosamine (Sigma) - the eluate being collected 
as 10x 1 ml fractions before being snap-frozen in liquid nitrogen, and stored at
-70®C. In some experiments N-acetylglucosamine (O.IM) was added to the 
resuspended crude nuclear pellet before the 30 minute nuclear extraction stage.
15. Generation of cDNA encoding NF-kB p50 amino acids 35-381.
Making use of a pBluescript (Stratagene) plasmid with a cDNA insert encoding 
tlie p i05 precursor to p50 (kindly provided by Dr.A.Israel), a region of cDNA 
corresponding to the roughly-defined DNA binding and dimérisation region 
(Kieran et ah, 1990; Ghosh et ah, 1990) was amplified by polymerase chain 
reaction (PCR). The two oligonucleotide PCR primers used had sequences 5' 
GATGAAGGATCCAATATGGCACTGCCAACAGCAGATGGC 3* for the 
N-tenninal coding sequence (making use of the internal methionine-35 codon does
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not affect DNA binding activity), and 5'
TATAGCGAATTCCTAGGCACCACTACCACCGCCGAAACT 3' for the 
C-terminal coding sequence (with a termination codon after amino acid 381). The 
PCR amplification would be expected to yield a product of about 1065bp with 
Bam HI and Eco RI restriction enzyme cleavage sites just beyond the N- and 
C-teimini respectively of the coding sequence.
PCR amplification was carried out in a lOOul volume containing luM  of each 
primer, lOOng of the pl05 plasmid, 0.2mM of each dNTP, IxPCR buffer (Perkin 
Elmer Cetus), 2 Units of Amplitaq (Perkin Elmer Cetus), and 10"^M 
tétraméthylammonium chloride (Sigma). Reaction mixtures were overlaid with 
mineral oil and subjected to the following thermal cycling program (Techne
PHC-1) denature at 94°C / 1.5 minutes, anneal at 55°C / 1.5 minutes, extend at
72°C /  2 minutes, repeated for 25 cycles with a final 10 minute extension cycle. 
Immediately after the completion of the Üiermal cycling program, the DNA 
product was phenol, and then chloroform extracted, and 5ul of the DNA product 
assayed for homogeneity and expected size by gel electrophoresis on a 0 .8% 
agarose gel. The PCR-generated DNA was then precipitated by addition of 0.1 
volume of 3M sodium acetate (pH5.2) and 0.6 volumes of isopropanol, standing at 
room temperature 5 minutes, then centrifuged at 13000 rpm at room temperature 
for 5 minutes. After washing with 70% ethanol and diying the DNA pellet under 
vacuum, the PCR product was digested with 10 units each of Bam HI and Eco RI 
restriction enzymes and lul of the correct lOx restriction enzyme buffer made up 
to a total volume of lOul.
The Bam HI/Eco RI digested PCR product was then made up to a volume of
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lOOul with TEN j 00 again extracted witli phenol and chloroform before the
addition of 20ug of phenol-extracted yeast tRNA (Sigma) and the mixture then 
isopropanol precipitated as described before. The resulting pellet was then 
redissolved and ligated at room temperature overnight into O.lug of Bam HI/Eco 
RI digested pGEX-2T bacterial expression vector (Smith and Johnson, 1988) in a 
total volume of 20ul - the ligation reaction conditions were as described above. 
The overnight ligation mixture was used to transform E.coli JMlOl by the 
one-step TSS transformation protocol, the bacterial suspension was plated out on 
Luria-agar/ampicillin (lOOug/ml) plates, and ampicillin resistant transformants
identified after overnight incubation at 37°C.
16. Generation of cDNA encoding cysteine to serine mutants of NF-kB 
p50o
To generate cDNA molecules encoding mutant p50 proteins, a PCR mutagenesis 
teclinique was employed (Ho et al., 1989) - PCR amplification conditions were as 
described above but with two internal mutagenising primers and the two external 
primers described previously to generate two partial length mutant cDNA 
products (Figure 2.3). Thus for mutation of the amino acid 62 cysteine codon 
(TGT) to a serine codon (TCC), the two partial length mutant cDNA molecules 
were made by PCR amplification as described above - but using the N-terminal 
external primer with the mutation primer 5'
ATGGGATGGGCCTTCGGATACATAACGGAAACG 3' to generate a 120bp 
N-terminal encoding cDNA, and using the C-temiinal external primer with the 
mutation primer 5‘ CGTTTCCGTTATGTATCCGAAGGCCCATCCCAT 3' to 
generate a 940bp C-terminal encoding cDNA.
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To generate the amino acid 119 cysteine codon (TGT) to serine codon (TCC) 
mutation, partial length mutant cDNAs were made using the N-teiminal external 
primer with the mutation primer 5'
GATCCCATCCTCGGAGTGTTTTCCCACCAG 3’ to generate a 270bp 
N-terminal encoding cDNA, and using tlie C-terminal piimer with the mutation 
primer 5’ CTGGTGGGAAAACACTCCGAGGATGGGATC 3' to generate a 
790bp C-temiinal encoding cDNA. While for the amino acid 273 cysteine codon 
(TGT) to serine codon mutation (TCC), the partial length mutant cDNA molecules 
were made using the N-terminal external primer wiüi the mutation primer 5' 
CTGAACTTTGTCGGAAAGAAGATAAATTTCCTCCCC 3’ to generate a 
730bp N-terminal encoding cDNA, and using the C-teiminal primer with the 
mutation primer 5’ GGGGAGGAAATTTATCTTCTTTCCGACAAAGTTCAG 
3’ to generate a 330bp C-terminal encoding cDNA molecule.
The partial length PCR amplification products were then directly purified by 
agarose gel electrophoresis in gels ranging in concentration from 0 .8% to 3% 
agarose (Sigma) as appropriate, made up with, and running in, IxTBE buffer /  
0.2ug/ml ethidium bromide. Agarose gel bands coiTesponding to the correct size 
partial length PCR products were cut out and l-2ul of both gel bands used to 
provide the two partial length templates for each final amplification reaction. The 
conditions for the second round of PCR amplification were as described 
previously - but using l-2ul of each partial length template DNA gel band, with 
the N-terminal and C-terminal encoding primers. In addition, the thermal cycling 
program was slightly altered to give longer annealing and extension times of 2 and 
2.9 minutes respectively. Samples of the final mutant PCR amplification products
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were analysed by agarose gel electi'ophoresis on a 0 .8% gel as described above - 
showing essentially homogeneous bands of the expected 1065bp size. The DNA 
products were then isopropanol precipitated, Eco RI and Bam HI digested, and 
ligated into similarly digested pGEX-2T expression vector as described above. 
Finally, the ligation mixtures were used to transform E.coli JMlOl, the bacterial 
suspensions plated out on Luria-agar/ampicillin plates as above, and ampicillin 
resistant transformants isolated.
17. Sequencing of cDNA encoding cysteine to serine mutants of 
NF-kB p50.
To confirm that the PCR mutagenesis scheme had yielded the expected 
products, the inserted sequences of the recombinant pGEX-2T plasmids encoding 
the p50 mutants were sequenced directly using a double stranded DNA cycle 
sequencing system (Gibco BRL). Piimer labelling for the sequencing reactions 
employed 2pmoles of primer, lOuCi y-^^P ATP, 1 unit T4 polynucleotide kinase,
0.5ul 10xT4 kinase buffer (0.5M Tris.HCl,pH7.6, lOOmM MgCl2 , 50mM DTT,
ImM speimidine.HCl, ImM EDTA,pH8.0), in a total volume of 5ul, the mixture
was then incubated at 37®C for 30 minutes, the reaction then stopped by heating
the mixture to 55°C for 5 minutes, and the labelled primers stored at 4®C. The 
template DNA for the sequencing reactions was prepared directly from single 
bacterial colonies - l-2mm diameter single colonies were transferred to 0 .5ml 
Eppendoif tubes containing 12ul of single colony lysis solution (lOmM 
Tris.HCl,pH7.5, ImM EDTA, 50ug/ml Proteinase K (Sigma)), the tubes were
vortexed briefly, then incubated at 55®C for 15 minutes. Finally, the Proteinase K
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was inactivated by heating to 80*^ C for 15 minutes, the tubes placed on ice for 1 
minute, then centrifuged at 13000 ipm in a microcentrifuge at room temperature 
for 3 minutes, and 9ul of supernatant carefully removed (as two 4.5ul aliquots) to 
provide the template for sequencing both strands of the mutant DNA. The 
sequencing reactions used specific dideoxy termination mixtures for each base 
type. Pre-reaction mixtures with a total volume of 32ul - containing 4.5ul 
template supernatant, 2 Units Taq DNA polymerase (Perkin Elmer Cetus) were 
mixed, centrifuged, and placed on ice. To each of four 0.5ml Eppendoif tubes was 
added 2ul of one of the dideoxy termination mixes, followed by 8ul from the 
pre-reaction mixture, these were mixed and overlaid with lOul of mineral oil. The
tubes were then transferred to a thermal cycling block (preheated to 95*^C), and 
PCR amplification carried out using the following regime - 30 seconds denaturing
at 95 *^ C, 30 seconds annealing at 55*^C, followed by 60 seconds extension at 70®C
- repeated for 20 cycles, with a final 2.5 minute /  70®C extension step, and the 
reaction terminated by the addition of 5ul of stop solution (Gibco BRL) to each
tube. Tlie PCR sequencing reaction products were then stored at -20’^ C before 
being analysed by denaturing gel electrophoresis within 24 hours.
18. pGEX-2T bacterial fusion protein expression system.
Tlie bacterial expression of recombinant NF-kB p50 protein derivatives made 
use of the pGEX-2T expression vector developed by Smith and Joluison (Smith 
and Jolinson, 1988) - in this system the foreign protein is expressed after induction 
with isopropyl-B-D-thiogalactopyranoside (IPTG) (Sigma) as a fusion with the 
C-terminus of a 26kD glutathione S-transferase from a parasitic helminth. This
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system has the advantage that a large proportion of such fusion proteins prove 
soluble in aqueous solution, and can be affinity purified by passage over 
glutathione-agarose matrices. Further, the vector has been engineered such that 
the linker region between the C-terminus of the glutathione S-transferase and the 
mutiple cloning site encodes a recognition sequence for the protease thrombin, 
allowing the fusion protein to be cleaved and the foreign protein to be isolated. In 
addition, the pGEX-2T plasmid also encodes an ampicillin resistance gene - 
allowing the selection of bacterial transformants.
As described previously, Eco RI and Bam Hl-digested pGEX-2T vector was 
ligated with similarly digested p50-encoding PCR products, the ligation mixtures 
used to transform E.coli JMlOl, and ampiciUin-resistant transfonnants isolated.
To confirm that these ampicillin resistant colonies represented the expected
recombinant plasmids, 10ml cultures were grown up to an A^qq of 0.6 in Luria
broth and lOOug/ml ampicillin, then induced with the addition of 0.5mM IPTG
for 4 hours at 25 °C. Samples of the induced bacterial cultures (1.5ml) were 
centrifuged briefly in a microcentrifuge, the supernatant discarded, and the pellet 
typically resuspended by vortexing in 50ul of 4x concentrated SDS gel sample
buffer and 150ul of ultrapure water. The suspension was heated to 100®C for 3 
minutes and quenched on ice, vortexed extensively to shear cellular DNA and lOul 
analysed by sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis on 
a 10% polyacrylamide gel under reducing conditions. Those bacterial 
transformants expressing a correct size recombinant fusion protein were then 
isolated for further study.
19. Affinity purification of bacterially expressed p50 proteins,
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For the large scale purification of bacterially-expressed NF-kB p50 protein, a 
two-stage purification was used - an initial glutathione-agarose purification of the 
intact fusion protein, followed by cleavage of the essentially pure fusion protein 
by incubation with thrombin, and a calf thymus double stranded DNA-Sepharose 
affinity purification step. Using the appropriate E.coli JMlOl transformants,
500ml Luria broth/1 OOug/ml ampicillin cultures were grown at 37*C until A^qq 
was approximately 0.6, IPTG was added to 0.5mM and the cultures induced for 4 
hours at 2 5 Bacterial cells were collected by centrifugation in a Beckman JA14 
rotor at 2500 ipm at 4'^C for 10 minutes and the growth media discarded. Except
where indicated, all further operations were carried out at 4*^ C with ice-cold 
buffer solutions. The bacterial pellets were resuspended in 10ml of high salt 
buffer (20mM sodium phosphate,pH7.0, 0.5M NaCl, ImM DTT), then disrupted 
by sonication on ice (4x20 seconds, MSE Soniprep 150). After the addition of 
Triton X-100 detergent to the bacterial lysates to 1%, the lysates were clarified by
centrifugation in a Beckman JA20 rotor at 14000 ipm at 4*^ C for 1 hour, and the 
supernatants recovered and passed over 1ml glutathione-agarose (Sigma) columns 
(pre-equilibrated with high salt buffer). The 1ml glutathione-agarose columns 
were then washed extensively with 10ml of high salt buffer, then eluted with 
reduced glutathione/liigh salt buffer (lOmM reduced glutathione (Sigma), 50mM 
Tris.HCl,pH8.0,0.5M NaCl) and 0.5ml fractions collected. Fractions containing 
fusion protein were identified by SDS polyacrylamide gel electrophoresis under 
reducing conditions, pooled and the fusion proteins cleaved by incubation with 6
units of human thrombin (Sigma) per mg of fusion protein at 20'^C for 3 hours.
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For the second purification stage, the concentration of sodium chloride in the 
cleaved fusion protein solutions was lowered to 150mM by dilution with lOmM 
sodium phosphate buffer,pH7.4, 2mM DTT - and applied to 1ml calf thymus 
double stranded DNA-Sepharose columns (pre-equilibrated in PBS, 2mM DTT). 
The calf thymus DNA-Sepharose columns were then washed extensively with 
10ml of PBS, 2mM DTT and bound protein eluted by raising the NaCl 
concentration to 0.6M. 0.5ml fractions were collected and assayed for protein 
concentration by the Bradford reagent dye binding method (Bradford, 1976) and 
for homogeneity by SDS-polyacrylamide gel electrophoresis before being pooled, 
aliquoted in 50ul fractions, and snap-frozen in liquid nitrogen before storage at
-70"*C.
20. Radiolabelling of DNA restriction fragments and oligonucleotides.
To label the 16bp blunt-ended double stranded kB motif oligonucleotide with 
^^P, 10 pmoles of single stranded 16-mer kB motif oligonucleotide were incubated 
in 20ul of (50mM Tris.HCl,pH7.6, lOniM MgCl2 , 5mM DTT, O.lmM
spermidine.HCl, O.lmM EDTA,pH8.0) buffer with 5 Units of T4 polynucleotide 
kinase (New England Biolabs), and 29 pmoles of y^^P ATP (Amersham, specific
activity 3000Ci/mmol) at 37"^C for 30 minutes in a 1.5ml screw-cap tube. Tlie
reaction was then terminated by heating to 100*^C for 2 minutes, and 16 pmoles 
(3.2ul) of complementary strand 16-mer kB motif oligonucleotide added, before 
allowing the mixture to cool gradually to room temperature over 2-3 hours. 
Radiolabelled, double stranded 16bp kB motif oligonucleotide was separated from 
unincoiporated y^^P ATP and excess complementary single strand unlabelled
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oligonucleotide by electrophoresis on a non-denaturing 12% polyacrylamide gel. 
Radioactivity in the wet gel was visualised by autoradiography with X-ray film 
(Fuji RX), and the polyacrylamide gel slice containing the double stranded 
oligonucleotide recovered. The double stranded, radiolabeUed oligonucleotide was
then passively eluted from the gel slice by addition of 400ul of TEN^qq buffer,
and eluting overnight at room temperature, before storage at 4°C.
For the radiolabelling of other double stranded oligonucleotides (and some 
restriction fragments) with overhanging 5’ ends, the Klenow fragment of E.coli 
DNA polymerase I was used with dATP to incorporate radioactivity into the 
double stranded DNA. The double stranded HIV-L oligonucleotide was 
radiolabelled with the following mixture - lOul of 50mM Tris.HCl,pH7.5, lOmM
MgSO^, O.lmM DTT, 50ug/ml BSA containing lOOng of HIV-L double stranded
oligonucleotide, 2 mnoles each dCTP, dTTP, dGTP, 0.5ug gelatin, 25uCi a^^P 
dATP, and 2 Units of the Klenow fragment of E.coli DNA polymerase I - was 
incubated at room temperature for 15 minutes, then 4 nmoles of dATP added, and 
the mixture incubated at room temperature for a fuither 20 minutes. Finally, the 
reaction was stopped by addition of 3ul of DNA dyes (20% glycerol, 50mM 
EDTA,pH8.0, trace bromophenol blue), and radiolabelled double stranded HIV-L 
oligonucleotide separated from unincoiporated nucleotide by electrophoresis on a 
non-denaturing 8% polyacrylamide gel. The gel slice containing the double 
stranded oligonucleotide was isolated as described above, and was passively eluted
overnight at room temperature in 200ul of TEN^qo buffer, before storage at 4°C. 
To generate the various circularly permuted kB site restriction fragments for
7 4
DNA bending studies, the p2xAT/HIV-R plasmid construct carrying the HIV-R 
oligonucleotide (with an identical kB motif to that in the HIV-L oligonucleotide) 
was digested with one of the following restriction enzymes - Hind III, Sph I, Bam 
HI, Avi II, or Eco RV in lOul of the appropriate restriction enzyme buffer 
(50mM NaCl for Hind III and Sph I, lOOmM NaCl for Bam HI and Avi II, 
150mM NaCl for Eco RV) containing lug gelatin, 1.8ug of p2xAT/HIV-R
plasmid was digested with lOunits of restriction enzyme for 2 hours at 31 ^ C. To 
the lOul restriction digest mixtures, 1.5ul of lOx T4 DNA polymerase buffer was 
added (0.33M Tris-acetate,pH8.0, 0.66M potassium acetate, O.IM magnesium 
acetate, 5mM DTT, 1 mg/ml BSA), followed by 2units of T4 DNA polymerase,
and made up to 15ul with ultrapure water. This mixture was incubated at 37’^ C 
for 7 minutes in the absence of deoxynucleoside triphosphates, then 6nmoles each 
of dCTP, dGTP, and dTTP added, followed by 15uCi a^^P dATP and 0.2nmoles
dATP, and the mixture incubated at 37^C for 15 minutes. Finally, 4nmoles dATP
was added and the reaction incubated again at 37*C for 15 minutes. Nucleotide 
incoiporation was stopped by the addition of SDS to 0.15% followed by addition 
of 4.5ul of DNA dyes, the radiolabelled restriction fragments were then separated 
from unincorporated radiolabelled nucleotide by electrophoresis on a 
non-denaturing 5% polyacrylamide gel. The gel slices containing the 600bp 
circularly permuted kB site restriction fragment were identified as described 
above, and the slices then electroeluted (Schleicher and Schuell, Biotrap) in 200ul 
of l/20xTBE buffer, after elution sodium chloride was added to lOOmM and the
cicularly peimuted binding site probes stored at 4*C.
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21. Determination of protein concentration.
For the estimation of protein concentrations, a microscale variant of Bradford's 
dye binding method was used (Bradford, 1976), 5-1Oui of protein sample was 
added to 1ml of Bradford reagent (0.1 mg/ml Coomassie brilliant blue G250, 5% 
v/v ethanol, 10% v/v orthophosphoric acid), mixed and allowed to stand for 10
minutes before measurement of A595. In each case absorbance measurements
were performed against blanks containing an equal volume of the appropriate 
buffer in 1ml Bradford reagent. Tliese absorbance measurements were then 
correlated with a freshly-generated calibration curve (0-25ug of bovine serum 
albumin in 1ml Bradford reagent) to estimate tlie protein concentration of the 
unknown sample.
22. Gel electrophoresis.
For gel electrophoresis DNA binding assays, non-denaturing polyacrylamide 
gels (6% polyacrylamide for assays using oligonucleotide probes, and 5% 
polyacrylamide for the 600bp circularly peimuted restriction fragment probes) 
were prepared using a 44 : 0.8 ratio of acrylamide : N,N'-methylene-bis 
acrylamide. Tlius, 50ml of 0,5xTBE buffer supplemented with the desired overall 
acrylamide concentration (using a 44 : 0.8 ratio 40% acrylamide stock solution) 
was polymerised with 200ul of 25% w/v ammonium persulphate solution and 20ul 
of TEMED, and the mixture cast into 1.5mm thick gels (BRL V15-17). Gel plate 
assemblies were then mounted in BRL V15-17 apparatus and buffer tanks filled 
with 0.5xTBE prior to sample loading and electrophoresis at 200V for typically 
40 minutes. After electrophoresis, radioactive gels were either quantitated directly 
by Cerenkov counting wet gel slices, alternatively polyacrylamide gels were dried
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under vacuum (Bio-Rad) onto DBAE paper (Wliatman DE81) and radioactivity 
visualised by autoradiography.
For the purification of radiolabelled oligonucleotides and restriction fragments, 
non-denaturing polyacrylamide gels (ranging from 12% polyacrylamide for small 
oligonucleotides to 5% polyacrylamide for 600bp restriction fragments) were 
prepared using a 29 : 1 ratio of acrylamide : N,N'-methylene-bis acrylamide.
Thus 25ml of IxTBE buffer supplemented with the necessary overall aciylamide 
concentration (using a 29 : 1 ratio 30% acrylamide stock solution) was treated 
with lOOul of 25% w/v ammonium persulphate solution and lOul of TEMED, and 
the polymerising mixture cast into 0.75mm thick gels (BRL V15-17). Gel plate 
assemblies were mounted in BRL V I5-17 apparatus and buffer tanks filled with 
IxTBE buffer prior to sample loading and electrophoresis at 200V for typically 1 
hour. After electrophoresis, the gel bands corresponding to the DNA molecules of 
interest were identified by autoradiography of the wet gel, the gel bands cut out, 
and the DNA eluted.
For protein characterisation, denaturing SDS polyacrylamide gel electrophoresis 
based on the method of Laemmli (Laemmli, 1970) was carried out in a mini gel 
system (Bio-Rad Mini Protean) under reducing and non-reducing conditions.
23. Reagents and buffer solutions.
All reagents used in these studies were Analar grade or its equivalent.
The following buffer solutions were used routinely during these studies 
TE (lOmM Tris.HCl, pH7.5, ImM EDTA, pH8.0)
TENioo (lOmM Tris.HCl, pH7.5, ImM EDTA, pH8.0, lOOmM NaCl)
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TEN300 (lOmM Tris.HCl, pH7.5, ImM EDTA, pH8.0, 300mM NaCl)
TBE (lOOmM Tris.Borate, ImM EDTA, pH8.3)
SDS Gel Running Buffer (25mM Tris.HCl, 200mM glycine, 0.1% SDS, pH8.3)
24. DNA Binding assays.
Protein DNA-binding activity was deteimined using gel electrophoresis on 6% 
(5% for large restriction fragment-derived probes) non-denaturing 
polyacrylamide (44 : 0.8 acrylamide : bis acrylamide) gels. Typically, lu l of 
protein solution (fully reduced by the addition of DTT to 25mM and incubating 
on ice for 15 minutes) was added to 18ul gel mobility shift binding buffer (85mM 
NaCl, 8.5% v/v glycerol, 22mM Hepes,pH7.5,1.3mg/ml BSA, 0.17% NP40, 
3.6mM spermidine (except when specifically omitted), 0.85mM DTT, 0.85mM
EDTA,pH8.0, 6 ,ImM MgCl2) and incubated on ice for 15 minutes. Finally, l-2ul
of radiolabelled DNA probe was added and the solution incubated at 20*C for 15 
minutes before the addition of 4ul of mobility shift gel dyes, and loading onto the 
gel. After electrophoresis in 0.5xTBE buffer at 200V for typically 40 minutes, 
radioactivity in gels was either deteimined directly by Cerenkov counting, or by 
drying the polyacrylamide gel under vacuum onto DEAE-cellulose paper 
(Wliatman, DE81), followed by autoradiography and scintillation counting of 
dried gel slices.
25. Use of cysteine-reactive reagents.
For the inactivation of p50 protein DNA binding activity, p50 protein/gel 
mobility shift binding buffer mixtures were treated with N-ethyImaleimide 
(NEM) or iodoacetate before the addition of radiolabelled probe DNA. For NEM 
inactivation of DNA binding activity, 80mM NEM stock solution was added to
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give a lOmM NEM concentration in the p50 protein/binding buffer mixture, and
the mixture incubated at 20® C for 10 minutes. While for iodoacetate inactivation 
of DNA binding activity, 250mM neutral iodoacetate, 30mM Tris.HCl,pH8.0 stock 
solution was added to give a final concentration of 25mM iodoacetate in the p50
protein/binding buffer mixture and incubated at 20°C for 15 minutes before the 
addition of the radiolabeUed probe. In those experiments demonstrating the 
differing dose-response curves for iodoacetate inactivation of the p50 protein 
mutants, the amount of iodoacetate stock solution added was varied accordingly. 
Similarly, in the experiment demonstrating the ability of the bound 
oligonucleotide to protect p50 protein against iodoacetate inactivation, the 
oligonucleotide probe was added before and after treatment with varying amounts
of 250mM neutral iodoacetate stock solution and its incubation at 20®C for 15 
minutes.
For the cross-linking of appropriately positioned cysteine residues in the various 
species of p50 protein aa35-381 dimer, p50 proteins were reduced by addition of 
DTT to 25mM and incubation on ice for 15 minutes, before the addition of 
lOOmM diazenedicarboxylic acid bis [N,N'-dimethylamide] (diamide. Sigma), 
0.5M NaCl stock solution to give a final diamide concentration of 33mM, and
incubation at 37®C for 1 hour. After the formation of disulphide bonds had been 
induced by diamide treatment (Kosower et al., 1969), the reactions were quenched 
by the addition of 250mM neutral iodoacetate stock solution to give a final
iodoacetate concentration of 60mM and then incubated at 20®C for 30 minutes.
26. Radioactive counting.
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For Cerenkov counting of radioactivity in wet polyacrylamide gels, gel slices 
were counted in 10ml glass vials using the channel of a liquid scintillation
spectrometer (Inteitechnique SL30), while for liquid scintillation counting of 
samples, samples were suspended in 4ml of Ecoscint A (National Diagnostics) in 
5ml polypropylene pony vials (Packard)
27. Radiolabelling of the p50 DNA binding site.
For the "^^ C iodoacetate radiolabelling of the NF-kB p50 subunit aa35-381 
protein, lOOug of p50 protein in 400ul of PBS, 20mM DTT, was incubated on ice 
with 200ul of HIV oligonucleotide-Sepharose affinity resin for 3 hours, the 
mixture centrifuged briefly in a microcentrifuge, and the supernatant removed.
The HIV-Sepharose resin was then washed with 2ml of O.IM NaCl, lOmM sodium 
phosphate buffer,pH7.5, 2mM DTT and the supernatant removed. Neutral 250mM 
iodoacetate solution (see above) was added to give a final iodoacetate
concentration of lOmM, and the mixture incubated for 15 minutes at 20°C. The 
affinity resin was then washed with 2ml of O.IM NaCl, lOmM sodium phosphate 
buffer,pH7.5,2mM DTT, the supernatant removed and bound p50 protein eluted 
with 1ml 0.6M NaCl, lOmM sodium phosphate,pH7.5, 2mM DTT. The 1ml of 
eluate was concentrated to 300ul by centrifugation through a Centricon-30 
membrane, and neutral ^^C iodoacetate solution added to give a ^^C iodoacetate
concentration of lOmM, before incubation for 25 minutes at 20°C. Finally, tlie 
reaction was quenched by addition of DTT to 50mM and incubating for 25
minutes at 20° C.
28. Isolation and sequencing of a radiolabelled cysteine-containing 
peptide.
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Tlie quenched radiolabeUed p50 subunit aa35-381 protein was then precipitated 
by addition of TCA to 10%, and centrifuged in a Beckman TLIOO rotor at 50000
ipm at 4*C for 20 minutes. Uie supernatant was removed, and precipitated 
protein washed twice briefly with ice-cold acetone, before air drying on ice. The 
dried p50 protein pellet was then redissolved in 50ul of 8M urea (Sigma), 0.4M 
ammonium bicarbonate buffer, the urea concentration reduced to 2M by dilution 
with water, and the p50 protein digested with 3ug of bovine trypsin (Sigma) at
37*C for 24 hours. Tlie trypsin digested p50 protein was then analysed by reverse 
phase chromatography using a Waters HPLC system with a Delta-Pak Cl 8 column 
and a 0 to 80% acetonitrile gradient in 0.06% v/v trifluoroacetic acid (Sigma) run 
at a flow rate of 0.5ml per minute. Peptides eluted from the Cl 8 column were 
collected over 180 x 0.25ml fractions and lOul aliquots from each fraction spotted 
onto 5mm x 5mm squares of Wliatman 3MM chromatography paper, dried, and 
the chromatography paper immersed in 5ml Ecoscint A and scintillation counted. 
Peak radioactivity HPLC fractions were identified, and the corresponding peptides 
subjected to N-terminal amino acid sequencing (kindly perfomied by 
Dr.W.Kaszubska, Glaxo IMB, Geneva).
81
TAGTAGT -454
U3
TGGAAGGGCTAATTCACTCCCAACGAAGACAAGATATCCTTGATCTGTGGATCTACCACA
C O U P  API C O U P
CACAAGGCTACTTCCCTGATTA 
A PI
3CAGAACTACACACCAGGGCCAGG ilGTCA GATATCCAC
NF - AT
PGACC rTTGGATGGTGCTACAAGCTAGTACCAGTTGAGCCA ÎATAAGGTAGAAGAGGCCA
ACAAAGGAGAGAACACCAG
NF - AT
3TTGTTACACCCTGTGAGCCTGCATGGGATGGATGACC
U S F
AGAGAGAAGTG TTAGAGTGGAGGTTTGACAGCCGCCTAGC 
TCP-la
ATTTCATCACGTGG 2CCGAG
N F - K B
AGCTGCATCCGGAG TACTTCAAGAACTGCT ÎATATCGAGCTTGCTACAA
CTG
N F - K B Spl(3) S p l (2) Spl (1)
3GGACTTTCC ^G 5GAGGCGTGGCC TGGGCGGGAC rGGGGAGTGGC
T A T A B o x INT U 3  1 R  ^ B P - l / L B P - 1
3GGACTTTCC
3AGCCCTCAGAT
ICTGGGAGC rCTC TGGCTA JCTAGGGAACCCACTGCTTAAGCCTCAATAAAGCTTGCCT
R Ÿ  U5
TGAGTGCTTCAAGTAGTGTGTGCCCGTCTGTTGTGTGACTCTGGTAACTAGAGATCCCTC
-394
-334
-274
-214
-154
-94
-34
CCTGCA lATAA 3CAG CTGCTTTTTGCCTGTACT 3GGTCTCTCTGG TTAGACCAGATCTGA +2 6
UBP -2 CT F / N F I TAR Region
+ 86
+146
AGACCCTTTTAGTCAGTGTGGAAAATCTCTAGC +200
RESULTS.
Chapter 1. Purification and characterisation of HeLa cell NF-kB,
1.1 Purification of HeLa cell NF-kB protein
In common with other retroviruses, the integrated proviral form of HIV-1 is 
flanked by two long terminal repeats (LTRs), these LTR sequences contain 
binding motifs for multiple endogenous transcription factors. Alterations in the 
activities of several of these cellular factors in response to cell activation or 
differentiation ensure that in the infected cell, the initial transcription of the 
HIV-1 pro virus responds to many of the same regulatory mechanisms controlling 
the expression of cellular genes, hi addition to the complex pattern of binding sites 
for cellular factors in the HIV-1 LTR (extending from -454 to -t-184 relative to 
the proviral transcriptional start site), regulatory regions in DNA and RNA foims 
of the LTR act as targets for virally-encoded transactivator proteins (Figure 1.1).
As noted above, the HIV-1 LTR extends from -454 to +184 relative to the 
transcriptional start site (Ratner et al., 1985; Wain-Hobson et al., 1985), and can 
be conveniently classified into three main regulatory regions - a modulatory 
element extending from -454 to -78, a core promoter element extending from -78 
to -1, and the trans-activating response (TAR) element from +1 to +60. Within 
this modulatory element, there are at least six well-defined motifs which bind 
cellular transcription factors, in addition to several poorly-characterised motifs, 
hiterestingly, the modulatory element motifs are a mixture of positive and 
negative regulatory elements. Tlius, as discussed in the Introduction, the two kB 
sites of the proviral enliancer region (-105 to -80) have been shown to be critical 
for increased gene expression from the HIV-1 LTR in response to T-cell
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Figure 1.1 Location of trans acting factor binding sites on the HIV-1 
LTR.
The regions of the HIV-1 LTR (-454 to +184) which bind cellular trans-acting factors are 
indicated by boxed sequences, the following abbreviations were used :- COUP - chicken 
ovalbumin upstream promoter, AP-1 - activator protein 1, NF-AT - nuclear factor of 
activated T-cells, USF - upstream stimulatory factor, TCF-la - T-cell factor-la, N F - k B  -  
nuclear factor kB , Spl- Spl transcription factor, TATA - TATA binding protein, INT - 
initiator element, UBP-1 - untranslated binding protein-1, LBP-1 - leader binding 
protein-1, UBP-2 - untranslated binding protein-2, CTF/NFI - CCAAT transcription 
factor/nuclear factor I. The U3, R, and U5 regions of the LTR are indicated, and the 
transcriptional start site at +1 is indicated by a horizontal arrow.
activation signals (Tong-Starksen et al., 1987; Nabel and Baltimore, 1987). Recent 
in vivo footprinting studies (Demarchi et al., 1992) have confirmed that in a 
productively HIV-1-infected H-9 T-cell line, major protein footprints are 
observed over the -105 to -80 enhancer region as predicted from numerous in 
vitro studies.
Other positive or potentially positive factor binding motifs include the -138 to 
-123 region which binds the 55kD cellular transcription factor T C F-la 
(Wateiman and Jones, 1990; Waterman et al., 1991) - a T-ceU-specific 
transcription factor which can bind to pyrimidine-rich sequences in both the 
T-ceU receptor C a gene and the HIV-1 LTR. This TC F-la protein shares a 68 
amino acid conseived so-called high mobility group (HMG) motif with a number 
of other transcription factor proteins - including the HMG proteins (Wen et al.,
1989), the RNA polymerase I enhancer binding protein hUBF (Jantzen et al.,
1990), and the gender-determining testis-specific factor SRY (Gubbay et al.,
1990). The observation that primary isolates of HIV-1 containing duplications of 
T C F-la binding sites show increased growth rates in T-lymphocytes compared to 
wild type isolates (Golub et al., 1990) suggests that binding of the TC F-la 
transcription factor may be involved in positive regulation of HIV-1 growth.
StiU further upstream from the transcriptional start site lies the so-called 
NF-AT region - within this region are two purine-rich regulatory sequences 
which bind cellular factors which some workers have proposed to have positive 
effects on HIV gene expression. One region extending from -292 to -255 binds the 
factor NF-AT - a factor present in low levels in unstimulated T-cells and other 
ceU lines whose binding activity increases dramatically upon ceU activation (Shaw
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et al., 1988), while another region extending from -216 to -203 is homologous to 
the NF-AT binding site of the IL-2 gene enhancer.
A final potentially positive type of regulatory sequence comprises binding sites 
for the cellular inducible transcription factor AP I - this heterodimeric complex 
of c-fos and c-jun gene family products has been shown to be important in the 
expression of a number of cellular genes (Angel et al., 1988; Landschulz et al., 
1988). Within the LTR, there are two AP-1 recognition sites - running from -347 
to -343, and -333 to -329 inclusively (it is interesting to note that the intragenic 
transcriptional enhancer identified in the HIV-1 pol gene contains three functional 
AP-1 sites (van Lint et al., 1991)).
Binding of the AP-1 factor to its recognition site in promoter elements, for 
example in the simian vims SV40 promoter, mediates increases in the 
transcription rate of the promoter in response to stimuli such as treatment with the 
active phorbol ester phorbol myristyl acetate (PMA), semm growth factors such 
as epidermal growth factor (EOF), tumour necrosis factor a , and certain 
transforming oncoproteins - for example polyomavims middle T antigen. 
However, it is also possible that the individual fos and jun protein subunits, by 
interacting (via their leucine zipper structures) with certain other nuclear and 
transcription factor proteins could generate new protein species with negative 
effects on gene expression (Landschulz et al., 1988).
Upstream from the T C F-la site is a negative regulatoiy element (NRE) 
(initially thought to be between residues -185 and -340, Rosen et al., 1985), this 
comprises binding sites for the upstream stimulatory factor (USE) - a cellular 
protein initially identified as a factor increasing the activity of the adenovims
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major late promoter (Carthew et al., 1985) - located between residues -173 and 
-160, and a binding site for the chicken ovalbumin upstream promoter 
transcription factor (COUP-TF). It seems likely that the USF binding site acts as a 
negative regulatory element in the HIV LTR, since HlV-1 constructs containing 
deletions of this region show increased gene expression and growth kinetics (Lu et 
al., 1989). However, it may also be that USF (a helix-loop-helix motif protein) 
may be able to heterodimerise with other (potentially positive regulatory) 
helix-loop-helix motif proteins - which may themselves be able to bind as 
homodimers to the USF motif (Murre et al., 1989).
Tlie COUP-TF binding site in the NRE extends from -371 to -334, and contains 
a palindromic recognition sequence which is recognised by the 68kD form of 
COUP-TF - this factor being abundant in T-lymphocytes. The mutation of 
COUP-TF binding sites in the HIV-1 LTR gives rise to a two- to three-fold 
increase in HIV-1 gene expression - evidence for a negative regulatory role in the 
context of the LTR (Orchard et al., 1990; Cooney et al., 1991). However, more 
complex regulatory possibilities also exist - for example, one of the AP-1 binding 
sites of the LTR overlaps with the COUP-TF element, allowing the possibility of 
one factor preventing the binding of the other by direct competition. Further, 
since COUP-TF proteins belong to the steroid/thyroid hormone receptor 
superfamily, and the fos and jun proteins may be able to form complexes with 
such receptor proteins and antagonise their transcriptional activity (Schüle et al.,
1990), the possibility may exist for both the AP-1 and COUP-TF binding sites to 
mediate positive and negative effects on gene expression from the LTR.
Tlie second major region of the HIV-1 LTR is the core promoter element -
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extending from -78 to -1 relative to the transcriptional start site - within this 
region are binding sites for three cellular, positive regulatory factors - the 
transcription factor Spl, the TATA-binding general transcription factor TFIID, 
and initiator binding proteins.
Core promoter element sequences extending from -78 to -46 have been shown 
by mutagenesis studies to contain three binding sites for the cellular transcription 
factor Spl (Jones et al., 1986), the mutation of all three Spl binding sites was 
shown to eliminate the ability of added exogenous Spl protein to stimulate in vitro 
transcription directed by the HIV-1 LTR. Similarly, transfection studies of HIV-1 
constructs have demonstrated that constmcts with mutations of one or two Spl 
binding sites showed only small decreases in basal and tat-induced gene 
expression, while constructs with mutations of all three Spl binding sites showed 
severe decreases in basal and tat-induced gene expression (Harrich et al., 1989).
Tlie second positive core promoter element sequence is a consensus TATA box 
running from -28 to -24, representing the binding site for the TATA binding 
protein TFIID. Mutagenesis studies have shown that the TATA box has a critical 
role in the activation of HIV-1 gene expression - by tat, and by other viral 
transactivator proteins (Garcia et al., 1989). Similarly to the Spl case, mutation of 
the TATA element dramatically reduces in vitro transcription activity directed by 
the HIV-1 LTR (Jones et al., 1988). Again, transfections of HIV-1 LTR plasmids 
bearing mutations in the TATA element showed marked decreases in basal and 
tat-induced gene expression (Garcia et al., 1989). An interesting observation from 
DNase I footprinting experiments in the above study suggested the binding of 
cellular factors over both the TATA element and flanking sequences - hence the
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flanking sequences in addition to the TATA box may be critical determinants of 
LTR function.
The final type of element in the core promoter are two potential initiator 
elements - a type of motif initially identified by Smale and Baltimore (Smale and 
Baltimore, 1989) as a sequence surrounding the RNA start site in the terminal 
deoxynucleotidyl transferase (TdT) gene which helped to determine the position 
of RNA initiation in this TATA-less gene - in the HIV-1 LTR, these possible 
initiator elements extend from -18 to 4-1.
The third, and final, region of the HIV-1 LTR is the trans-activating response 
(TAR) element which extends from +1 to +60 relative to the transcriptional start 
site. This region shows an interesting duality - both the TAR regions in the 
proviral DNA and the transcribed RNA bind several protein factors, with the 
TAR RNA also binding the virally-encoded trans-activator protein tat.
Studies of the TAR region DNA using techniques such as DNase I footprinting 
and gel electrophoresis mobility shifts have shown that several cellular proteins 
bind to this region - these include the ceUular factors UBP-l/LBP-1, UBP-2 and 
CTF/NFI. The UBP-l/LBP-1 factor binds to a high affinity site extending from 
-16 to +27 (and also to a low affinity site extending from -38 to -16) (Kato et al.,
1991). In vitro transcription experiments reported in the above study with 
purified UBP-l/LBP-1 suggested that binding to the low affinity site inhibited 
HIV-1 LTR gene expression by preventing TFIID from binding to the TATA 
element - however, if the promoter was preincubated with TFIID then no such 
inhibition was seen. The role of the high affinity UBP-l/LBP-1 site is less clear - 
it did not cause repression of transcription in the above study. However, in the
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study by Kato et al. no convincing evidence could be obtained for the proposed 
positive role (Jones et al., 1988) of the high affinity UBP-l/LBP-1 site. Tlie role 
of bo til the cellular UBP-2 factor (Garcia et al., 1989) which binds to TAR DNA 
sequences +28 to +36, and the cellular CTF/NFI factor (Garcia et al., 1989; Jones 
et al., 1988) binding TAR DNA sequences from +41 to +46 remains as yet 
unclear.
In transcribed HIV-1 RNA, the TAR region is also able to interact with a 
variety of protein factors - both cellular and virally-encoded, by virtue of its 
ability to form a stable stem-loop structure extending from nucleotide +1 to +60. 
Within this region of the viral RNA, there is very extensive self-complementarity, 
allowing the formation of a 24 base pair stem structure - whose only significant 
interruption is a non-paired bulge on one side of the stem incoiporating 
nucleotides +23 to +25, and the loop structure comprising nucleotides +30 to +35, 
The TAR RNA region between +18 and +44 is critical for the function of the 
viral tat transactivator protein (Garcia et al., 1989; Feng and Holland, 1988; Roy 
et al., 1990), and within this several elements (the bulge, the loop, and the stem 
structure) shown to be needed for complete tat activation.
The +23 to +25 bulge in the TAR RNA stem-loop structure seives as a high 
affinity binding site for the viral tat protein, although tat binding is also 
modulated by sequences in the loop region (Roy et al., 1990; Dingwall et al.,
1990). In contrast, the TAR RNA loop sequence contains binding sites for cellular 
proteins which may cooperate with tat protein in amplifying gene expression. Two 
cellular factors - p68 and TRP-185 - have been identified (Marciniak et al., 1990; 
Wu et al., 1991) which bind to the TAR RNA loop sequences. Binding of the
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TRP-185 factor requires both wild type loop sequences and an intact bulge 
structure (unlike tat, the nature of the bulge sequence seems to be unimportant), 
and increases transcription from the HIV-1 LTR in vitro - it seems unclear at 
present whether TRP-185 stimulates transcriptional initiation or elongation (Wu et 
al., 1991).
The question of the mechanism of action of the tat transactivator protein 
remains unresolved, early studies suggested that tat exerted its function on the 
TAR RNA - fusion proteins of tat with sequence-specific RNA binding proteins 
were able to bind and activate gene expression from the HIV-1 LTR in constructs 
where the TAR region had been substituted by the appropriate regulatory element 
(Selby and Peterlin, 1990; Southgate et al., 1990). However, similar fusion protein 
experiments have been performed linking tat to the DNA binding domains of 
sequence-specific DNA binding proteins such as the transcription factor jun 
(Berkliout et al., 1990), with similar activation of gene expression from the HIV-1 
LTR. In any case it is clear that in the presence of tat, steady-state levels of 
transcription from the HIV-1 LTR are increased by 20- to 50-fold - likely 
representing contributions from tat protein stimulating transcriptional initiation 
and increasing the efficiency of the transcriptional elongation process (Laspia et 
al., 1989).
Since the general initial aim of this project was to investigate the role of the 
transcription factor NF-kB in the initial transcriptional activation process from 
the HIV-1 LTR, a strategy of purifying the heterodimeric p50-p65 NF-kB factor 
to homogeneity was decided upon. It was envisaged that amino acid sequence 
information from the purified polypeptides could then be used to isolate cDNA
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clones encoding the NF-kB subunits, and the proteins overexpressed for use in in 
vitro studies of transcriptional activation.
Following several unsuccessful attempts to purify the p50-p65 NF-kB 
heterodimer to homogeneity by multiple rounds of HIV enhancer 
oligonucleotide-Sepharose affinity chromatography - a technique significantly 
improved by Tjian and coworkers (Kadonaga and Tjian, 1986) - a more 
sophisticated purification strategy was adopted. As described in the Materials and 
Methods section, this purification scheme involved an initial HIV enhancer 
oligonucleotide-Sepharose column affinity chromatography step, followed by 
FPLC chromatography on a Pharmacia-LKB Mono-Q (diethylaminoethyl 
equivalent) column - and use of the very early eluting minor peak of NF-kB DNA 
binding activity from this chromatography step. This material was then applied to 
a non-specific Exoli DNA-Sepharose column under non-binding conditions, the 
flowthrough fraction collected and used in a final round of HIV enhancer 
oligonucleotide affinity chromatography.
The rationale behind this scheme was prompted by the observation that multiple 
rounds of HIV enhancer oligonucleotide affinity chromatography yielded a 
significant initial purification step, but subsequent stages did not give any fuither 
purification - presumably the contaminating polypeptide species were proteins 
with non-specific DNA binding activity for the affinity resin (although large 
amounts of synthetic poly dAdT.dAdT/dGdC.dGdC DNA were included in the 
load material applied to the HIV oligonucleotide affinity resin columns, this 
simple sequence DNA might not be effective at competing away all non-specific 
binding). Thus the material eluted from the first HIV enhancer oligonucleotide
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Figure 1.2 Purification of native NF-kB protein.
A. Protein fractions from the HIV oligo /  Mono-Q / E.coli DNA / HIV oligo column 
chromatography purification analysed by SDS-PAGE under reducing conditions, 
followed by silver staining (BioRad) of the gel. For gel analysis, 200ul aliquots of the 
various protein fractions were TCA precipitated, and then resuspended in 6ul of Ix 
sample buffer (see Materials and Methods) before boiling, quenching on ice, and loading 
onto the gel. The following abbreviations were used for the sample tracks:- M, molecular 
weight standards; IL, crude HeLa cell nuclear extract load for first HTV enhancer 
oligonucleotide-Sepharose affinity chromatography stage; IFT, flowthrough fraction 
from the first chromatography stage; IW, wash fraction from the first chromatography 
stage; IE, eluate from the first chromatography stage; EcL, Mono-Q-derived load for 
E.coli DNA-Sepharose chromatography stage; 4L, load for the fourth chromatography 
stage (HIV oligonucleotide-Sepharose chromatography); 4FT, flowthrough fraction from 
the fourth chromatography stage; 4W, wash fraction from the fourth chromatography 
stage; 4E, eluate from the fourth (final) chromatography stage. The positions of the 
various molecular weight standard marker proteins are indicated.
B. Protein fractions from the above 4 column purification procedure assayed for 
kB-DNA binding activity by a gel electrophoresis DNA binding assay in which the 
standard incubation mixture (see Materials and Methods) had been supplemented with 
0.06 ug/ul poly dAdT.dAdT/dGdC.dGdC carrier DNA - in each case 2ul of protein 
fractions were used in the assays. The abbreviations for the sample tracks are as in panel 
A, with no material loaded in the track marked the positions of the DNA-protein 
complex and the free HIV-L oligonucleotide probe are indicated are indicated by B and F 
respectively.
M IL IFT IW lE EcL 4L 4FT 4W 4E M
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affinity purification round (Figure 1.2, Panel A) was still grossly impure 
(although the bulk of the contaminating protein was found in the flowthrough and 
wash fractions). This material was then loaded onto the Mono-Q FPLC column 
and proteins eluted with a 0 to 5M NaCl gradient - it had been noted in earlier 
studies (Clark, 1989) that if a HeLa cell nuclear extract was loaded onto a 
DEAE-Sepharose column, a significant fraction of NF-kB activity would fail to 
bind to the column, while the remainder would bind and could be eluted with a 
salt gradient.
Elution of kB  binding proteins from the Mono-Q column yielded a moderate 
amount of N F -kB DNA binding activity which eluted from the column before the 
salt gradient was applied (Figure 1.3, Panels A and B). The kB  DNA binding 
activity of the various fractions was monitored using the standard gel 
elctrophoresis DNA binding assay (Figure 1.3, Panel B) and fractions 9 to 14 - 
which were found to be largely free of contaminating protein (Figure 1.3, Panel 
A) - pooled, and the NaCl concentration adjusted to 0.35M before passing over the 
E.coli DNA-Sepharose column. Comparison of the polypeptide species in the 
E.coli DNA column load and the final HIV enhancer oligonucleotide affinity 
column load (Figure 1.2, Panel A) showed the selective removal of some proteins 
after passage over the E.coli DNA column - most notably a species of 
approximately 120 kD molecular weight. Passage of this E.coli DNA column 
flowthrough material over a final round of HIV enhancer oligonucleotide affinity 
chromatography yielded a final eluate (Figure 1.2, Panel A - Fraction 4E) which 
contained 6 polypeptide species visible after silver staining of the SDS-PAGE gel - 
relatively minor amounts of proteins of approximately 140,48, 36 and 34 kD
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Figure 1.3 FPLC Mono-Q column chromatography of NF-kB protein.
A. The UV absorbance output trace at 280nm is shown (solid line) for the elution of the 
FPLC Mono-Q column with a 0 to 5M NaCl salt gradient (dashed line), the positions of 
the fractions collected from the gradient are indicated along the base.
B. Fractions 1-27 eluted from the Mono-Q column assayed (3ul of each fraction) for 
NF-kB DNA binding activity by gel electrophoresis DNA binding assay with the 
standard incubation mixture supplemented with 0.06 ug/ul poly 
dAdT.dAdT/dGdC.dGdC carrier DNA and using the HIV-L oligonucleotide probe. The 
amounts of radioactivity in the DNA-protein complexes were determined by direct 
Cerenkov counting of wet polyacrylamide gel slices.
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molecular weight, and two major species of approximately 55 and 43 kD 
molecular weight - the 43 kD component being noticeably concentrated in the 
final eluate compared with the preceding flowthrough and wash fractions.
Tliis final eluate fraction although highly purified was still heterogeneous and 
hence likely to be unsuitable for amino acid sequence analysis, the overall 
recovery of NF-kB DNA binding activity was also very low (Table I). From the 
gel electrophoresis DNA binding assays (Figure 1.2, Panel B, Figure 1.3, Panel B) 
it can be seen that large amounts of NF-kB DNA binding activity (approximately 
47%) were lost to the flowthrough fraction from the first HIV oligonucleotide 
affinity chromatography round - whether this was due to overloading of the 
affinity column by competition from other DNA-binding proteins in the crude 
extract, or due to the addition of excessive amounts of non-specific carrier DNA 
to the crude extract is unknown. Fuitlier losses occurred inevitably in the FPLC 
Mono-Q chromatography stage since only a small fraction (approximately 25%) 
of NF-kB DNA binding activity appeared in the early eluting fractions which 
were largely free of contaminating proteins - whether the proportion of early 
eluting activity could be increased by use of different sources of crude extract, or 
cell physiological state is not known.
1.2 Lectin affinity column characterisation of HeLa cell NF-kB 
protein
Following reports that a number of nuclear proteins had been found to carry 
0-glycosidically linked N-acetylglucosamine residues (Holt and Hart, 1986), it was 
demonstrated by Tjian and coworkers that this sugar group was present on a 
variety of RNA polymerase II transcription factors (Jackson and Tjian, 1988) -
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such as human Spl, AP-1, AP-2, AP-4, CTF/NFI, Drosophila Zeste, GAGA and 
Adf-1 (although only some members of the CTF/NFI and AP-1 families seemed to 
carry this modification), but was not present on a limited sample of RNA 
polymerase I and III transcription factors. Jackson and Tjian made use of this 
property (Jackson and Tjian, 1989) to purify human Spl transcription factor by a 
rapid and high yielding affinity purification scheme involving passing crude HeLa 
ceU nuclear extracts over a column of agarose-conjugated wheat germ agglutinin 
(WGA) - a lectin with binding specificity for N-acetylglucosamine and a variety 
of sialic acid residue species, eluting the bound material and passing the 
N-acetylglucosamine-bearing proteins over a conventional Spl recognition site 
oligonucleotide affinity column. In the above study, the WGA-agarose affinity 
column step gave an approximately 200-fold purification of Spl, with a recovery 
of over 90% of the initial Spl activity - suggesting that this technique might be 
applicable to NF-kB protein purification.
The protocol used for the WGA-agarose affinity purification of NF-kB proteins 
was virtually identical to that of Jackson and Tjian (1989) - however it was found 
that once the crude HeLa cell nuclear extract was applied to the WGA-agarose 
column it proved impossible to elute the NF-kB DNA binding activity from the 
column (Figure 1,4, Panel A). That this effect was not unique to NF-kB proteins 
was confirmed by carrying out parallel gel electrophoresis DNA binding assays 
with a radiolabeUed restriction fragment probe encoding multiple binding sites for 
the Spl transcription factor - this showed identical behaviour, the Spl binding 
activity could not be eluted from the WGA-agarose column with O.IM KCl 
buffer containing 0.3M N-acetylglucosamine (data not shown).
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Figure 1.4 Attempted lectin affinity chromatography of NF-kB protein.
A. Protein fractions from the attempted wheat germ agglutinin-agarose affinity 
purification of N F - kB  DNA binding proteins following the method of Jackson and Tjian 
(1989) were analysed by gel electrophoresis DNA binding assay with the standard 
incubation mixture supplemented with 0.06 ug/ul poly dAdT.dAdT/dGdC.dGdC carrier 
DNA. Assays used radiolabelled HIV-R oligonucleotide as the probe, 2ul of protein 
fractions were used in each assay. The following abbreviations were used for the sample 
tracks L, high salt HeLa cell nuclear extract load to WGA-agarose column; FT, 
flowthrough fraction from the WGA-agarose column; Wl, high salt wash fraction; W2, 
low salt wash fraction; 1-10, sequential 1ml eluate fractions. The DNA-protein complex 
and free oligonucleotide bands are indicated by B and F respectively.
B, Protein fractions from the attempted wheat germ agglutinin-agarose affinity 
purification of NF-kB DNA binding proteins using the modified protocol involving 
addition of N-acetylglucosamine to O.IM to the nuclear extraction buffer. Gel 
electrophoresis DNA binding assay conditions and figure legend abbreviations were as in 
Panel A above.
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Numerous variations of the WGA-agarose chromatography procedure failed to 
elute NF-kB DNA binding activity from the column - including raising the 
N-acetylglucosamine concentration in the eluant to 0.7M. Compare this with the 
observation that while 0.3M N-acetylglucosamine buffer was used in die elution 
protocol of Jackson and Tjian (1989) to elute Spl, the Spl protein could still be 
eluted efficiently by 20mM N-acetylglucosamine buffer (S.P.Jackson pers. 
comm.).
Despite the observation of identical behaviour by the transcription factor Spl, it 
might be possible to argue that passage over the WGA-agarose column had in 
some way inactivated the NF-kB DNA binding protein. From the behaviour of 
NF-kB and Spl in binding seemingly irreversibly to the WGA affinity column, it 
seemed possible that polyvalent binding of the proteins to the affinity matrix 
might be occurring - it having already been demonstrated in one study (Jackson 
and Tjian, 1988) that Spl protomers carried approximately eight 
N-acetylglucosamine residues. Since one method of overcoming irreversible 
binding due to polyvalent interactions with lectin columns in cell fractionation 
experiments has been to include the cognate simple sugar in the binding mixture 
applied to the column, a similar approach was used here, with 
N-acetylglucosamine being added to O.IM in the high salt buffer used for the 
nuclear extraction. This approach was at least partially successful - in that NF-kB 
(and Spl) DNA binding activity could be eluted from the column with virtually 
100% recovery, however the binding activity was present in the 0.42M KCl high 
salt buffer wash fraction (Figure 1.4, Panel B) - since this fraction still contains 
approximately 50% of the total protein applied to the WGA-agarose affinity resin,
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it did not represent a useful purification step. Although several attempts were 
made with modified protocols to elute the NF-kB DNA binding activity after the 
contaminating non-binding proteins, none of these were successful, and any 
attempts to use WGA-agarose affinity chromatography as a purification step 
abandoned. However, the results obtained here do at least suggest that all NF-kB 
DNA binding proteins present in nuclear extracts of the S3 HeLa cell line used in 
these studies are modified with multiple sugar residues capable of binding to 
wheat germ agglutinin - most probably, N-acetylglucosamine residues.
1.3 DNA Bending of crude and affinity purified native HeLa cell 
NF-kB
Prompted by many reports of the importance of DNA bending in the assembly 
of large nucleoprotein structures involved in the control of transcription, DNA 
replication and site-specific recombination processes (Schultz et al., 1991; Zorbas 
et al., 1989; Thompson and Landy, 1988), and of observations that binding of 
NF-kB to its recognition site seemed to distort the structure of the DNA with 
indications of disruptions in base pairing (Clark et al., 1990), the DNA bending 
properties of NF-kB were studied using gel electrophoresis DNA binding assays 
with restriction fragment probes carrying tlie HIV-R kB motif in 
circularly-permuted locations. This technique, originally developed by Wu and 
Crothers (Wu and Crothers, 1984) will detect DNA bending induced by protein 
binding to a specific recognition site by the position-dependent variation in 
electrophoretic mobility of the DNA-protein complexes. In this type of analysis, 
the DNA with the highest mobility has the bend-inducing protein bound near the 
end of the DNA fragment, and the DNA with the lowest mobility has the protein
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bound at the middle of the fragment. Identifying tliose fragments with the highest 
and lowest mobilities allows tlie mapping of tlie bend centre, while an estimate of 
tlie angle of bending can be derived from the ratio of the electrophoretic 
mobilities of complexes with the protein bound at the end of tlie DNA and at the 
centre of the DNA fragment (Tiiompson and Landy, 1988).
The circular permutation bending analysis in these studies used the 
p2xAT/HIV-R plasmid, this carries a duplication of a region containing the HIV-R 
idB binding motif and several unique restriction endonuclease cleavage sites - such 
that upon digestion witli the restriction enzymes Hind III, Sph I, Bam HI, Avi II 
and Eco RV, an approximately 600bp fragment is released from the parental 
DNA. The various 600bp restriction fragments were radiolabelled and used 
in gel electrophoresis DNA binding assays, these were essentially identical to the 
standard assay - but used a 5% non-denaturing (44:0.8) polyaciylaniide gel, and 
binding incubation mixtures supplemented with 0.16 ug/ul poly 
dAdT.dAdT/dGdC.dGdC carrier DNA and an additional 1% NP40.
Tlie results of these studies showed an interesting pattem (Figure 1.5, Panel A) - 
with crude HeLa cell nuclear extracts prepared according to the method developed 
by Dignam (Dignam et ah, 1983) (Figure 1.5, Panel A) the mobility pattem of the 
various penmited binding site complexes shows the smooth V-shape (with 
complexes with the kB binding site at the end of the (Bam HI) restriction 
fragment showing the highest mobility) seen in many other circular permutation 
studies, and there also seems to be only one complex band. Further, the 
pre-addition of HIV-R icB site oligonucleotide and p2xAT/HIV-R plasmid showed 
an unexpected variation in competition behaviour - although pre-addition of the
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Figure 1.5 DNA bending induced by binding of NF-kB proteins.
A. DNA bending and competition studies using Dignam HeLa cell nuclear extract and 
NF-kB proteins purified by four cycles of HIV oligonucleotide affinity chromatography. 
Gel electrophoresis DNA binding assay conditions followed the standard procedure but 
with the addition of poly dAdT.dAdT/dGdCdGdC carrier DNA to 0.16 ug/ul, and 
addition of an extra 1% NP40 to the binding incubation mixture, gel electrophoresis was 
carried out on a 5% (44:0.8) non-denaturing polyacrylamide gel. The following 
abbreviations were used :- M, DNA restriction digest size markers (1/Hind III and 
pUC13/Hinf I); H, Hind III digest generated 600bp probe; S, Sph I digest generated 
probe; B, Bam HI generated probe; A, Avi II generated probe; E, Eco RV generated 
probe, PI. indicates precompetition by 3.4ug of undigested p2xAT/HIV-R plasmid, 01. 
indicates precompetition by lug of HIV-R kB  oligonucleotide, the DNA-protein complex 
and free restriction fragment probe are indicated by B and F respectively. For those 
experiments using Dignam nuclear extract, 0.2ul of extract were used in each case, while 
for those experiments using the four cycle HIV oligo affinity purified protein, lul of final 
eluate was used in each case.
B. DNA bending and competition studies using N F - kB  proteins purified by HIV 
enhancer oligonucleotide-Sepharose affinity chromatography, followed by FPLC 
Mono-Q, E.coli DNA-Sepharose, and a final HIV enhancer oligonucleotide-Sepharose 
affinity purification stage. The experimental details and abbreviations were identical to the 
previous experiment. For each experiment, 4ul of the four-stage purified eluate was used 
as the source of N F - kB  DNA binding activity.
Dig.N.E. Dignam N.E. 4xHIV-Seph. Cycles 4*HIV-Seph.r m. ' PI. 0 1 .' m  *H S B a  e ' m 'H  S B a  E M" PI. OI
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4E Eluate 4E Eluate
* PI. 01.
undigested p2xAT/HIV-R plasmid could compete away binding of the NF-kB 
binding proteins in the Dignam nuclear extract, the addition of a much greater 
molar excess (lug) of the HIV-R oligonucleotide could not compete away 
formation of the radiolabelled complex. Finally, examination of the mobilities of 
the free restriction fragments used as the probes in these experiments indicates 
that they all show identical mobilities - thus there are no inherent bends in these 
DNA sequences which could be spuriously interpreted as bending in the 
DNA-protein complexes.
In contrast, NF-kB binding proteins which had been partially purified by four 
cycles of HIV enhancer oligonucleotide-Sepharose affinity chromatography 
showed both a different pattem of complex mobilities and competition behaviour - 
each restriction fragment probe species now yielded three complexes of differing 
mobilities (Figure 1.5, Panel A). Interestingly, the complexes involving Hind HI, 
Sph I, Avi n , and Eco RV-generated restriction fragments aU seemed to show 
identical mobilities across these four tracks, while the three complexes involving 
the Bam Hl-generated fragment all showed a much higher mobility. One 
possibility might be that these partially purified NF-kB binding proteins might no 
longer bend the DNA, or might bend it over a smaller angle upon bindiug to their 
recognition site. Further, aU three of these radiolabelled complex species could 
now be competed by pre-addition of HIV-R kB site oligonucleotide (as well as by 
the undigested p2xAT/HIV-R plasmid).
Bearing the above behaviour in mind, some of the final eluate from the HTV 
oligo affinity / FPLC Mono-Q / E^coli DNA / HIV oligo affinity chiomatography 
purification scheme described in section 1.1 was studied by the same technique.
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This revealed (Figure 1.5, Panel B) the presence of essentially only one 
DNA-protein complex in each lane - with the same pattern of relative mobilities 
seen with protein purified by four rounds of HIV enhancer 
oligonucleotide-Sepharose affinity chromatography. Interestingly, the actual 
mobilities of the complexes seemed to be very similar to those of the highest 
mobility species in the above experiment using NF-kB proteins purified by four 
rounds of HIV enhancer oligonucleotide-Sepharose affinity chromatography.
From the above considerations, an analysis of the DNA bending angle and 
location of the bend centre induced by binding of NF-kB proteins can only be 
applied to the crude HeLa cell nuclear extract. Even here, although the pattem of 
the DNA-protein complexes seems homogeneous, the proteins giving rise to this 
must be a heterogeneous mixture.
1.4 Stimulation of NF-kB DNA binding activity by the polyamine 
spermidine
In view of the known ability of entities such as the polyamine spermidine and 
magnesium chloride to stimulate in vitro transcription reactions, these components 
were tested for any effect on the binding activity of HIV enhancer oligonucleotide 
affinity-purified NF-kB proteins by the standard gel electrophoresis DNA binding
assay (initially the binding assay incubation mixture contained neither MgCl2 nor
spermidine). Supplementing the incubation mixture with increasing amounts of 
speimidine (Figure 1.6, Panel A) caused a dramatic increase in the amount of 
DNA -protein complex formed, with titration experiments indicating that maximal 
stimulation was achieved by 3mM speimidine. Diis stimulation of NF-kB DNA 
binding activity by spermidine was also apparent with crude nuclear extracts of
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Figure 1.6 Stimulation of the DNA binding activity of affinity purified 
NF-kB by the addition of the polyamine spermidine.
A. Stimulation of DNA binding activity of HTV enhancer oligonucleotide-Sepharose 
affinity purified NF-kB proteins by addition of spermidine to the standard binding
incubation mixture (but lacking spermidine and MgCl2). Standard gel electrophoresis 
DNA binding assay conditions, radiolabelled HTV-L oligonucleotide used as the kB 
binding site probe, all experiments used 2ul of purified protein eluate. Positions of the 
DNA-protein complex and free oligonucleotide probe are indicated by B and F 
respectively.
B. Effect of the addition of MgCl2 on DNA binding activity and complex mobility in the
presence and absence of 3mM spermidine. DNA binding assay conditions as in the 
experiment in Panel A.
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active phorbol ester-treated Jurkat T-cells (data not shown). The addition of
MgCl2 to the binding assay incubation mixture did not yield any significant
increase in the amount of complex formed in either the presence or absence of
3mM spermidine, however MgCl2 addition did cause the DNA-protein complex to
show decreased electrophoretic mobility (Figure 1.6, Panel B). Hence aU other gel 
electrophoresis DNA binding assays were performed with the presence of 3.6mM
speimidine in the binding mixture (and 6.1mM MgCl2) - except where
specifically omitted.
Chapter 2. Identification of conserved cysteines in the NF-kB p50 
aa35-381 construct and the production of individual cysteine to serine 
mutant proteins.
2.1 Stimulation of NF-kB DNA binding activity by dithiothreitol
Following a report that the DNA binding activity of the heterodimeric AP-1
(fos-jun) transcription factor was modulated by the oxidation-reduction state of a
single conserved cysteine residue in each subunit (Abate et al., 1990) and that
mutation of these residues to serine enhanced the DNA binding activity of the
mutant, but abolished modulation of DNA binding activity by oxidation-reduction
state, the influence of oxidation-reduction state on the DNA binding activity of
NF-kB proteins was investigated.
As an initial experiment to determine if native NF-kB proteins could have their
DNA binding activity modulated in a similar way, a variety of sources of native
NF-kB proteins - nuclear and cytoplasmic extracts of Jurkat T-cells, Dignam
HeLa cell nuclear extract, and affinity purified NF-kB proteins were studied in
the standard gel electrophoresis DNA binding assay (with the binding incubation
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Figure 2.1 Stimulation of the DNA binding activity of various sources of 
NF-kB proteins by treatment with DTT,
Various sources of N F - kB  DNA binding proteins were used in the gel electrophoresis 
DNA binding assay (standard procedure but without addition of DTT to 25mM to the 
protein samples, and with addition of poly dAdT.dAdT/dGdC.dGdC carrier DNA to 
0.06 ug/ul to the binding incubation mixture). Jurkat nuclear extract experiments used 
2,5ul of nuclear extract, Jurkat cytoplasmic extract experiments used 2.5ul of cytoplasmic 
extract followed by addition of sodium deoxycholate to 1%, incubating 5 minutes at room 
temperature, then addition of NP40 to 1,5% and incubating again for 5 minutes at room 
temperature to liberate N F - kB  from the I kB  inhibitor protein (Baeuerle and Baltimore, 
1988a). Dignam HeLa cell nuclear extract experiments used lul of extract, while affinity 
purified NF-KB protein experiments used 2ul of protein eluate. In tracks marked 
HIV-L', specific binding was competed out by addition of lug of unlabelled HIV-L kB  
site oligonucleotide after the formation of the DNA-protein complex. In tracks marked 
'NEM', DNA binding activity was inactivated by addition of N-ethylmaleimide to lOmM 
and incubating 10 minutes at room temperature prior to quenching by addition of DTT to 
25mM, incubating on ice 10 minutes, and adding the radiolabelled HIV-L 
oligonucleotide. In tracks marked DTT', N F - kB  DNA binding activity was stimulated 
by the addition of DTT to 25mM and incubating 10 minutes on ice prior to the addition of 
the radiolabelled HIV-L oligonucleotide probe.
Jurkat Nue. Jurkat Cyto. HeLa Nue. AfT.Pur. NF-kB
HIV-LNEMDTT
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mixture supplemented with 0.06 ug/ul poly dAdT.dAdT/dGdC.dGdC carrier 
DNA). From this experiment it was apparent that all of these sources of N F -kB  
proteins formed specific DNA-protein complexes with the radiolabelled HIV-L 
kB  motif oligonucleotide probe (Figure 2.1), that the DNA binding activity of aU 
of these protein sources increased after addition of the reducing agent 
dithiothreitol (DTT) to 25mM and incubating on ice for 10 minutes, and that aU 
DNA binding activity could be abolished by addition of N-ethylmaleimide (NEM) 
to lOmM and incubating at room temperature for 10 minutes prior to quenching 
the reaction with DTT and addition of the HIV-L kB  motif radiolabelled probe. 
Since these results suggested that DNA binding activity might be modulated by the 
oxidation-reduction state of one or more cysteine residues, it would be essential to 
identify those cysteine residues for further study of this behaviour.
2.2 Conservation of rel region in NF-kB p50, and identification of 
candidate cysteine residues for mutagenesis 
With the timely publication of cDNA sequences encoding the p50 subunit of 
p50-p65 NF-kB (Kieran et al., 1990; Ghosh et al., 1990) it was now possible to 
study a single overexpressed protein species. Analysis of in vitro 
transcribed/translated proteins derived from the above cDNA sequences indicated 
that the p50 protein is initially translated as a lOSkD non-DNA binding precursor 
- only after a proteolytic cleavage event to remove roughly the C-terminal half 
can the p50 protein bind to its kB  recognition motif. In addition, the region of the 
p50 protein found to be responsible for its DNA binding and dimérisation 
functions was located roughly between amino acids 19 and 399 of the human p50 
NF-kB subunit (Kieran et al., 1990) - it was decided to generate a p50 protein
1 0 0
Figure 2.2 Comparison of the amino acid sequence of human NF-kB p50 
with related proteins.
The deduced amino acid sequence of the human p50 N F - kB  subunit (h-p50) (Kieran et 
al., 1990) compared with the deduced amino acid sequences of the murine p65 N F - kB  
subunit (m-p65) (Nolan et al., 1991), the Drosophila morphogen dorsal (dorsal) 
(Steward, 1987), the mouse c-rel protein (mc-rel) (Grumont and Gerondakis, 1989), rel 
B (rel B) (Ryseck et al., 1992), and the REV-T v-rel protein (v-rel) (Wilhelmsen et al., 
1984). Sequence numbering is relative to the methionine start codon of relB, while dots 
indicate spaces introduced to optimise sequence identity during alignment.
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construct running from amino acid 35 (translation from this third internal 
methionine codon having been shown to give p50 proteins still capable of binding 
DNA - A.Israel, pers. comm.) to amino acid 381 (just before the glycine-rich 
hinge’ region).
Compaiison of the predicted amino acid sequence of this DNA binding and 
dimérisation region of the p50 protein with other reported amino acid sequences 
revealed a high degree of similarity to a region in the turkey oncoprotein v-rel 
and a similar region in the Drosophila maternal effect morphogen protein dorsal 
(Kieran et al., 1990; Ghosh et al., 1990). Further, within the p50 amino acid 35 to 
381 region selected for this study, were seven cysteine residues - most 
interestingly, three of these were absolutely conseived among the various amino 
acid sequences of this family (Figure 2.2). These three cysteines occurred at 
positions 62,119 and 273 in the p50 amino acid sequence and were obvious 
candidates for individual site-directed mutagenesis to serine residues.
2.3 Generation of cDNAs encoding wild type and cysteine to serine 
m utant NF-kB p50 aa35-381 proteins 
For the generation of a cDNA encoding wild type NF-kB p50 protein amino 
acids 35 to 381, the appropriate region of DNA was amplified by the polymerase 
chain reaction (PCR) using the appropriate oligonucleotide primers and a 
pBluescript plasmid containing the cDNA encoding the p i05 precursor to p50 
(kindly provided by A.Israel) as the template source. As described in the Materials 
and Methods section, 25 cycles of DNA amplification yielded an essentially 
homogeneous product with the predicted size of approximately 1065bp upon 0.8% 
agarose gel electrophoresis (result not shown).
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Figure 2.3 Schematic of PCR site-directed mutagenesis.
The first stage of the PCR mutagenesis scheme used two external primers (a and d) 
encoding recognition sites for Bam HI and Eco RI restriction enzymes, and two internal 
mutagenising primers (b and c) to generate two partial length mutant cDNA products - 
AB and CD. These were then gel puiified and mixed together to provide the template for 
a second PCR amplification stage using only the external primers (a and d) to generate the 
full length mutant cDNA product.
PCR Mutagenesis
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For the generation of the three mutant cDNA species encoding the cysteine to 
serine mutations at amino acid positions 62,119, and 273, a rapid PCR 
mutagenesis method was used (Ho et al., 1989) - as described in the Materials and 
Methods section, this involved the use of two internal mutagenising primers and 
the two external PCR primers to generate two partial length mutant cDNA 
products. The partial length cDNA products were essentially homogeneous and of 
the expected sizes when analysed by agarose gel electrophoresis (data not shown). 
The remainder of the partial length products were agarose gel purified to free 
them from contaminating primers and nucleotides, and l-2ul of each gel band 
used to provide the template DNA for a second round of 25 cycles of PCR 
amplification as described in the Materials and Methods section. Analysis of the 
three final mutant products by 0 .8% agarose gel electrophoresis revealed that all 
had the expected size of approximately 1065bp and were essentially homogeneous 
(results not shown), a schematic of this mutagenesis strategy is shown in Figure 
2.3.
After the ligation of the Bam HI / Eco Rl-digested cDNA products into the 
similarly digested pGEX-2T bacterial expression vector and the isolation of the 
appropriate ampicillin-resistant E.coli transfoimants (see Materials and Methods 
section), the cDNA surrounding the cysteine to serine mutation sites of the three 
mutants was sequenced using a PCR-based double stranded DNA cycle sequencing 
kit (Gibco-BRL, see Materials and Methods) allowing the direct sequencing of 
plasmid DNA isolated from lysed bacterial single colonies. The sequence data 
from the two mutant cDNA species indicated (Figure 2.4) that the mutagenesis 
procedure had generated the expected products, and that over the region of
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Figure 2.4 Sequence confirmation of cysteine to serine mutations.
The PCR sequencing reaction products for the non-coding DNA strand around the 
amino acid 62 cysteine to serine (TGT to TCC) mutation and the coding DNA strand 
around the amino acid 119 cysteine to serine (TGT to TCC) mutation are shown.
aa62 Cys to Ser 
Non-Coding Strand
A G C T
GCAATACATAGGCTTCCGGGTAGGG
GGGTAGGAGCCTCACAAAAGGGTGG
a a ll9  Cys to Ser 
Coding Strand 
A G C T
readable sequence («150 nucleotides surrounding the mutation site) no inadvertent 
mutations had been generated.
2.4 Expression of wild type and cysteine to serine mutant NF-kB p50 
aa35-381 proteins in Exoli
For the expression of the proteins encoded by the above wild type and mutant 
cDNAs, it was decided to use the E.coli /  pGEX-2T system, the bacterial 
pGEX-2T expression vector had already been demonstrated to give efficient 
expression and easy purification of a large number of eukaryotic proteins (Smith 
and Johnson, 1988). Fuitheimore, the same expression vector had aheady been 
used successfully to express the full length p i05 precursor to NF-kB p50 in E.coli 
(Kieran et al., 1990).
As described previously (Materials and Methods) NF-kB p50 cDNA /  pGEX-2T 
ligation mixtures were transfoimed into E.coli JMlOl and ampiciUin resistant 
colonies isolated, these were then screened directly by SDS-PAGE under reducing 
conditions for the overexpression of a «65 kD fusion protein upon induction of 
overnight cultures with IPTG. Following the identification of the various clones 
expressing wild type and aa62, 119, and 273 cysteine to serine mutant p50 
aa35-381 fusion proteins, 500ml E.coli cultures were grown to the appropriate
density at 37®C before the induction of fusion protein expression. Purification of 
the individual p50 aa35-381 fusion proteins by glutathione-agarose affinity 
chromatography, was followed by thrombin cleavage of the fusion protein and 
calf thymus DNA-Sepharose affinity chromatography to recover the p50 aa35-381 
DNA-binding proteins (Materials and Methods). The glutathione-agarose affinity 
chromatography yielded virtually pure glutathione S-transferase-NF-KB p50
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Figure 2.5 Glutathione-agarose affinity purification of GST-NF-kB p50 
aa35-381 fusion proteins.
Coomassie brilliant blue R-250 stained 10% polyacrylamide SDS-PAGE (Materials 
and Methods) gels of glutathione-agarose affinity purification of glutathione 
S-transferase-NF-KB p50 aa35-381 fusion proteins. AU sample tracks used 20ul of 
protein solution, with the addition of 7ul of 4x sample buffer, before boiling samples, 
quenching on ice and loading. The following abbreviations were used for the various 
tracks M, protein molecular weight standards; L, crude bacterial load to 
glutathione-agarose columns; FT, flowthrough from columns; W, 0.5M NaCl buffer 
wash through columns; E, lOmM reduced glutathione / 0.5M NaCl buffer eluate from 
glutathione-agarose affinity columns. The positions of the molecular weight standard 
marker proteins are indicated.
WT p50 aa62
M FT W L FT W E
20 0 -
97-
68-
43-
29-
a a l l9
M L FT W E (Th)
aa273  
M * L FT W E *
2 0 0 *
97-
6 8 -
43-
29
2 0 0 -
97-
6 8 -
43-
29"
Figure 2.6 Double stranded calf thymus DNA-Sepharose affinity 
purification of NF-kB p50 aa35-381 fusion proteins.
Coomassie brilliant blue R-250 stained 10% polyacrylamide SDS-PAGE (Materials 
and Methods) gels of double stranded calf thymus DNA-Sepharose affinity purification 
of NF-kB p50 aa35-381 proteins. AU sample tracks used 20ul of protein solution, with 
the addition of 7ul of 4x sample buffer, before boiling samples, quenching on ice and 
loading. The following abbreviations were used for the various tracks :- M, protein 
molecular weight standards; L, 150mM NaCl load to double stranded DNA-Sepharose 
affinity columns; FT, flowthrough from columns; W, 150mM NaCl buffer wash through 
columns; 0.6,0.6M NaCl buffer eluate from DNA-Sepharose affinity columns. DBD and 
GST indicate the positions of the N F - kB  p50 aa35-381 and glutathione S-transferase 
proteins respectively. The two protein molecular weight marker bands represent 43 and 
29kD.
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aa35-381 fusion proteins in the various eluates (Figure 2.5). In the case of the 
aa ll9  cysteine to serine mutant, the fusion protein was thrombin-cleaved before 
SDS-PAGE analysis.
To purify the thrombin-cleaved p50 aa35-381 proteins from the glutathione 
S-transferase and other contaminating proteins, the thrombin cleaved proteins in 
ISOmM NaCl were applied to double stranded calf thymus DNA-Sepharose 
columns, washed, and eluted with 0.6M NaCl buffer. This second DNA affinity 
chromatography stage had the additional advantages that all of the protein which 
bound to and eluted from the column should be active in DNA binding and also be 
free from non-specifically bound E.coli DNA. SDS-PAGE analysis of the various 
protein fractions from the DNA affinity chromatography stage revealed (Figure 
2.6) that all of the p50 amino acid 35-381 species were freed of all contaminating 
proteins by this purification stage. However, some other features were also 
apparent - all the purified species were present as doublet bands - this proteolytic 
clipping event has been localised to the C-terminus of the wild type p50 aa35-381 
species (data not shown), and presumably occurs in the same location in the 
mutant species. It was also noticeable that the aa62 cysteine to seiine mutant 
seemed to bind only poorly to the DNA affinity column - most of the p50 protein 
remaining in the flowthrough fraction, the reason for this remains unclear. The 
yields of the various proteins from the purification of the bacteriaUy expressed 
material are given in Table 2.1.
Chapter 3. Characterisation of the KB-specific binding activity of the 
four NF-kB p50 aa35-381 proteins.
3.1 Initial characterisation of binding activity
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Figure 3.1 Initial characterisation of kB motif DNA binding activity of the 
four NF-kB p50 aa35-381 protein variants.
A. Schematic of the positions of the conserved (bold type) and nonconserved cysteine 
residues, and the positions of the cysteine to serine mutations in the four NF-kB p50 
aa35-381 protein species.
B. SDS-PAGE analysis of the four purified NF-kB p50 aa35-381 proteins, M indicates 
the protein molecular weight marker track, positions of the molecular weight standards 
are indicated.
C. Gel electrophoresis DNA binding assay with equal amounts of NF-kB p50 
aa35-381protein in each track (1.9ng) carried out under standard conditions in the 
presence of spermidine with double stranded 16-mer kB motif oligonucleotide probe, 
upper bands represent the DNA-protein complex.
A C
W ild  ty p e  w .t 62 119 273
 C62— C 8 8 ------ C l l 9 —C l2 4 — C l62--------------C262— C273 ------
aa62 Cys —► Ser 
 S62 — C 8 8 ------- C 1 1 9 - C 1 2 4 ---------C l62-----------C262— C 2 7 3 ------
a a ll9  Cys -►  Ser
 C 62— C * 8 -------Si 19 —Cl24 -C l62------------C262— C273 -----
aa273 Cys Ser
 C 62— C 8 8 ------- C 1 1 9 - C 1 2 4 ---------C162------------C262— S273 ------
B
M w.t. 62 119 273
200k D -^  —
116kD —97.4kD -^  —68kD-^-*
29kD-^ fc_
Witli purified homogeneous proteins now available, it was possible to begin 
meaningful in vitro characterisation of the DNA binding activity of the four 
NF-kB p50 aa35-381 species (Figure 3.1, Panel A). Initial trials demonstrated that 
the kB motif DNA binding activity of all four species was stimulated by treatment 
with the reducing agent DTT, and that addition of DTT to 25mM to the protein 
itself or to the total binding incubation mixture and incubating for 15 minutes on 
ice was sufficient to give full stimulation of kB motif DNA binding activity (data 
not shown).
An initial gel electrophoresis DNA binding assay under the standard conditions 
(Materials and Methods) with the double stranded 16-mer kB motif 
oligonucleotide demonstrated that the four variant p50 proteins had significantly 
different DNA binding activities (Figure 3.1, Panel C) when die binding assays 
were perfomied with equal amounts of protein (1.9ng per track). Quantitation of 
the amounts of ^^P radioactivity in the DNA-protein complexes by liquid 
scintillation counting of dried gel slices yielded the following ratios of binding 
activity (normalised relative to the wild type protein) of :- wild type, 1.000; aa62 
cysteine to serine mutant, 0.097; aa ll9  cysteine to serine mutant, 0.530; aa273 
cysteine to serine mutant, 0.463. Thus the aa62 cysteine to serine mutant NF-kB 
p50 aa35-381 protein showed an interesting ten fold decrease in its binding 
affinity for the double stranded 16-mer kB motif oligonucleotide, with the two 
other cysteine to serine mutant proteins demonstrating intermediate binding 
affinities.
3.2 Determination of dissociation constants for interaction of the four 
NF-kB p50 aa35-381 proteins with DNA by Scatchard analysis
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Figure 3.2 Gel electrophoresis DNA binding assays for dissociation 
constant analysis.
Gel electrophoresis DNA binding assays under standard conditions using large 
excesses of oligonucleotide probe in an attempt to saturate binding of the four N F - kB  p50 
aa35-381 protein species, all binding assays used 0.0029ug of p50 proteins. The bound 
and free 16-mer kB  motif oligonucleotide probe bands are indicated by B  and F  
respectively.
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Alüiough the previous experiment revealed the relative affinities of the four 
NF-kB p50 aa35-381 proteins for the kB motif, for the deteimination of absolute 
values for binding affinities, gel electrophoresis DNA binding assays were
performed at 20*^C in the presence of the standard 3.6mM spermidine on the four 
protein species and increasing amounts of double stranded 16-mer kB motif 
oligonucleotide (Figure 3.2). The dried polyaciylamide gel bands containing the 
DNA-protein complex and the free oligonucleotide probe were assayed for 
radioactivity by liquid scintillation counting and the concentrations of free 
oligonucleotide probe and bound oligonucleotide probe in the binding mixture 
calculated. From Scatchard plots of the ratio of concentrations of bound 
oligonucleotide probe/free oligonucleotide probe versus the concentration of 
bound oligonucleotide probe (Figure 3.3, small inserts) it was possible to derive
estimates for dissociation constant (K^ )^ values for the various NF-KB p50
aa35-381 protein species with the double stranded 16-mer kB motif 
oligonucleotide under the standard DNA binding assay conditions (Figure 3.3).
Tiie Kj) values obtained for the various p50 protein derivatives are of the same
general magnitude as values obtained for many other sequence-specific DNA
binding proteins, although they are not as small as the values obtained from
some studies using native NF-KB proteins (Zabel et al., 1991; Urban and Baeuerle, 
1990) - see Discussion section. Tlie relative numerical values of the dissociation 
constants show good agreement (when expressed as association constants 
normalised to the wild type NF-KB p50 aa35-381 protein value) with the initial 
values measured in section 3.1 :- wild type, 1.000; aa62 cysteine to serine mutant,
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Figure 3.3 Binding curves and Scatchard plot analysis of values for 
the four NF-kB p50 aa35-381 proteins.
From a knowledge of the amount of 16-mer kB motif oligonucleotide probe in the 
bound and free bands, binding saturation curves and Scatchard plots were constructed for 
the four protein species. Straight lines were fitted to the Scatchard plot data by linear
regression analysis and values derived from the reciprocals of the negative gradients.
W ild type
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aa273
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0.103; aa ll9  cysteine to serine mutant, 0.591; aa273 cysteine to serine mutant, 
0.433.
3.3 Rate of dissociation of DNA-protein complexes at O^C in the 
presence and absence of spermidine
To explain these changes in dissociation constants at 20®C in the presence of 
spermidine some change must have occurred in either the rate at which the mutant 
proteins associate with DNA, or in the rate at which the DNA-protein complex 
dissociates, or in both of these factors. One early clue that some increase in the 
dissociation rate constant of the aa62 cysteine to serine mutant p50 protein might 
be at least partly responsible for its lower affinity for the kB motif came from 
obsei'vations that in gel electrophoresis DNA binding assays, a faint smear of 
radioactivity could often be seen mnning ahead of DNA-protein complexes 
involving the aa62 mutant protein, but not with complexes involving the other 
proteins (data not shown). Bearing in mind the known ability of the 
polyacrylamide gel matrix to stabilise protein-DNA interactions (Fried and 
Crothers, 1984), it seemed possible that the amino acid 62 cysteine to serine 
mutant NF-kB p50 aa35-381 protein - 16-mer kB motif oligonucleotide complex 
might have a larger dissociation rate constant than that of the DNA-protein 
complex involving the wild type p50 protein.
To answer this question, preformed radiolabelled 16-mer icB 
oligonucleotide-p50 protein complexes (with roughly equal DNA binding activity)
in the presence of 3.6mM spermidine were challenged at 0®C with a 100-fold 
molar excess of unlabelled HIV-L kB motif oligonucleotide (previous attempts to
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Figure 3.4 Gel electrophoresis DNA binding assays for determining
dissociation rate constants at 0®C in the presence of spermidine.
Gel electrophoresis DNA binding assays (with roughly equal amounts of DNA binding
activity for all four p50 protein species) were carried out at 0®C in the presence of 
3.6mM spermidine. Preformed radiolabelled DNA-protein complexes were challenged 
with a 100-fold molar excess of unlabelled HIV-L kB  motif oligonucleotide, samples 
were removed from the binding mixture at the times indicated and loaded immediately on 
a running non-denaturing gel. The T=0 tracks represent the amount of DNA binding 
activity before addition of unlabelled HTV-L competitor oligonucleotide. Eq indicates the 
amount of radiolabelled DNA-protein complex present at equilibrium - i.e. equivalent to 
the amount of radiolabelled DNA-protein complex seen when the probe and unlabelled 
HTV-L competitor oligonucleotide are added simultaneously. B and F represent the 
DNA-protein complex and free oligonucleotide probe respectively.
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measure complex breakdown at 20® C had failed because dissociation was too 
rapid). Samples of tlie mixture were removed at specific timepoints and loaded 
immediately onto a mnning non-denaturing gel, while for longer timescale 
experiments, aliquots of the preformed complexes were removed and individually 
challenged with cold oligonucleotide to allow the simultaneous loading of all 
samples.
Because of the difficulty of estimating how long the radiolabelled DNA-protein 
complex takes to enter the gel and be effectively separated from free 
oligonucleotide, the effective time of all data points was taken relative to the time 
at which the first sample after unlabelled oligonucleotide challenge was loaded on 
the gel. The DNA binding assay unlabelled oligonucleotide challenge experiments
carried out at 0®C in the presence of 3.6mM spermidine (Figure 3.4) showed that 
the initial suggestion that the aa62 cysteine to serine mutant p50 protein - 16-mer 
kB motif oligonucleotide complex was unstable seemed to be correct. It was 
immediately apparent that the DNA-protein complex involving the aa62 cysteine 
to serine mutant p50 protein had broken down sufficiently to give the equilibium 
level of radiolabelled DNA-protein complex by the time the sample from the 0.17 
minute timepoint entered the gel. A further interesting observation was that 
radiolabelled DNA-protein complexes involving the other two mutant NF-kB p50 
aa35-381 proteins seemed to be dissociating more rapidly than the complex 
involving the wild type protein.
After scintillation counting of the amounts of radioactivity in the various 
complexes, the data were plotted assuming that dissociation would be a first-order 
process. The plot of the integrated pseudo first-order rate equation. In (A/Ao)
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Figure Integrated pseudo first-order rate equation plots for 
dissociation of wild type, aall9, and aa273 cysteine to serine p50 
protein-DNA complexes in the presence of spermidine.
Integrated pseudo first-order rate equation plots for the dissociation of wild type, 
aal 19, and aa273 cysteine to serine N F - kB  p50 aa35-381 protein-16-mer kB  motif
oligonucleotide probe complexes in the presence of 3.6mM spermidine at 0®C. Open 
squares represent wild type p50 protein, solid squares represent aal 19 cysteine to serine 
mutant p50 protein, solid circles represent aa273 cysteine to serine mutant p50 protein.
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versus time, for dissociation of complexes involving the four p50 protein species
in tlie presence of spermidine at 0®C (Figure 3.5) shows some interesting features. 
Firstly, tlie individual plots are linear - suggesting that for the wild type and aal 19 
and aa273 mutant p50 proteins dissociation is a first order process. The relative 
numerical values of the dissociation rate constants for the wild type, aal 19, and 
aa273 NF-kB p50 aa35-381 proteins in the presence of speimidine (Table 3.1)
measured at 0*^0 are in good agreement with their dissociation constants measured
at 20*C in the presence of spermidine (Figure 3.3).
Tliis carries the implication that if the dissociation constants remain broadly
unchanged between and 20 *^ C, then the association rate constants for these 
three proteins are likely to be very similar. However, the complex involving the 
aa62 cysteine to serine p50 mutant breaks down too rapidly to be measured by this 
gel electrophoresis method - leaving only the equilibrium level of binding. This 
obseivation is interesting in that if the association rate constant of the aa62 
cysteine to serine mutant were the same as that of the other three proteins, then
for an overall value of approximately 6.3xlO"^M, a dissociation rate constant
of approximately 0.07 s’  ^would have been predicted - this should be within tlie 
detection limits of the teclinique (compare this with the value of approximately 
0.35 s'  ^obtained for the aa62 mutant in the absence of spermidine). Thus the 
implication is that in the presence of spermidine the wild type, aal 19, and aa273 
cysteine to serine mutant p50 proteins posess similar association rate constants
(with estimated values of approximately 10  ^M'^s'^ at 0"^C), whereas the aa62
cysteine to serine mutant NF-kB p50 aa35-381 protein should have a significantly
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Table 3.1 Dissociation rate constants for the four NF-kB p50 aa35-381
protein-16-mer kB motif oligonucleotide complexes at 0*C in the presence 
and absence of 3.6mM spermidine.
+ Spd. - Spd.
-1 - 1W .T . 0.0070 s 0.00071 s
-1 -1a .a .62 > 0.35 s 0.35 s
- 1 -1a .a .119 0.014 s 0.0011 s
- 1 - 1a .a .273 0.019 s 0.0033 s
Figure 3.6 Gel electrophoresis DNA binding assays and integrated pseudo 
first-order rate equation plots for dissociation of all four p50 
protein-DNA complexes in the absence of spermidine.
A. Integrated pseudo first-order rate equation plots for the dissociation of wild type, 
aa62, aal 19, and aa273 cysteine to serine N F - kB  p50 aa35-381 protein-16-mer kB  motif
oligonucleotide probe complexes in the absence of spermidine at 0®C. Open squares 
represent wild type p50 protein, solid squares represent aal 19 cysteine to serine mutant 
p50 protein, solid circles represent aa273 cysteine to serine mutant p50 protein, and open 
circles represent the aa62 cysteine to serine mutant p50 protein.
B. Gel electrophoresis DNA binding assays (with roughly equal amounts of DNA
binding activity for all four p50 protein species) were carried out at 0®C in the absence of 
spermidine. Preformed radiolabelled DNA-protein complex aliquots were individually 
challenged with a 100-fold molar excess of unlabelled HIV-L kB  motif oligonucleotide at 
the appropriate time, then samples loaded simultaneously onto a running non-denaturing 
gel. The T=0 tracks represent the amount of DNA binding activity before addition of 
unlabelled HIV-L competitor oligonucleotide , Eq indicates the amount of radiolabelled 
DNA-protein complex present at equilibrium, B and F represent the DNA-protein 
complex and free oligonucleotide probe respectively.
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larger association rate constant.
The plots determining dissociation rate constants in the absence of spermidine
(Figure 3.6) at 0®C show additional interesting features - again the relative values 
of the dissociation rate constants for the wild type, aall9 , and aa273 cysteine to
serine mutant p50 proteins correlate reasonably well with the values
determined in the presence of spermidine (Table 3.1). Although explicit values 
have not been determined in the absence of spemiidine, gel electrophoresis DNA 
binding assays differing only in the presence or absence of spermidine in the 
binding buffer have indicated that for the bacterially expressed NF-kB p50 
aa35-381 constructs, the absence of spermidine has only a small effect on the 
overall binding affinities of the various proteins for the kB motif. Tlie ratios of 
binding in the presence of spermidine to the absence of spermidine for the wild 
type, aa62, aall9 , and aa273 cysteine to serine mutant NF-kB p50 aa35-381 
proteins were 0.60,2.21,0.85, and 0.77 respectively.
However, the absolute values for the dissociation rate constants for the wild 
type, aal 19, and aa273 cysteine to serine mutant p50 proteins in the absence of 
spermidine were approximately 10-fold lower than in its presence. Also, in the 
absence of spermidine it was now possible to determine an approximate value for 
the dissociation rate constant for the aa62 cysteine to serine p50 mutant protein of 
approximately 0.35 s'l, this suggests that the aa62 cysteine to serine mutant NF-kB 
p50 aa35-381 protein also has a significantly higher association rate constant than 
the otlier protein species in the absence of spermidine.
Chapter 4. Demonstration of a change in binding site specificity for
the aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein.
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4.1 Competition of DNA binding activity by non-specific competitor 
DNA
Bearing in mind the above changes in the dissociation constants and kinetic 
behaviour of the cysteine to serine mutant p50 proteins towards the 16-mer kB 
motif oligonucleotide, it seemed possible that the DNA binding site specificity of 
the mutant p50 proteins might have altered. To test this possibility, competition 
studies were carried out for aU four p50 protein species with sheared double 
stranded E.coli DNA in the presence of speimidine with radiolabelled HIV-L 
kB motif oligonucleotide as the probe. From an examination of gel 
electrophoresis DNA binding assays carried out with roughly equal amounts of 
binding activity for tlie four p50 protein species in the presence of increasing 
amounts of non-specific E.coli DNA competitor (Figures 4.1, 4.2) it is clear that 
the aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein-HIV-L kB motif 
oligonucleotide complex is competed much more readily than the DNA-protein 
complexes involving the other three protein species. When the amounts of 
radiolabeUed DNA-protein complex remaining in the above E.coli DNA 
competition experiments are plotted versus the amount of competitor DNA used 
(Figure 4.3), it seems clear that while the wild type, aal 19, and aa273 cysteine to 
serine mutant p50 proteins all show similar competition behaviour, the aa62 
cysteine to serine p50 mutant is competed much more easily by the E.coli DNA . 
The fact that the aal 19 and aa273 cysteine to serine mutant p50 proteins behave 
veiy similarly to the wild type protein suggests that even though their affinity for 
the kB motif is slightly reduced, their binding site specificity remains very 
similar, if not identical, to that of the wild type NF-kB p50 aa35-381 protein.
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Figure 4.1 Gel electrophoresis DNA binding assays for E.coli DNA 
competition of wild type and aa62 cysteine to serine mutant p50 
protein-HIV-L k B  motif oligonucleotide complexes.
Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated amounts of competitor E.coli double stranded DNA before addition of the 
HTV-L kB motif oligonucleotide probe. B and F indicate the positions of the 
DNA-protein complex and free oligonucleotide bands respectively.
WT p50
ng Com petitor E.coli DNA
6.28 12.5 18.8 25.1 31.4 47.1 78.5 157 235i# W W W W w w
aa62
ng Competitor E.coli DNA
6.28 12.5 18.8 25.1 31.4 47.1 78.5 157 235
Figure 4.2 Gel electrophoresis DNA binding assays for E.coli DNA 
competition of aal 19 and aa273 cysteine to serine mutant pSO 
protein-HIV-L kB motif oligonucleotide complexes.
Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated amounts of competitor E.coli double stranded DNA before addition of the 
HTV-L kB motif oligonucleotide probe. B and F indicate the positions of the 
DNA-protein complex and free oligonucleotide bands respectively.
a a l l9
ng Competitor E.coli DNA
6.28 12.5 18.8 25.1 31.4 47.1 78.5 157 235
f* 0 *WWWWMWWw
aa273
ng Competitor E.coli DNA
6.28 12.5 18.8 25.1 31.4 47.1 78.5 157 235U U ii
wëëëëëëëëM
Figure 4.3 Non-specific E.coli DNA competition plot for the four NF-kB 
p50 aa35-381 protein species.
The relative amounts of HIV-L kB  motif oligonucleotide DNA binding activity 
remaining under standard assay conditions in the presence of increasing amounts of 
non-specific Exoli double stranded DNA competitor are plotted for the four N F - kB  p50 
aa35-381 protein species. The DNA binding activities for the four p50 protein species in 
the absence of any competitor DNA were normalised, and this data point plotted 
equivalent to Ing competitor DNA. Open squares represent wild type p50 protein, open 
circles represent the aa62 cysteine to serine mutant p50 protein, solid squares represent 
the aal 19 cysteine to serine mutant p50 protein, and solid circles represent the aa273 
cysteine to serine mutant p50 protein.
1.0
0.8
W)
I  0.6
5
I  0.4o0^
0.2
0.0
1 10 100 1000
E.coli C om petitor DNA (ng)
4.2 Change in DNA binding specificity of the aa62 cysteine to serine 
mutant p50 protein
Having some evidence from the E.coli DNA competition experiments that the 
DNA binding specificity of the aa62 cysteine to serine mutant p50 protein had 
altered, it was decided to test this directly, and to try to gain some insight about 
the nature of the new specificity. Thus both the wild type and aa62 cysteine to 
serine mutant p50 proteins in the presence of spermidine under the standard 
binding conditions were assayed for the ability of various oligonucleotide variants 
of the kB  motif to compete for binding of the double stranded 16-mer kB motif 
oligonucleotide. The sequences of these competitor oligonucleotides are given in 
Table 4.1, with the KB-like motif indicated in bold.
Plots of the relative amounts of radioactive DNA-protein complex remaining 
versus the dilution factor - defined as (-(Molarity of probe oligo/(Molarity of 
probe oligo + Molarity of competitor oligo)) +1) should yield a straight line of 
gradient = -1 when the radiolabelled oligonucleotide probe is competed with 
identical unlabelled oligonucleotide. In contrast, when the competitor 
oligonucleotide represents a poorer binding site for p50, the data points wiU fall 
above the straight line - i.e. the molar excess of unlabelled competitor 
oligonucleotide needed to reduce the amount of radiolabeUed DNA-protein 
complex to 50% will be greater than 1. Whereas for a better competitor kB motif, 
the data points will faU below the straight line - i.e. the molar excess of 
competitor oligonucleotide needed to reduce the amount of radiolabeUed 
DNA-protein complex to 50% wiU be less than 1.
Competition specificity experiments were carried out in the presence of
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spermidine for the human immunodeficiency vims type 1 enhancer HIV-L kB 
motif (HIV-L), the kB motif variant from the human B-interferon gene regulatory 
element (IRE), a virtually symmetrical variant of the kB motif (EBP 'cons'), the 
kB motif variant from the mouse H-2K^ enhancer (H2TF1), a mutant kB site with 
a sequence of 8 continuous puiine residues (SVUP), two mutants of the kB motif 
which show virtually no binding of native eukaryotic NF-kB (SVl-M l, SV1-M3), 
and a more subtle kB motif mutant which stiU shows some binding to native 
NF-kB (SV1-M2). The sequences of these oligonucleotides are given in Table 4.1.
Plots of the relative amounts of radiolabeUed DNA-protein complex remaining 
versus the dilution factor of the competitor oligonucleotide are given for aU eight 
competitor species (Figures 4.4 - 4.11) and the estimated relative molarities 
(compared with the molarity of the oligonucleotide probe) of competitor 
oligonucleotide needed to reduce the amount of radiolabeUed DNA-protein 
complex by 50% are given in Table 4.1. From these analyses several interesting 
points emerge :- for example competition of the double stranded 16-mer kB motif 
oligonucleotide by the HIV-L oligonucleotide might be expected to yield a straight 
line plot since both kB sites in the HIV-1 LTR enhancer have the same sequence - 
however as can be seen from Figure 4.4 and Table 4.1 the HIV-L oligonucleotide 
is clearly a slightly poorer competitor. One significant difference between these 
two oligonucleotides may be the number of base pairs the kB motif is from the 
end of the double stranded region - three base pairs for the 16-mer kB motif 
oligonucleotide and two base pairs for the HIV-L oligonucleotide. Given 
observations from the E.coli lac repressor-operator system (Winter et al., 1981) 
that dissociation constants rose significantly as operator DNA fragments became
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Figure 4.4 Gel electrophoresis DNA binding assays for HIV-L 
oligonucleotide competition and binding specificity analysis for wild type 
and aa62 mutant p50 proteins.
A. Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated molar excess of unlabelled HIV-L competitor oligonucleotide before addition of 
the double stranded 16-mer kB motif oligonucleotide probe. Approximately equal 
amounts of wild type and aa62 mutant p50 protein DNA binding activity were used. B 
and F indicate the positions of the DNA-protein complex and free oligonucleotide probe 
bands respectively.
B. Plot of relative amount of radiolabelled DNA-protein complex remaining versus 
dilution factor for HIV-L oligonucleotide, solid squares represent wild type, and open 
squares represent aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein.
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Figure 4.5 Gel electrophoresis DNA binding assays for IRE
oligonucleotide competition and binding specificity analysis for wild type
and aa62 mutant p50 proteins.
A. Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated molar excess of unlabelled IRE competitor oligonucleotide before addition of 
the double stranded 16-mer kB  motif oligonucleotide probe. Approximately equal 
amounts of wild type and aa62 mutant p50 protein DNA binding activity were used. B 
and F indicate the positions of the DNA-protein complex and free oligonucleotide probe 
bands respectively.
B. Plot of relative amount of radiolabelled DNA-protein complex remaining versus 
dilution factor for IRE oligonucleotide, solid squares represent wild type, and open 
squares represent aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein.
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Figure 4.6 Gel electrophoresis DNA binding assays for H2TF1
oligonucleotide competition and binding specificity analysis for wild type
and aa62 mutant p50 proteins.
A. Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated molar excess of unlabelled H2TF1 competitor oligonucleotide before addition of 
the double stranded 16-mer kB  motif oligonucleotide probe. Approximately equal 
amounts of wild type and aa62 mutant p50 protein DNA binding activity were used. B 
and F indicate the positions of the DNA-protein complex and free oligonucleotide probe 
bands respectively.
B. Plot of relative amount of radiolabelled DNA-protein complex remaining versus 
dilution factor for H2TF1 oligonucleotide, solid squares represent wild type, and open 
squares represent aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein.
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shorter, it is likely that similar effects might occur if the kB motif is located near 
the end of the oligonucleotide. However, the above arguments should not prevent 
valid comparisons of the binding affinity of wild type and aa62 cysteine to serine 
mutant p50 proteins for each competitor oligonucleotide. As would be expected 
for tlie HIV-L oligonucleotide (Figure 4.4), tlie competition plots for the wild 
type and aa62 mutant p50 proteins coincide, giving identical relative molarities of 
competitor oligonucleotide for 50% binding (Table 4.1).
From the competition plots for the IRE type of kB motif oligonucleotide 
(Figure 4.5, Table 4.1), it can be seen that tlie two cuiwes for wild type and aa62 
cysteine to serine mutant proteins virtually coincide - suggesting no significant 
difference in binding specificity between the two proteins towards the IRE type of 
kB motif.
In contrast, for the wild type p50 protein, the H2TF1 type of kB motif (Figure
4.6, Table 4.1) competes significantly better than the 16-mer kB motif, while for 
the aa62 mutant p50 protein, the H2TF1 type of kB motif is a slightly poorer 
competitor than the 16-mer kB motif oligonucleotide - this difference constitutes 
evidence of the aa62 mutant p50 protein having an altered DNA binding 
specificity. In the case of the EBP'cons' type of kB motif, for the wild type p50 
protein this motif is a significantly better competitor than the 16-mer kB motif, 
and while the aa62 mutant p50 protein has a significantly lower affinity for this 
EBP'cons’ sequence than the wild type p50 protein, this sequence is still a 
somewhat better competitor than the 16-mer icB motif oligonucleotide (Figure
4.7, Table 4.1). The SVUP kB motif variant containing eight sequential purine 
residues shows interesting competition behaviour (Figure 4.8, Table 4.1) -
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Figure 4.7 Gel electrophoresis DNA binding assays for EBP'cons'
oligonucleotide competition and binding site specificity analysis for wild
type and aa62 mutant p50 proteins.
A. Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated molar excess of unlabelled EBP'cons' competitor oligonucleotide before 
addition of the double stranded 16-mer kB motif oligonucleotide probe. Approximately 
equal amounts of wild type and aa62 mutant p50 protein DNA binding activity were 
used. B and F indicate the positions of the DNA-protein complex and free oligonucleotide 
probe bands respectively.
B. Plot of relative amount of radiolabelled DNA-protein complex remaining versus 
dilution factor for EBP'cons' oligonucleotide, solid squares represent wild type, and 
open squares represent aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein.
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Figure 4.8 Gel electrophoresis DNA binding assays for SVUP
oligonucleotide competition and binding specificity analysis for wild type
and aa62 mutant p50 proteins.
A. Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated molar excess of unlabelled SVUP competitor oligonucleotide before addition of 
the double stranded 16-mer kB  motif oligonucleotide probe. Approximately equal 
amounts of wild type and aa62 mutant p50 protein DNA binding activity were used. B 
and F indicate the positions of the DNA-protein complex and free oligonucleotide probe 
bands respectively.
B. Plot of relative amount of radiolabelled DNA-protein complex remaining versus 
dilution factor for SVUP oligonucleotide, solid squares represent wild type, and open 
squares represent aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein.
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although this sequence is a fairly poor competitor for both p50 protein species 
compared to the 16-mer kB motif oligonucleotide, it does seem to show a higher 
binding affinity towards the aa62 cysteine to serine mutant NF-kB p50 aa35-381 
protein.
The three mutant kB motif oligonucleotides SVl-M l, SV1-M2, and SV1-M3 all 
show similar behaviour (Figures 4.9,4.10, and 4.11, Table 4.1) - in that they are 
poor competitors for binding of both the wild type and aa62 cysteine to serine 
mutant p50 proteins, but again showing higher affinities towards the aa62 cysteine 
to serine mutant p50 protein.
The DNA binding assays in the above oligonucleotide competition experiments 
were aU performed in the presence of the polyamine spermidine - which as 
demonstrated in Results, Chapter 3 causes an increase in the dissociation rate 
constants of the DNA-protein complexes (and which presumably also causes 
roughly corresponding changes in the association rate constants). One well-known 
effect of spermidine is to promote changes in the confoimation of double stranded 
DNA which can be either profound such as the switch from the B-DNA to the 
Z-DNA conformation (Rich et al., 1984), or subtle - such as promoting or 
inhibiting transient breakdowns in base pairing (Plum and Bloomfield, 1990). To 
investigate if there was an effect of spermidine on some or all of the types of kB 
motif, data from the above competition studies performed in the presence of 
spermidine were conelated with new DNA binding assays performed in the 
absence of spermidine. The results of these comparisons suggested that there were 
no significant differences in competition behaviour by a range of oligonucleotides 
in the presence or absence of spermidine (data not shown).
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oligonucleotide competition and binding specificity analysis for wild type
and aa62 mutant p50 proteins.
A. Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated molar excess of unlabelled SVl-Ml competitor oligonucleotide before addition 
of the double stranded 16-mer kB  motif oligonucleotide probe. Approximately equal 
amounts of wild type and aa62 mutant p50 protein DNA binding activity were used. B 
and F indicate the positions of the DNA-protein complex and free oligonucleotide probe 
bands respectively.
B. Plot of relative amount of radiolabelled DNA-protein complex remaining versus 
dilution factor for SVl-Ml oligonucleotide, solid squares represent wild type, and open 
squares represent aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein.
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oligonucleotide competition and binding specificity analysis for wild type
and aa62 mutant p50 proteins.
A. Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated molar excess of unlabelled SV1-M2 competitor oligonucleotide before addition 
of the double stranded 16-mer kB  motif oligonucleotide probe. Approximately equal 
amounts of wild type and aa62 mutant p50 protein DNA binding activity were used. B 
and F indicate the positions of the DNA-protein complex and free oligonucleotide probe 
bands respectively.
B. Plot of relative amount of radiolabelled DNA-protein complex remaining versus 
dilution factor for SV1-M2 oligonucleotide, solid squares represent wild type, and open 
squares represent aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein.
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oligonucleotide competition and binding specificity analysis for wild type
and aa62 mutant p50 proteins.
A. Gel electrophoresis DNA binding assays were carried out under standard conditions 
(see Materials and Methods) in the presence of spermidine with the addition of the 
indicated molar excess of unlabelled SV1-M3 competitor oligonucleotide before addition 
of the double stranded 16-mer kB  motif oligonucleotide probe. Approximately equal 
amounts of wild type and aa62 mutant p50 protein DNA binding activity were used. B 
and F indicate the positions of the DNA-protein complex and free oligonucleotide probe 
bands respectively.
B. Plot of relative amount of radiolabelled DNA-protein complex remaining versus 
dilution factor for SV1-M3 oligonucleotide, solid squares represent wild type, and open 
squares represent aa62 cysteine to serine mutant NF-kB p50 aa35-381 protein.
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Table 4.1 Sequences of competitor oligonucleotides and relative 
molarities of competitor oligonucleotide needed to reduce the amount of 
radiolabelled DNA-protein complex by 50%.
Oligo Nucleotide Sequence Rel .Molarity 50% Binding
W.T.pSO ae62 p50
16bp W T kB 5' CTG G G G A C T T T C C  AGG 3* 3- CAC C C C T G A A A G G  TCC 5* - -
HIV-L 5' GATCTA G G G A C T T T C C  gcg 3*3- AT C C C T G A A A G G  CCCCTAG 5- 1.81 1.81
IRE 5‘ GATCAAAGTGGGAAATTCC TCTG 3*3* t ttcacC C T T T A A G G  acacctag s- 1.35 1.35
H2TF1 5' GATCT G G G G A T T C C C C ag 3'3* A CCCCTAAGGGGTCCTAg 5* 0.40 1.96
EBP'cons' 5* GATCATG G G G A A T T T C C C cag 3'3* TAG C C C T T A A A G G G gtcctag S' 0.30 0.58
SVOP S' GATCTGAGGC G G A A A G A A C C  AGCTG 3'3' ACTCCG C C T T T C T T G G  tcgacctag S' 39.0 9.64
SVl-Ml S' GATCTAGGGTGT C C A A A G T C C C  G 3'3' ATCCCACA G G T T T C A G G G  CCTAG S' 54.5 6.25
SV1-M2 S' GATCTAGGGTGT G G A A T G T C C C  G 3'3' ATCCCACA C C T T A C A G G G  CCTAG S' 25.3 4.00
SV1-M3 S' GATCTAGGGTGT G G A A A G T G G C  CG 3'3' ATCCCACA C C T T T C A C C G  gcctag s' 199 27.6
Chapter 5. Direct demonstration of the presence of cysteine 62 in the 
DNA binding site of NF-kB p50 aa35-381, and regulation of DNA 
binding activity by reduction of a disulphide bond involving cysteine 
62.
5.1 Protection of wild type NF-kB p50 aa35-381 DNA binding activity 
against iodoacetate inactivation by prior formation of a DNA-protein 
complex
Following the demonstration in a study of redox regulation of the DNA-binding 
activity of the fos-jun heterodimeric transcription factor that incubation of the 
heterodimer with an oligonucleotide containing an AP-1 binding site prior to 
treatment with N-ethylmaleimide protected the DNA binding acivity from 
inactivation (Abate et al., 1990), a similar type of protection experiment was 
attempted with the wild type NF-kB p50 aa35-381 protein. Thus gel 
electrophoresis DNA binding assays were performed under standard conditions 
with fully reduced (by treatment with DTT to 25mM / incubating on ice 15 
minutes before addition to the binding mixture) wild type p50 protein with
increasing iodoacetate concentrations / incubation at 20*C for 15 minutes with 
addition of the iodoacetate to the indicated concentration botli before (Figure 5.1, 
Panel A, upper section) and after (Figure 5.1, Panel A, lower section) addition of 
the radiolabelled 16-mer kB motif oligonucleotide probe. Dose-response curves 
for a similar experiment for iodoacetate inactivation by addition both before and 
after addition of the 16-mer kB motif oligonucleotide probe are shown in Figure
5.1, Panel B.
It is clear that when the wild type p50 protein was incubated with iodoacetate
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Figure 5.1 Gel electrophoresis DNA binding assays for wild type p50 
protein with addition of iodoacetate before and after addition of the 
double stranded 16-mer k B  motif oligonucleotide.
A. DNA-protein complex bands from gel electrophoresis DNA binding assays carried 
out under staandard conditions (see Materials and Methods) in the presence of spermidine 
using wild type p50 protein with addition of iodoacetate to the indicated concentration and
incubation at 20®C for 15 minutes before (upper panel) and after (lower panel) formation 
of the DNA-protein complex.
B. Dose-response curves for the amount of radiolabelled DNA-protein complex using 
wild type p50 protein with addition of iodoacetate to the indicated concentration before 
(solid diamonds) and after (open squares) formation of the DNA-protein complex.
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prior to addition of the kB motif oligonucleotide, then a dose-dependent decrease 
in DNA binding activity was seen - however when the DNA-protein complex was 
allowed to form before the addition of the iodoacetate, then DNA binding activity 
was essentially unaltered even in the presence of 30mM iodoacetate. The 
observation that both iodoacetate and N-ethylmaleimide cause inhibition of p50 
DNA binding activity strengthens the case for the involvement of cysteine residues 
in the redox modulation of p50 protein DNA binding activity, but more 
importantly (as in the case of the fos-jun heterodimer - Abate et al., 1990) 
protection against iodoacetate inactivation by preforming a DNA-p50 protein 
complex implies that these cysteine residues are intimately involved in binding to 
the kB motif.
5.2 Iodoacetate sensitivity of wild type and mutant NF-kB p50 
aa35-381 proteins
To identify the cysteine residue(s) located in the p50 DNA binding site, wild 
type and aa62, aal 19, and aa273 cysteine to serine mutant p50 proteins were 
treated with increasing concentrations of iodoacetate before addition of the 
16-mer kB motif oligonucleotide probe and the specific DNA binding activity 
remaining determined using the gel electrophoresis DNA binding assay. From the 
amounts of specific DNA-protein complex remaining (Figure 5.2, Panel A) over 
the range of iodoacetate concentrations studied, it was clear that the wild type, 
aal 19, and aa273 cysteine to serine mutant p50 proteins all showed similar 
titration behaviour, while the aa62 cysteine to serine p50 mutant was considerably 
less sensitive towards iodoacetate inactivation.
When the fractions of radioactive DNA-protein complex remaining (determined
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Figure 5.2 Gel electrophoresis DNA binding assays for iodoacetate
sensitivity of wild type and mutant p50 proteins.
A. DNA-protein complex bands from gel electrophoresis DNA binding assays carried 
out under standard conditions (see Materials and Methods) in the presence of spermidine 
w ith roughly equal amounts of kB specific DNA binding activity of all four p50 protein 
species, prestimulated with 25mM DTT / incubating 15 minutes on ice (wild type 2.1ng, 
aa62 5,7ng, aall9 2.9ng, aa273 4.2ng of p50 protein). Iodoacetate solution added to the
indicated concentration, and the mixtures incubated at 20® C for 15 minutes, before 
addition of radiolabelled 16-mer kB motif oligonucleotide.
B. Dose-response curves for iodoacetate inactivation of the four p50 protein species, the 
amounts of radioactive DNA-protein complex in the absence of any iodoacetate treatment 
were normalised and the amounts of radioactive DNA-protein complex formed after 
iodoacetate treatment expressed relative to this. The symbols used for the various p50 
protein species were :- solid diamond wild type p50, solid square aa62 cysteine to serine 
mutant p50, open square aal 19 cysteine to serine mutant p50, open diamond aa273 
cysteine to serine mutant p50 protein.
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by scintillation counting) were plotted versus iodoacetate concentration (Figure
5.2, Panel B), the much lower iodoacetate sensitivity of the aa62 cysteine to serine 
p50 mutant was apparent. Thus, at an iodoacetate concentration of 2.5mM, the 
DNA-binding activity of the wild type, aal 19, and aa273 mutant p50 proteins was 
reduced by approximately 90%, whereas the DNA binding activity of the aa62 
cysteine to serine mutant was reduced by only 40%. Tlie iodoacetate concentration 
needed to reduce DNA binding activity by 50% was 10-15 fold higher for the 
aa62 cysteine to serine mutant than for the other three NF-kB p50 subunit 
aa35-381 constructs.
Tiiese findings when coupled with the obseivations from previous chapters on 
the stimulation of kB-specific DNA binding activity by reducing agents, the 
weaker binding affinity of the aa62 cysteine to serine mutant for the kB motif, 
and the altered DNA binding specificity of the aa62 cysteine to serine mutant p50 
protein all suggest that cysteine 62 is intimately associated with the DNA binding 
site, and is the site of redox regulation, of NF-kB p50 aa35-381.
5.3 Iodoacetate affinity labelling of cysteine 62 in the DNA 
binding site of wild type NF-kB p50 aa35-381
Although the above evidence was very suggestive of the intimate association of 
cysteine 62 with the DNA binding site of p50, more direct evidence was needed 
for a definitive assignment. The approach chosen was of differential labelling - a 
method first used to radiolabel the active site of an antibody (Koshland et al., 
1959). Tlie rationale behind this choice was that since preformation of the 
DNA-protein complex could protect the cysteine residue(s) in the DNA binding 
site of p50 against iodoacetate inactivation, reaction of the DNA-protein complex
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with unlabelled iodoacetate should modify all the exposed cysteine thiol(ate) 
groups. Then, after removal of the excess unlabelled iodoacetate, the DNA-protein 
complex could be dissociated by increasing the NaCl concentration to 0.6M and 
the newly-exposed cysteine groups radiolabelled by reaction with iodoacetate. 
An outline of the iodoacetate differential labelling scheme used is shown in 
Figure 5.3 - this used HIV enhancer oligonucleotide-Sepharose resin to bind the 
wild type NF-kB p50 aa35-381 protein during the reaction with unlabelled 
iodoacetate, and allowed easy removal of the oligonucleotide binding site(s) from 
the reaction mixture.
The differential labelling (see Materials and Methods) of lOOug of wild 
type NF-kB p50 aa35-381 protein (Figure 5.4) illustrates some of the behaviour 
seen before with wild type p50 protein - thus comparing the amount of «38kD 
NF-kB p50 aa35-381 protein in the wash fractions (W1 and W2 - Figure 5.4,
Panel A), it can be seen that there is no evidence of iodoacetate treatment of the 
preformed DNA-protein complex causing breakdown of the complex. From the 
autoradiogram (Figure 5.4, Panel B) of the SDS-PAGE gel, it is clear there is 
only one radiolabelled species (albeit as a doublet band) in the track. It seems 
likely that the higher molecular weight polypeptide bands present in all tracks in 
Panel A represent some contaminant proteins, possibly present in the SDS gel 
sample buffer since from other gels there was no evidence of their presence in the 
p50 protein used as the starting material, nor would they be expected to be present 
in the C30FT Centricon-30 flowthrough fraction when there was no evidence of 
the ~38kD p50 protein in either the SDS-PAGE (Figure 5.4, Panel A) or gel 
electrophoresis DNA binding assays (Figure 5.4, Panel C).
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Figure 5.3 Outline of iodoacetate labelling / substrate protection 
scheme for cysteine residues in the DNA binding site of wild type NF-kB 
p50 aa35-381 protein.
Given below is the outline of the DNA binding site substrate protection scheme used 
for lOOug of wild type p50 protein, the estimated recovery of radiolabelled wild type p50 
for trypsin digestion was ~75ug.
100 Mg WT p50 / 20mM DTT (400^1) (L)
Add to 200^1 HlV-Sepharose resin, incubate 3 hours 
Centrifuge and remove supernatant (FT)
Wash resin with 2ml 0.1 M NaCl buffer / 2inM DTT (W l)
Add 250mM neutral iodoacetate to lOmM, incubate 15min at 20®C 
Wash rosin with 2ml O.IM NaCl buffer / 2mM DTT (W2)
Elute WT p50 with I ml 0.6M NaCl buffer / 2mM DTT
Concentrate eluate in Centricon-30 down to ~30ppl, discard 
the filtrate (C30FT)
Add ^^C iodoacetate solution to ~IOmM, incubate 25min at 20*C
Add DTT to 50mM to quench remaining iodoacetate 
Precipitate protein by adding TCA to 10%
Rcdissolvc protein pellet in 50).il NH^IICO) buffer / 8M urea 
^  Dilute with water down to 200p i / 2M urea 
Digest with 3pg trypsin for 24hours at 3T C
Separate peptides by reverse phase HPLC on a CIS column with a 
0 to 80% acetonitrile gradient, assay fractions for radioactivity
Figure 5.4 Analysis of fractions from the substrate protection 
labelling of cysteine residues in the DNA binding site of wild type NF-kB 
p50 aa35-381 protein.
A. SDS-PAGE analysis of substrate protection experiment (see Materials and 
Methods) fractions, visualised by Coomassie staining:- M, protein molecular weight 
standards; final p50 protein eluate after labeling; L, initial load (l(X)ug p50 
protein, 400ul buffer) to HIV enhancer oligonucleotide-Sepharose affinity resin; FT, 
supernatant from loading p50 protein onto affinity resin; Wl, first O.IM NaCl wash of 
p50-Ioaded affinity resin; W2, second (after reaction of DNA-protein complex with 
unlabelled iodoacetate) O.IM NaCl wash of p50-loaded affinity resin; C30FT, discarded 
Centricon-30 filtrate from concentration of eluted p50 protein prior to reaction with 
iodoacetate. The following volumes of protein fractions were used for the SDS-PAGE 
analysis - 8ul, L - 4ul, FT - 4ul, Wl - 20ul, W2 - 20ul, C30FT - 20ul. The 
molecular weights (in kD) of the marker proteins are indicated.
B. Direct autoradiogram of the above SDS-PAGE dried gel, abbreviations as in Panel A.
C. Gel electrophoresis DNA binding assays carried out under standard conditions (see 
Materials and Methods) in the presence of spermidine with ^ ^ P  radiolabelled HIV-L kB  
motif oligonucleotide. Abbreviations as used in Panel A, indicates no protein addition, 
'L' and *FT* tracks used lul of protein solution, tracks 'Wl', 'W2', and 'C30FT' used
5ul of protein solution. B and F indicate the positions of the DNA-protein complex and 
free oligonucleotide bands respectively.
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The l^C-labelled p50 protein, after quenching of the iodoacetate radiolabelling 
reaction with DTT (see Materials and Methods) was TCA precipitated - this had 
the advantage of removing unincorporated radioactivity without any need for 
dialysis - the p50 protein pellet was then redissolved in 50ul of 8M urea / 
ammonium bicarbonate buffer. The redissolved pellet was diluted with water to 
give a urea concentration of 2M, and then digested with 3ug of trypsin (i.e. a «25
: 1 substrate : trypsin ratio) at 37®C for 24 hours.
The trypsin-digested affinity labelled NF-kB p50 aa35-381 protein was 
then analysed by reverse phase HPLC chromatography using a Waters HPLC 
system with a Delta-Pak C18 column and a 0-80% acetonitrile gradient (see 
Materials and Methods). Peptides eluted from the reverse phase C l8 column were 
collected over 180 x 0.25ml (30 second) fractions and lOul aliquots of each 
fraction dotted onto (5mm x 5mm) squares of Whatman 3MM chromatography 
paper, after drying, the 3MM squares were immersed in 5ml of Ecoscint A and 
scintillation counted. The plot of ^^C radioactivity versus fraction number 
(Figure 5.5, Panel A) suggested a relatively simple pattern of radioactive peptides 
in the HPLC eluate. The two highest radioactivity eluate fractions - numbers 54 
and 102 - were subjected to N-terminal amino acid sequencing (kindly performed 
by Dr.W.Kaszubska, Glaxo IMB, Geneva) this revealed (Figure 5.5, Panel B) that 
fraction number 54 contained three peptide species - the predominant one 
representing amino acids 60-69 of the NF-kB p50 aa35-381 protein (i.e. 
containing cysteine 62). The two minor peptides represented amino acids 158-163 
(containing the non-conserved cysteine 162) and amino acids 195-197 of the 
NF-kB p50 aa35-381 protein. N-terminal amino acid sequencing of fraction 102
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Figure 5.5 I^C Radioactivity of eluate fractions from HPLC reverse 
phase chromatography of trypsin digested, DNA binding site labelled wild 
type NF-kB p50 aa35-381 protein, and amino acid sequence of peak 
fractions.
A. lOul Aliquots of HPLC reverse phase chromatography eluate fractions from the 
0-80% acetonitrile gradient spotted and dried on 3MM paper before liquid scintillation 
counting of l^C radioactivity. The positions of the two peak radioactive fractions - 
numbers 54 and 102 - are indicated by arrows.
B. Amino acid sequence analysis of material in the two peak radioactive HPLC eluate 
fractions numbers 54 and 102 (N-terminal amino acid sequence analysis kindly 
performed by Dr.W.Kaszubska, Glaxo IMB, Geneva). Fraction 54 contained a major 
peptide species corresponding to amino acids 60 to 69 of N F - kB  p50 aa35-381, and two 
minor species - one of these corresponding to amino acids 158-163 of the p50 protein, 
the other to amino acids 195-197 of the p50 protein. Fraction 102 contained material 
whose N-terminal amino acid sequence analysis indicated that it originated from the 
N-terminus of N F - kB  p50 aa35-381.
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yielded sequence corresponding to the N-terminus of the NF-kB p50 aa35-381 
protein - suggesting that it might represent undigested material.
Surprisingly, no radioactivity could be detected in the sequencing cycle for 
cysteine 62 (nor for the cysteine 162), however this might have been due to a low 
level of radiolabelling efficiency in this experiment. The iodoacetate affinity 
labelling experiment has since been repeated with an estimated incorporation of 
95% of the theoretical amount of and has yielded definitive sequence data 
with only two significant radioactive peptide peaks - one radioactive peptide 
containing cysteine 62, and with radioactivity detectable only at the cysteine 
position, the other peptide radiolabelled at a non-cysteine residue (data not 
shown). It seems clear that cysteine 62 (and no other cysteine species) is intimately 
associated with the DNA binding site of the NF-kB p50 aa35-381 protein.
5.4 Demonstration that the wild type, a a ll9 , and aa273 cysteine to 
serine m utant NF-kB p50 aa35-381 proteins can exist as 
intermolecular disulphide linked dimers
Bearing in mind the presence of cysteine 62 in the DNA binding site of the wild 
type (and presumably the aal 19 and aa273 cysteine to serine mutants) NF-kB p50 
aa35-381 protein, it seemed reasonable from symmetry arguments that the 
corresponding cysteine 62' from the other subunit would occupy a similar 
position. To try to gain some information if these two residues were close 
together or far apart in the DNA binding site, aU four p50 protein species were 
fuUy reduced by treatment with DTT and then incubated with the reagent 
diazenedicai'boxylic acid his [N, N'-dimethylamide] (diamide) - a sulphydryl 
oxidising agent which induces the formation of disulphide bonds if cysteine
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residues are appropriately positioned (Kosower et aL, 1969).
All four p50 protein species both with and without diamide treatment were then 
analysed by non-reducing SDS-PAGE and visualised by silver staining (Figure 
5.6) - this revealed the presence of interchain disulphide links with the wild type, 
aa ll9 , and aa273 cysteine to serine mutant p50 proteins, but no evidence of any 
interchain links with the aa62 cysteine to serine mutant NF-kB p50 aa35-381 
protein. This finding indicated that the interchain disulphide bonds formed in the 
wild type protein must at least involve one amino acid 62 cysteine residue.
From symmetry arguments it seemed quite likely that cysteine 62 might form a 
disulphide bond with cysteine 62', however this experiment could not give a 
definitive answer to this question - in any case cysteine 62 does not form a 
disulphide bond with cysteine 119' or with cysteine 273' - since bpth the aal 19 
and aa273 cysteine to serine mutants can be interchain disulphide crosslinked by 
diamide treatment. However, as mentioned in Section 5.3, new affinity labelling 
results which demonstrate the incorporation of radioactivity into only the 
cysteine 62 residue lend weight to the idea of a cysteine 62-cysteine 62' interchain 
disulphide bond in the oxidised form of the wild type NF-kB p50 aa35-381 
protein.
A further interesting observation from the diamide-treated tracks (Figure 5.6) 
is that the mobility of the monomer bands of all four p50 protein species is 
slightly faster after diamide treatment - which tends to suggest some intrasubunit 
disulphide bond formation. Since this behaviour is seen with aU four NF-kB p50 
aa35-381 species, the cysteines involved in this intrasubunit disulphide bond 
formation presumably belong to the non-conserved cysteine residues (at positions
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Figure 5.6 Demonstration that the wild type, aall9 , and aa273 cysteine to 
serine mutant NF-kB p50 aa35-381 proteins can exist as intermolecular 
disulphide linked dimers.
Equal amounts (»1.04ug) of all four NF-kB p50 aa35-381 species fully reduced by 
treatment with DTT to 25mM and incubating on ice 15 minutes followed by either
addition of (+) or no addition of (-) diamide to 33mM, incubation at 37®C for 1 hour, and 
quenching with excess iodoacetate (see Materials and Methods) were analysed by 
SDS-PAGE under non-reducing conditions, followed by silver staining of the gel. 
Positions of the molecular weight standard proteins (run under reducing conditions) are 
indicated.
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88,124,162, and 262 of the NF-kB p50 subunit sequence (Kieran et al., 1990). 
The identification of which of these cysteines are involved in this intrasubunit 
crosslinking would require the individual mutagenesis of these non-conserved 
cysteine residues.
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DISCUSSION.
This study has investigated the elements which a homodimer of the DNA 
binding and dimérisation region of the p50 polypeptide subunit of the 
transcription factor NF-kB uses to recognise and bind to the kB motif - a DNA 
regulatory element important in the transcriptional control of a wide range of 
cellular and viral promoters and enliancers. It has been shown that the DNA 
binding activity of native cellular kB -binding proteins and the bacterially 
expressed NF-kB p50 subunit amino acid 35-381 construct are regulated by their 
oxidation state, and that this regulation involves cysteine 62 forming a disulphide 
bond with a cysteine residue of the other subunit - probably with cysteine 62'. 
Further, the DNA binding specificity of the p50 aa35-381 amino acid 62 cysteine 
to serine mutant has been shown to have changed - tlie mutant protein has a 
10-fold lower binding affinity for the kB motif - at least partly due to a much 
larger dissociation rate constant for this mutant protein compared to the wild type 
protein.
1, Characterisation and properties of native HeLa cell kB motif 
binding proteins
The initial aim of this work was the purification of the transcription factor 
NF-kB from HeLa cells to allow the eventual isolation of cDNA clones encoding 
this kB motif DNA binding activity, and the eventual overexpression of the factor 
to allow its use in studies of the initial transcriptional activation of the integrated 
HIV-1 pro virus. Initial attempts to use HIV enhancer oligonucleotide-Sepharose 
affinity chromatography to isolate purified NF-kB were singularly unsuccessful - 
for example using four rounds of HIV enhancer oligonucleotide affinity
124
chromatography on HeLa cell nuclear extracts yielded a final eluate which 
appeared to contain at least 100 polypeptide species upon silver staining of 
SDS-PAGE gels (data not shown).
More sophisticated purification schemes (Results, Figure 1.2) involving multiple 
selection criteria yielded a much more satisfactory result - with two major 
polypeptide species of approximately 55 and 43kD molecular weight, and minor 
amounts of 140, 48, 36, and 34kD molecular weight polypeptides. However, since 
tliis final eluate material was still heterogeneous and contained only 1-2% of the 
initial KB-specific DNA binding activity, and with increasing evidence that the p50 
and p65 subunits of NF-kB might belong to a family of related proteins, this 
purification route seemed unpromising as a source of material for amino acid 
sequence data, and was abandoned.
Unsuccessful attempts were also made during these studies to directly clone 
cDNAs encoding NF-kB subunits by screening a recombinant phage Xgtll cDNA 
expression library in E.coli with radiolabelled concatenated kB motif 
oligonucleotide. Although several putative positive phage clones were isolated, 
further characterisation suggested that the expressed fusion proteins also bound 
with high affinity to concatenated non-binding mutant variants of the kB motif - 
this was taken to indicate that the phages did not encode NF-kB subunits (data not 
shown).
Interesting reports of the presence of 0-linlced N-acetylglucosamine residues on 
nuclear proteins (Holt and Hart, 1986), of the presence of these residues to 
varying degrees on a variety of RNA polymerase II transcription factors (Jackson 
and Tjian, 1988), and of the successful use of wheat germ agglutinin-agarose
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(WGA-agarose) lectin affinity chromatography as a first step in the purification of 
tlie transcription factor Spl (Jackson and Tjian, 1989) suggested the use of wheat 
germ agglutinin (this lectin shows highly specific binding towards 
N-acetylglucosamine and various sialic acid sugar species) -agarose affinity 
chromatography as a first step in tlie purification of NF-kB. This approach 
although unsuccessful, did yield some interesting insights - as detailed before 
(Results, Figure 1.4, Panel A), all KB-specific DNA binding proteins in HeLa cell 
nuclear extracts (see Materials and Methods) bound to the WGA-agarose affinity 
resin. However, these KB-specific DNA binding proteins could not be eluted from 
the resin under the conditions used for the purification of the Spl transcription 
factor (Jackson and Tjian, 1989) - nor could Spl DNA binding activity (used as a 
control). Increasing the N-acetylglucosamine concentration in the eluant to 0.7M 
(close to the solubility limit for N-acetylglucosamine) had no effect - neither 
KB-specific nor Spl DNA binding activity eluted from the WGA-agarose affinity 
resin.
Although the purification by Jackson and Tjian (1989) of the Spl transcription 
factor showed a greater than 90% recovery of the intial Spl DNA binding activity 
applied to the WGA-agarose affinity column, other groups have demonstrated 
somewhat lower recoveries of glycosylated RNA polymerase II transcription 
factors from WGA-agarose affinity purification procedures. The purification 
from liver nuclear extracts of the liver-specific hepatocyte nuclear factor 1 
(HNFl) transcription factor (Lichtsteiner and Schibler, 1989) involved 
heparin-agarose, WGA-agarose, and synthetic DNA oligonucleotide-Sepharose 
affinity chromatography stages, the recovery efficiencies over each of these stages
126
- 80%, 20-30%, and 80% respectively - indicated tliat a large fraction of the 
HNFl applied to the WGA-agarose column could not be eluted with eluant buffer 
containing 0.3M N-acetylglucosamine.
Having some supporting evidence for the apparently irreversible binding of 
native, HeLa cell-derived RNA polymerase II transcription factors to 
WGA-agarose affinity resins from this study, it was interesting to note a report 
(Kearse and Hart, 1991) that lymphocyte activation in murine splenic T-cells and 
T-ceU hybridomas resulted in rapid increases in the apparent levels of 0-linked 
N-acetylglucosamine on many nuclear proteins, while in contrast the levels of 
0-linked N-acetylglucosamine on a distinct set of cytoplasmic proteins decreased 
rapidly after cell activation - with both types of changes reverting to control levels 
within a few hours. The appearance of a transient increase in the level of 0-linked 
N-acetylglucosamine on most nuclear proteins of T-cell hybridoma cells when 
activated for sustained periods of up to 6 hours witli a combination of the active 
phorbol ester PMA, and the calcium ionophore ionomycin was most pertinent to 
the present studies. A very similar type of transient activation was seen in the 
pattern of activation of kB DNA-binding activity in the pre-B-cell line 70Z/3 
upon treatment with the active phorbol ester PMA for periods of up to 8 hours 
(Sen and Baltimore, 1986b).
Bearing in mind the observation that most HeLa cell line isolates do not possess 
constitutively active nuclear NF-kB DNA-binding activity - and the HeLa line 
used by Jackson and Tjian seems likely to have been one of these, whereas the 
HeLa cell line used in the present study does show constitutively active nuclear 
NF-kB DNA binding activity, it seems possible that the same cellular signalling
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process responsible for the presence of constitutively active NF-kB in the HeLa 
cell nucleus is also responsible for significant upregulation of the number of 
0-linked N-acetylglucosamine residues carried by NF-kB (and presumably by 
otlier RNA polymerase II transcription factors such as Spl). It seems likely that if 
different cell lines or noimal tissue were used as the cell source in a 
WGA-agarose affinity purification scheme, that NF-kB (and other RNA 
polymerase II transcription factors) could be eluted from the WGA lectin affinity 
column with high yield under mild conditions.
Tlie above type of purification scheme using cytoplasmic extracts from cell 
sources where NF-kB (and the other rel/dorsal protein family members) does not 
show constitutively active nuclear DNA binding activity would have the advantage 
that it could allow the recovery of the various IkB and related inhibitor proteins 
for study in their native forms. Similar arguments apply to other unrelated 
transcription factors also retained in the cytoplasm by interactions with inhibitor 
proteins - such as c-fos (Roux et al., 1990) - a transcription factor also known to 
be modified with N-acetylglucosamine residues in vivo (Jackson and Tjian, 1988), 
and the glucocorticoid receptor - complexed in the cytoplasm with heat shock 
proteins hsp 70 and hsp 90, and a 56 kD immunophilin protein (Ku Tai et al., 
1992).
As regards the actual function of modification with N-acetylglucosamine 
residues, this remains unknown - for example suggestions that this modification 
might act as a nuclear targeting signal in an analogous manner to the mannose 
6-phosphate lysosomal targeting signal are difficult to reconcile with the 
observation that after cell activation, the populations of 0 -linked
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N-acetylglucosamine-modified proteins disappearing from the cytosol were 
largely distinct from those increasing in the nuclear fractions (Kearse and Hart,
1991). Other interesting possibilities derive from the observation that of the 
limited number of 0-linked N-acetylglucosamine addition sites identified so far, a 
large proportion are similar to sites recognised by several serine/threonine protein 
kinases (Edelman et al., 1987) - with the possibility of some type of reciprocal 
relationship between glycosylation and phosphorylation (Kearse and Hart, 1991). 
Also possible is that the addition of O-linked N-acetylglucosamine residues might 
act to either block or target the protein for degradation by specific proteases - 
previous observations indicated that several proteins with intracellular half-lives 
of less than two hours contained one or more regions rich in proline, glutamic 
acid (and to a smaller extent aspartic acid), and serine or threonine - so-called 
'PEST' domains (Rogers et al., 1986) - these motifs are similar to known sites of 
attachment of 0-linked N-acetylglucosamine. Most interestingly, two of the 
proteins which were originally identified as rapidly degraded PEST proteins - 
c-fos and c-jun - have been shown to contain subsets modified by the addition of
O-linked N-acetylglucosamine (Jackson and Tjian, 1988).
Bearing in mind that most O-linked N-acetylglucosamine-bearing proteins are 
present in small amounts, and those which have been identified seem to be 
transcription factors, components of transport systems, or involved in cytoskeletal 
interactions, coupled with the highly regulated nature of the removal/addition 
process, and the observation that this event seems to have an important role in the 
early stages of T-cell activation (Kearse and Hart, 1991), seems to indicate that an 
understanding of this process will be critical for analysis of the activation of
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NF-kB DNA-binding activity and its translocation to the nucleus in response to 
cellular activation.
Since a common feature of DNA-protein complexes is the distortion - often 
bending - of the DNA recognised by the protein, it was decided to investigate if 
some such event occurred in the formation of the NF-kB-kB motif complex. Such 
bends at the protein recognition site on the DNA can be either intrinsic to the 
DNA as a result of some unusual nucleotide sequence, or the result of supercoiling 
of the DNA - further, protein binding can induce DNA bending - either as a cuive 
on the surface of the protein, or by proteins bound at separate sites constraining a 
loop of DNA between them. The formation of such tightly-wrapped DNA-protein 
complexes is often a prerequisite for DNA-handling processes such as 
transcription, recombination, replication and topoisomerisation (Travers, 1990; 
Lilley, 1991; Echols, 1986).
Given obseivations from previous studies using highly purified kB -binding 
proteins in dimethylsulphate (DMS) méthylation protection experiments with the 
HIV-1 LTR enhancer region that several bases within the promoter-proximal 
HIV-R kB motif of the HIV enliancer (-82A, -85C, -86 A, and -87G), and -96A in 
the promoter-distal HIV-L kB motif, showed enlianced rates of reaction with 
DMS in die presence of KB-binding proteins (Clark et aL, 1990), it seemed 
possible that some form of distortion was occurring at the kB  motifs in the 
presence of the highly purified KB-binding proteins. Tlius, making use of the 
p2xAT/HIV-R plasmid-derived circular permutation 600 bp probes in bending 
studies with crude HeLa cell nuclear extracts, the pattern of mobilities of 
circularly-permuted DNA-protein complexes did suggest the induction of a bend
130
centred on the kB motif (Results, Figure 1.5, Panel A). However, this protein 
preparation would contain all members of the NF-icB/c-rel family present in HeLa 
ceU nuclear extracts - making it difficult to determine which member(s) of the 
family were responsible.
Similarly, although the 4xHIV enhancer oligonucleotide-Sepharose affinity 
purified KB-binding protein preparation was highly purified it had not been 
shown which of die members of the NF-KB/c-rel family were present. The pattern 
of mobilities obtained from this protein source was intriguing - with the four 
complexes with the Hind m , Sph 1, Avi II, and Eco RV-generated probes showing 
three sets of identical mobility bands, with the Bam Hl-generated probe complex 
always showing a faster mobility (Results, Figure 1.5, Panel A). Whether these 
three species in each lane represent unique rel protein hetero- or homodimers, 
proteolysis products, or whether they represent differently posttranslationaUy 
modified forms is unknown. However, it does seem likely that the species giving 
rise to the fastest-migrating complexes can be isolated from the others by the HIV 
enhancer affinity /  FPLC Mono-Q /  E.coli DNA / HTV enhancer affinity 
procedure described in section 1.1 (Results, Figure 1.5, Panel B).
Although die circular permutation bending pattern data is difficult to interpret 
for the partially purified protein sources, the pattern of competition is most 
interesting - it is conceivable that the inability of a large molar excess of the 
HIV-R kB motif oligonucleotide to pre-compete binding of the HeLa cell Dignam 
nuclear extract may reflect a stabilising effect of a wrapping of the DNA 
surrounding the lObp kB motif recognition site over the surface of the NF-KB/rel 
protein(s). Hence it might be possible to explain the ability of the undigested,
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presumably supercoiled, p2xAT/HIV-R plasmid to compete at a much lower 
molar excess of kB sites. If the ability of the HIV-R oligonucleotide to compete 
for binding of the partially purified KB-binding proteins were due to the 
proteolytic removal of region(s) of the NF-KB/rel protein(s) which would 
otherwise stabilise wrapping of longer fragments of DNA, this might explain the 
unusual mobility pattern seen with the circular permutation studies. Although 
unexpected, this type of behaviour does not seem unique - studies of the binding of 
serum response factor (SRF) present in crude nuclear extracts to 152 bp probes 
carrying circularly permuted c-fos serum response element (SRE), and cardiac 
and skeletal actin gene promoter CAiG box binding sites (Gustafson et al., 1989) 
showed that the DNA-protein complex involving the c-fos SRE was only poorly 
competed, if at all, by a 100-fold excess of unlabelled CAiG box oligonucleotide. 
Furtlier, when nuclear extracts were partially proteolysed by proteinase K 
treatment, the DNA-protein complex showed a much higher mobility, with 
complexes where the SRE binding site was located at the end of the fragment 
migrating more quickly than the other complexes which all showed a similar 
mobility.
Other studies of DNA bending induced by binding of purified NF-KB (Schreck 
et al., 1990) and crude nuclear extracts (Kuprash and Nedospasov, 1992) have 
indicated the induction of significant bending angles. Interestingly, the study by 
Schreck and coworkers (1990) found using purified NF-kB polypeptides, tliat a
p50 subunit dimer induced a smaller angle of bending (75‘*) on binding to the 
immunoglobulin kB motif than did binding of the classical p50-p65 heterodimeric
form of NF-KB (approximately 110*^ ). Further, mapping of the bend centres
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induced by the two species of protein complex demonstrated that the bend centre 
obtained with the p50 homodimer mapped to a position which corresponded to the 
centre of the kB motif, whereas the p50-p65 heterodimer induced a bend whose 
centre had been shifted towards the 3’ end of the kB motif - significantly this 
location overlapped with previous detemiinations of a position at the 3’ end of the 
kB motif where nicking of the DNA stimulated the binding of NF-kB to its 
recognition site (Schreck et aL, 1990).
The study performed by Kuprash and Nedospasov (1992) using circularly 
permuted immunoglobulin kB site (and closely related kB site variant) probes 
with crude nuclear extracts demonstrated the presence of three distinct 
DNA-protein complex species - one, presumed to involve the p50 homodimer
showing an induced bend of approximately SO'^ , another presumed to involve the
p50-p65 heterodimer with an induced bend of approximately 102*^ , and a third
complex species of unknown origin with an induced bend of approximately 131®.
Tlie obvious difficulty with the above study (as with the bending patterns
obtained with crude extracts and affinity purified kB proteins in the present work)
is in identifying the protein species involved in any particular DNA-protein
complex. In any case, it is clear tliat at least the p50 liomodinier and p50-p65
heterodimer members of the NF-KB/rel/dorsal protein family are capable of
inducing a severe bend in the DNA upon binding to the kB motif. It seems very
likely that the analysis of the nucleoprotein complex assembled at the HIV-1 LTR
will be essential for understanding the initial transcriptional activation event.
However, considering one recent study of DNA bending by complexes of
full-lengtli and truncated variants of the fos and jun proteins (Keippola and
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Curran, 1991) which demonstrated large changes in both bend angle and direction 
depending on the protein constituents of the DNA binding dimer, this may prove a 
formidable problem with the NF-KB/rel protein family.
The identification of speimidine as a stimulatory factor for kB motif DNA 
binding activity in affinity purified protein preparations (Results, Figure 1.6,
Panel A) was initially inteipreted in terms of the promotion of a confonnational 
change in the HIV-L oligonucleotide kB motif (Rich et al., 1984; Clark et al., 
1990). It was thought that alteration of the conformation of the kB motif would 
allow a greater binding affinity for the NF-kB protein(s), and hence explain the 
very much greater amount of DNA-protein complex formed in the presence of 
3mM spermidine. Subsequently, it was reported by other workers (Schreck et al., 
1990) that the similar polyamine speimine (as well as spermidine) caused a similar 
massive increase in the amount of DNA-protein complex formed with purified 
p50-p65 heterodimeric NF-kB, much smaller increases were also found with
addition of 5mM Ca^" ,^ ImM Ba^"^, and 25uM Co^"^(NHg)^ to the binding
mixture. Tins group also interpreted their results in terms of a promotion of a 
structural alteration of die cognate DNA binding site, rather than a direct 
interaction of the agents with the protein.
However, other observations began to suggest that the true reason for the 
massive stimulation in the amount of DNA-protein complex fomied in the 
presence of spermidine might lie in the rates of formation and dissociation of the 
complex. It had been shown with affinity purified p50-p65 NF-kB that binding of 
kB motif oligonucleotide required 5-10 minutes to reach equilibrium in the 
absence of non-specific competitor DNA, while in the presence of non-specific
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competitor DNA, equilibrium was only reached after approximately 60 minutes.
In the same study, in experiments challenging pre-formed radiolabelled 
DNA-protein complexes with a 500-fold molar excess of unlabelled kB motif 
oligonucleotide, the half-life of the radiolabelled complex was approximately 45 
minutes (Zabel and Baeueiie, 1990). Wliile unlabelled kB motif oligonucleotide 
challenge experiments with preformed DNA-protein complexes using xB-binding 
proteins isolated from HeLa cells suggested that the amount of radiolabeUed 
DNA-protein complex was essentially unchanged after 1 hour (L.Clark, 
unpublished observation).
The above obseivations all suggested that formation of complexes between 
native kB-binding proteins and kB motif oligonucleotides was relatively slow 
compared to other sequence-specific DNA-binding proteins, and that the 
dissociation of these complexes was also slow - however, all of these observations 
were made in the absence of spermidine (or spermine) in the binding mixture 
buffer. In the standard presence of 3.6mM spermidine in the gel electrophoresis 
DNA binding assay incubation mixture (except where specifically omitted) used in 
the present studies, it is clear that native xB-binding protein-kB motif 
oligonucleotide complexes must have greatly increased dissociation rate constants. 
From a consideration of Results, Figure 2.1, using various sources of native 
KB-binding proteins, comparison of tracks marked and 'HIV-L' clearly shows 
that addition of lug of unlabelled HIV-L kB motif oligonucleotide after the 
formation of the radiolabelled DNA-protein complex competes away all of the 
radiolabelled complex in the «30 minutes before the samples are loaded on the 
mobility shift gel.
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Thus, the dissociation rate constants for all of these DNA-protein complexes 
must be considerably higher in the presence of spermidine. This in turn prompted 
the realisation that the massive stimulation in the amount of DNA-protein complex 
formed in the presence of spermidine (and spermine) may not reflect some 
conformational change in the k B motif (although this need not be ruled out), but 
rather a failure to reach binding equilibrium within the reasonably short timescale 
of the DNA binding assay.
2. Characterisation of the DNA binding properties of bacterially 
expressed NF-kB p50 subunit aa35-381 proteins
The possible involvement of oxidation-reduction of cysteine residues in the 
modulation of the KB-specific DNA binding activity of proteins in the NF-KB/rel 
family was suggested by observations that both N-ethylmaleimide and iodoacetate 
inactivated DNA binding activity and that treatment with DTT stimulated 
KB-specific DNA binding activity (Results, Figure 2,1). The obseivation that 
formation of a DNA-protein complex prior to treatment with iodoacetate 
protected the DNA binding activity of the purified NF-KB p50 subunit (amino 
acids 35-381) further strengthened the case for some intimate involvement of 
cysteine residue(s) in the DNA binding site (Results, Figure 5.1).
During the course of the present study, a report appeared confirming that the 
DNA binding activity of native NF-kB, and of an in vitro translated amino acid
1-399 p50 protein was increased by treatment with the reducing agent
2-mercaptoethanol (Toledano and Leonard, 1991) - however, the above study 
attributed the stimulation effect solely to the p50 subunit. While the present study 
has not addressed the role of the NF-kB p65 subunit in the stimulation of
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KB-specific DNA binding activity by reducing agents, it seems likely that it also 
contributes to this effect. Tlie above considerations prompted a search of the 
primary amino acid sequence of the cloned NF-kB p50 subunit (Kieran et al.,
1990; Ghosh et al., 1990). Three cysteine residues within the rel-homologous 
DNA binding and dimérisation region - at positions 62,119, and 273 relative to 
the p50 sequence of Kieran et al. (1990) were identified which were absolutely 
conseiwed among all members of the NF-KB/rel/dorsal protein family (Results, 
Figure 2.2). Tlie generation of cDNA encoding the wild type NF-kB p50 protein 
(amino acids 35-381), cDNAs encoding tlie amino acid 62,119, and 273 cysteine 
to serine mutants (Results, Figures 2.3; 2.4) and expression of the encoded 
proteins in E.coli (Results, Figures 2.5; 2.6) using the pGEX-2T glutathione 
S-transferase expression vector proved essentially trouble-free, allowing the 
isolation of purified NF-kB p50 proteins in large quantities.
The dissociation constant values obtained from the Scatchard plot analyses of the 
kB motif oligonucleotide binding behaviour of the wild type and cysteine to serine 
mutant NF-kB p50 aa35-381 proteins (Results, Figure 3.3) are of the same 
general magnitude as values obtained for several other sequence-specific DNA 
binding proteins binding to their recognition sites on short oligonucleotides. For 
example a study of the 27 kD POU DNA-binding domain of the octamer binding 
protein oct-1 (NFIII) binding to its recognition site on an 18-mer double-stranded
oligonucleotide yielded a K^ value of 7x10'^^ M (Venijzer et al., 1990), while a
study of the DNA binding domain of NFI binding to a recognition site on a
wlOObp restriction fragment yielded a value of 1.2x10"^  ^M (Cleat and Hay,
1989).
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However, tlie dissociation constants obtained here are somewhat higher than 
those obtained by other workers using native NF-kB proteins: 2.7x10"^^ M for 
affinity purified NF-kB (Zabel et al., 1991), 4x10'^^ M for renatured, gel purified 
p50“p65 complex, and 9x10"^  ^M for the renatured, gel purified p50 homodimer 
(Urban and Baeuerle, 1990). Altliough the reason for this discrepancy is not clear, 
several interesting possibilities exist. It is very likely that native NF-kB protein 
purified from eukaryotic cells carries post-translational modifications which 
might influence its DNA binding behaviour. From the present study it seems 
likely that most if not all native NF-KB/rel protein isolates will be modified with 
0-linked N-acetylglucosamine residues - although it is unclear whether this would 
influence DNA binding behaviour. It also seems likely that native NF-KB/rel 
proteins will be phospliorylated to varying degrees - this could represent at least 
part of the reason for the vast majority of native HeLa cell kB motif 
DNA-binding activity applied to the FPLC Mono-Q (DEAE equivalent) column 
binding to the column, with only a small fraction of the kB motif DNA-binding 
activity eluting from the column before the application of the salt gradient 
(Results, Figure 1.3).
Other groups have reported in vitro binding studies with overexpressed NF-kB 
subunit proteins - one study using recombinant baculovirus expressed p50 and p65 
proteins demonstrated that p65 homodimers bound to the immunoglobulin kB
motif in a 16bp oligonucleotide with a lower affinity (K^ = 32.2x10"^^ M) tlian 
did tlie full length p50 homodimer (Kp = 6 . 7 x 1 M), or the p50-p65 NF-kB 
heterodimer (K^ = 5.7x10"^^ M) (Fujita et al., 1992). Thus the dissociation
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constant for the recombinant baculovirus expressed p50-p65 NF-kB heterodimer 
is in reasonable agreement with the value of 2.7x10’^^  M for affinity purified 
native NF-KB (Zabel et ah, 1991).
However, another study comparing bacterially expressed p50 protein derivatives 
with native purified NF-kB (Kretzschmar et al., 1992) suggested that bacterially 
expressed p50 bound the immunoglobulin kB site on a 37bp oligonucleotide with a 
much lower affinity than did the native NF-kB. The dissociation constant 
measured for purified native NF-kB of 1.3x10"^^ M seems in reasonable 
agreement with the other studies quoted previously bearing in mind the larger 
oligonucleotide used in this study, however the dissociation constants obtained for
a p50 amino acid 18-503 (55kD) homo dimer (K^ = 8.3x10'^^ M) and for a p50 
amino acid 18-443 (49kD - approximating to the size of the native p50 subunit) 
homodimer (K^ = 2.6x10'^^ M) are larger than expected. It is likely that the
difference in measurements for the baculovirus expressed (6.7x10'^^ M) and
bacterially expressed (2.6x10"^^ M) p50 homodimers is an underestimate as the 
latter study used a significantly larger oligonucleotide in its DNA binding assays - 
larger DNA fragments causing an apparent decrease in dissociation constant values 
(Winter et al., 1981). In any case, it is clear that the bacterially expressed p50 
protein binds the kB motif with a considerably lower affinity than does the 
baculovirus expressed p50 protein - it seems likely tliat some form of 
posttranslational modification is responsible for this effect.
Another interesting observation from the study by Kretzsclimar et al.(1992) was 
the approximately 3-fold lower binding affinity of the p50 protein aa 18-443
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construct towards the kB motif compared with the p50 protein aa18-503 construct 
- if such a pattern were repeated for further deletions of the C-terminal p50 
sequence it might explain the still higher dissociation constant value of 6.5x10’ ®^ 
M seen with die wild type p50 protein aa35-381 construct in the present study. It 
is interesting to speculate on the reasons behind this lower binding affinity for the 
kB motif, it is possible that it may simply reflect some alteration in the relative 
orientation of those N-terminal regions of the p50 dimer implicated in the 
interaction with the kB motif. However a potentially more interesting possibility 
would be if each p50 monomer had a bipartite DNA-binding stmcture - it could 
be imagined that progressive C-terminal deletions of p50 might destroy the ability 
of the C-terminal component to bind DNA, leaving the N-terminal component 
functional but with a lower kB motif DNA binding affinity.
Tliere may be hints that support such a model - the presence in the p50 amino 
acid sequence of a nonliomologous 30 amino acid 'insertion’ (Kieran et al., 1990) 
in the DNA binding and dimérisation region witli highly conserved regions on 
either side hints at tlie possibility of two domains. Since it has been demonstrated 
in this study that cysteine-62 in the extreme N-terminal region is involved in 
contacting DNA, the C-terminal 'domain' may in addition to its dimérisation 
function have a more direct role in contacting the DNA and increasing the binding 
affinity of the p50 homodimer. It has also been hinted that the ability of the wild 
type p50 aa35-381 protein to discriminate against mutant variants of the kB motif 
is impaired compared to both crude and highly purified preparations of native kB 
binding proteins. Such a bipartite DNA-binding stmcture model would have 
several precedents - for example, studies of the oct-1 (NFIII) POU domain
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required for DNA binding have shown the requirement for both an oct-1 homeo 
domain and a POU-specific domain (Verrijzer et aL, 1990) - where the isolated 
homeo domain was shown to bind 600 times less well to the canonical octamer 
sequence than did the intact POU domain. In any case, analysis of the DNA 
contacts made by full length and truncated derivatives of the NF-kB p50 subunit 
by hydroxyl radical footprinting, and dimethylsulphate méthylation protection and 
interference would be worthwhile.
The variations in dissociation constants between the wild type and amino acid 
119, and 273 cysteine to serine mutant p50 aa35-381 proteins in both the presence 
(Results, Figure 3.3) and absence of spermidine seem to be explicable in terms of 
altered dissociation rate constants (Results, Figure 3,4, Figure 3.5, Figure 3.6, 
Table 3.1). Hence the prediction that Üiese three protein species should have 
similar association rate constants - if the dissociation constants remain broadly
unchanged between and 20*^0, the wild type, amino acid 119, and amino acid 
273 cysteine to serine mutant p50 proteins should have association rate constants
in the presence of spermidine in the region of 1x10^ M'^s"  ^ at O'^C. In contrast, tlie 
aa62 cysteine to serine mutant p50 aa35-381 protein in the presence of spemiidine 
has a disproportionately larger dissociation rate constant, and a larger association 
rate constant compared to the three otlier species. One interesting possibility is 
that this might reflect a different mechanism of complex formation - some 
energetically favourable rearrangement of the DNA-protein complex may occur 
with the wild type protein after the initial association event - reducing the 
apparent dissociation rate constant, while the aa62 cysteine to serine mutant might 
not undergo this rearr angement and would hence show a higher dissociation rate
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constant. With regard to this possibility, it would be interesting in the future to 
use the circular permutation DNA-bending analysis on the four different NF-kB 
p50 aa35-381 protein constnicts.
Given the comparatively small effects on dissociation constant values of the 
absence of spermidine (Results, Chapter 3), but the approximately 10-fold lower 
dissociation rate constant values for the wild type, aa ll9 , and aa273 proteins in 
the absence of spemiidine (Results, Table 3.1), the association rate constants for 
these three NF-kB p50 aa35-381 proteins in the absence of spermidine would be
expected to be in the order of 1-2x10^ M'^s'^ at C^C. Again, the aa62 cysteine to 
serine mutant p50 aa35-381 protein in the absence of spemiidine shows a 
disproportionately large dissociation rate constant (approximately 500-fold larger 
than the 0.00071 s"^  value for the wild type p50 aa35-381 protein), and would be 
predicted to have a larger association rate constant (of approximately 2x10^ M’ s^"^
at O^C) compared to the wild type, aa ll9 , and aa273 cysteine to serine mutant p50 
aa35-381 proteins.
Although other studies witli purified native or recombinant NF-kB p50 and p65
subunits have not specifically addressed the question of dissociation rate constants
of DNA-protein complexes, some observations on complex stability have been
reported. Tlius, as previously noted, the half-life of a preformed radiolabelled
DNA-protein complex using affinity purified native p50-p65 NF-kB and a 34bp
im m unoglobu lin  kB  m o tif  o ligon u cleo tid e  tow ards challenge b y  un labelled
oligonucleotide was approximately 45 minutes (Zabel and Baeuerle, 1990) in the
absence of spermidine (or spennine). Wliile in transcriptional activation studies
using baculovirus expressed full length NF-kB p50 subunit protein, DNA-protein
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complexes of p50 homodimer with H-2K gene and interferon-B gene kB motif (5' 
-GGGATTCCCC-3* and 5'-GGGAAATTCC-3’ respectively) «16bp 
oligonucleotides had half-lives of greater than 30 minutes - again in the absence of 
spermidine or spermine (Fujita et al., 1992). This compares reasonably closely 
with a half-life of approximately 16 minutes for challenge of the bacterially 
expressed wild type NF-kB p50 aa35-381 protein-16-mer kB motif 
oligonucleotide complex with unlabelled oligonucleotide in the absence of 
spennidine deteimined in the present study. As with dissociation constant 
detenninations, it seems very likely that the size of the protein constmct, the 
extent and nature of any posttranslational modifications, the size of the DNA 
fragment carrying the specific binding site, the presence of poly amines in the 
incubation buffer, and other factors will all influence dissociation rate constant 
measurements.
The dissociation rate constant values obtained from this study seem reasonable 
when compared with the range of values obtained in other eukaryotic systems - 
for example DNase I footprinting studies on purified native HeLa cell Spl 
transcription factor binding to its recognition site on a 450bp restriction fragment
showed that Spl dissociated rapidly from its recognition site at 25*C with a 
half-life of less than 1 minute - i.e. with a dissociation rate constant greater than 
0.011 s’  ^ (Sclimidt et al., 1989). Wliereas in the previously noted study of tlie 
DNA binding domain of native HeLa cell NFI protein (Cleat and Hay, 1989) 
binding to its recognition site on a -lOObp restriction fragment, the dissociation
rate constant for the DNA-protein complex was 3.2x10""^  s"^  at 20*^0.
As indicated before, the influence of posttranslational modifications and the
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presence of polyamines on dissociation and association rate constants is not 
restricted to NF-kB subunits - one interesting study of recombinant baculovirus 
expressed serum response factor (SRF) demonstrated that the recombinant SRF 
(phosphorylated at the major casein kinase II site) behaved identically to purified 
native HeLa cell SRF, and that dephosphorylation of the recombinant SRF, while 
not affecting its affinity for the c-fos serum response element (SRE), caused a 
large decrease in the rates of association with and dissociation from the c-fos SRE 
(Marais et al., 1992). Also observed in this study was tliat tlie rates of both 
formation and breakdown of phosphorylated and dephosphorylated SRF-c-fos 
SRE complexes were significantly increased by the presence of 3mM spermidine 
in tlie DNA binding assay buffer. The mechanism by which spemiidine acted in 
the above study was unknown, but one proposal by the authors was that it might 
screen negative charges on the DNA backbone and in some way lower the 
activation energy requirement for complex formation and dissociation, it seems 
possible that a similar mechanism may apply in the case of the bacterially 
expressed NF-kB p50 aa35-381 proteins (and also presumably to native 
kB-binding proteins).
The above type of phosphorylation modulation of exchange rate kinetics is only 
one possible mechanism for regulating transcription factor activity, many other 
cases are known of phosphorylation altering such behaviour as the sequestration of 
transcription factors in the cytoplasm, positively or negatively altering the DNA 
binding activity of the factor, and affecting the interactions of the factors 
transactivation domains with other components of the transcriptional machinery 
(Reviewed in Hunter and Karin, 1992). In the activation of the NF-KB
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transcription factor by phosphorylation, only one event is fairly 
well-characterised - that of the phosphorylation and inactivation of the various 
members of tlie IkB /  ankyrin repeat protein inliibitor family (Baeuerle and 
Baltimore, 1988a; Baeuerle and Baltimore, 1988b; Shirakawa and Mizel, 1989; 
Ghosh and Baltimore, 1990; Haskill et al., 1991; Davis et al., 1991; Hatada et al.,
1992). However, it is also possible that tlie NF-kB subunits themselves are 
phosphorylated under some or all cellular physiological conditions - a 
phosphorylation of NF-KB p50 might account for the significantly lower 
dissociation constant of baculovirus expressed p50 (Fujita et al., 1992) compared 
with that obtained with the bacterially expressed p50 (Kretzsclimar et aL, 1992). 
One plausible candidate for this modification is the potential serine 
phosphorylation site RRXS present (except in tlie cases of p49/p50B and 
RelB/I-Rel proteins) throughout the NF-KB/rel/dorsal family (Kieran et al., 1990; 
Nolan et al., 1991) located at amino acids 335 to 338 in the p50 sequence. 
Intriguingly, such sites which are potential substrates for casein kinase II 
phosphorylation have been identified in many proteins possessing a nuclear 
localisation signal. Wliile the presence of a nuclear localisation signal determines 
the specificity of protein transport, the presence of such a potential casein kinase 
n  phosphorylation site at a distance of -10-30 amino acid residues from a nuclear 
localisation signal has been identified as the factor deteimining the rate of nuclear 
transport (Rihs et al., 1991). Tills observation could thus provide an attractive 
explanation for the previous implication of casein kinase II phosphorylation in the 
transmission of growth signals to the nucleus - that it acted by controlling the rate 
of protein transport.
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The competition experiment using non-specific E.coli DNA suggested that the 
DNA binding specificity of the aa62 cysteine to serine mutant p50 aa35-381 
protein had indeed altered from Üiat of the wild type and aa ll9  and aa273 cysteine 
to serine mutant p50 aa35-381 proteins (Results, Figure 4.3), and that the reason 
for the lower binding affinity of the aal 19 and aa273 mutant p50 proteins towards 
tlie kB motif did not lie in an altered DNA binding specificity. To address this 
question a series of oligonucleotide competition experiments using variants of the 
immunoglobulin /  HIV enhancer kB motif were carried out on the wild type and 
aa62 mutant p50 protein. Hie results obtained (Results, Figures 4.4-4.11, Table 
4.1) demonstrate clearly that the aa62 cysteine to serine mutant p50 aa35-381 
protein has an altered DNA binding specificity.
As would be expected for competition of die 16-mer kB motif oligonucleotide 
by unlabelled HIV-L kB motif oligonucleotide, the competition behaviour of the 
wild type and aa62 cysteine to serine mutant p50 aa35-381 proteins are identical 
(Results, Figure 4.4). The reason for the relative molarity of unlabelled 
competitor needed to reduce the amount of radiolabelled complex by 50% being 
1.81 rather than 1.00 (Results, Table 4.1) probably lies in the size of the regions 
flanking the kB sites - as discussed in the Results section. For competition of the 
16-mer kB motif oligonucleotide by the imlabelled IRE type of kB motif, the 
competition behaviour of the wild type and aa62 cysteine to serine mutant p50 
proteins are identical (Results, Figure 4.5), while the comparatively similar 
affinity of the wild type p50 construct homodimer for the IRE and HIV-L kB 
motifs (the relative molarities of unlabelled competitor for a 50% reduction in 
radiolabelled complex being 1.35 and 1.81 respectively - Results, Table 4.1) are
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in good agreement with the results of kB motif binding affinity studies using 
baculovirus expressed p50 homodimers (Fujita et al., 1992).
In the case of the competition of the 16-mer kB motif oligonucleotide by 
unlabeUed H2TF1 type kB motif (Results, Figure 4.6), interesting differences 
appear with regard to binding of the wild type and aa62 cysteine to serine mutant 
p50 proteins - the relative molarity of the H2TF1 competitor oligonucleotide 
needed to cause 50% reduction in the amount of radiolabelled complex is only 
0.40 for the wild type p50 construct, but 1.96 for the aa62 cysteine to serine 
mutant p50 construct (Results, Table 4.1). Puzzlingly, tlie higher affinity of the 
p50 homodimer constmct in this study for the H2TF1 type of kB motif is at 
variance with dissociation constant detenninations for the baculovirus expressed 
p50 homodimer with immunoglobulin /  HIV enhancer, interferon-B, and H2 gene 
kB motif oligonucleotides (Fujita et al,, 1992) - all these types of kB motif 
showed similar dissociation constants of approximately 6x10'^^ M. However, other 
studies with both recombinant and purified native p50 subunit proteins have 
shown the binding affinity of the p50 homodimer to be significantly greater 
towards the H2TF1 type of kB motif compared to the immunoglobulin /  HIV 
enhancer kB motif (Kieran et aL, 1990; Baldwin and Sharp, 1988). In addition, 
this study demonstrates that the aa62 cysteine to serine p50 mutant has tlie same 
binding affinity for the HIV-L kB motif as for the H2TF1 type of kB motif.
Competition of the 16-mer kB motif oligonucleotide by unlabeUed, highly 
symmetric EBP'cons’ kB motif oligonucleotide (this like the H2TF1 kB motif 
having a 3' half-site which was a mirror image of the 5’ half-site), there were 
again some differences in behaviour between the wild type and aa62 cysteine to
147
serine mutant p50 proteins (Results, Figure 4.7). The molar excess of EBP’cons' 
competitor oligonucleotide required to reduce the amount of radiolabelled 
DNA-protein complex by 50% (0.30 and 0.58 respectively for the wild type and 
aa62 cysteine to serine mutant p50 proteins - Results, Table 4.1) indicate that the 
EBP'cons’ kB motif is a better competitor for the wild type p50 protein than is 
the 16-mer kB motif oligonucleotide. Tliis finding is supported by other studies 
showing that full-length bacterially expressed p50 bound similar palindromic kB 
sites with an affinity at least 5-fold greater than for the immunoglobulin /  HIV 
enliancer kB motif (Kretzschmar et aL, 1992).
The other four species of mutant kB motif - SVUP, SV l-M l, SV1-M2, and 
SV1-M3 (Results, Figures 4.8, 4.9,4.10, and 4.11, Table 4.1) all show similar 
patterns of behaviour - as noted before, they are poor competitors for binding of 
both the wild type and aa62 cysteine to serine mutant p50 aa35-381 proteins, but 
with higher affinities for the aa62 mutant p50 protein - implying that the aa62 
mutant p50 protein has lost the ability to discriminate between specific and 
non-specific DNA binding sites.
Although the substitution of serine in place of a cysteine residue is often thought 
of as being among the most conseivative amino acid substitutions possible, it 
should be noted that their side chain bond lengths and angles are significantly 
different - thus it is possible that the substitution by serine could disturb potential 
hydrogen bond contacts witli the kB motif on the DNA, and hence reduce the 
stability of the DNA-protein complex. That such effects can be dramatic is 
illustrated by the sulphate binding protein - where the substitution of a serine 
residue which contributes hydrogen bonds for ligand binding by cysteine results in
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the mutant protein sulphate binding affinity being over 1000-fold lower (He and 
Quiocho, 1991).
Many examples have been documented of relatively subtle amino acid 
substitutions affecting the sequences recognised and/or the binding affinities of 
sequence specific DNA binding proteins, most of the well-studied examples are 
prokaryotic repressor proteins, but some eukaryotic transcription factors have 
also been analysed. The 10-fold change in dissociation constant for the aa62 
cysteine to serine mutant p50 protein is paralleled by examples such as the E.coli 
CRP protein (Ebright et aL, 1984) - where it was shown that substitution of 
glutamic acid 181 by lysine, leucine or valine residues resulted in the mutant 
proteins preferentially recognising A.T base pairs (rather than the wild type G.C 
base pairs) at positions 7 and 16 of the symmetrical CRP recognition site. Thus, 
with the wild type CRP recognition site, the aal 81 glutamate to lysine change 
resulted in approximately 5-fold lower levels of reporter enzyme activity.
Eukaryotic examples of such changes in DNA binding specificity include the 
yeast bZIP type transcriptional activator GCN4 - which normally binds the 
optimal site ATGACTCAT with much higher affinity than tlie mutant site 
TTGACTCAA, mutation of a single invariant asparagine in the basic region 
(Asn-235) to tryptophan resulted in a mutant protein which bound both sites with 
similar affinity (Tzamarias et aL, 1992). Another recently characterised change in 
DNA binding specificity was that of the yeast TFIID general transcription factor, 
which normally binds to the consensus TATA element - TATAAA, genetic 
selection techniques allowed the identification of a mutant TFIID which allowed 
transcription from promoters containing the mutant TATA element - TGTAAA.
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The mutant TFIID protein contained three substitutions within a 12 amino acid 
region - two of which were necessary and mainly responsible for the new 
specificity - isoleucine-194 to phenylalanine, and leucine-205 to valine (Stmbin 
and Struhl, 1992). Botli of die above mutants were isolated by genetic methods in 
yeast - such a technique could have great advantages for identifying mutant NF-kB 
species with novel binding specificities. Indeed, Saccharomyces cerevisiae has been 
shown to lack endogenous kB -binding transcriptional activator proteins and has 
been used for transfection studies to map transcriptional activation domains of 
pl05 and IkBB (Morin and Gilmore, 1992). Intriguingly however, the fission 
yeast Schizosaccharomyces pombe has been shown to possess endogenous 
KB-binding transcriptional activation protein(s) (Toyama et al., 1992).
3. Identification of cysteine residues in the NF-KB p50 subunit DNA 
binding site
Tlie initial impetus behind the study of the oxidation-reduction regulation of 
NF-KB p50 subunit DNA binding activity came from in vitro studies 
demonstrating increased AP-1-specific DNA binding activity of the fos-jun 
heterodimeric transcription factor after treatment with the reducing agent 
dithiothreitol (DTT) (Abate et al., 1990) and the mediation of this stimulation by 
the oxidation-reduction state of a single conserved cysteine residue in each 
subunit. An initial experiment with various sources of crude kB -binding proteins 
suggested tliat such a regulatory mechanism might apply to NF-kB DNA binding 
activity, since treatment of the gel electrophoresis DNA binding assay incubation 
mixture with additional DTT to 25mM and incubating 15 minutes on ice caused a 
significant, in some cases massive, increase in specific kB motif DNA binding
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activity (Results, Figure 2.1). The possibility that this stimulation involved some 
intermediary protein rather than the direct action of DTT was lessened by the 
observation that extensively affinity purified kB binding proteins 
'Aff.Pur.NF-KB' also showed the same stimulation by DTT treatment. Tire fact 
that N-ethylmaleimide pretreatment of all protein sources prior to DNA-protein 
complex formation inactivated kB motif DNA binding activity strengthened the 
case for tlie involvement of a cysteine residue(s) in this process.
Comparison of the predicted amino acid sequences of a variety of members of 
the NF-KB/rel/dorsal protein family in the region corresponding to the previously 
roughly defined DNA binding and dimérisation region of the NF-KB p50 subunit 
(Results, Figure 2.2) (Kieran et aL, 1990; Ghosh et aL, 1990) indicated that witliin 
the amino acid 35 to 381 region of p50, were three cysteine residues which were 
absolutely conserved among all family members - at p50 amino acid positions 62, 
119, and 273. The bacterial expression of the wild type and amino acid 62,119, 
and 273 cysteine to serine mutants of die p50 protein aa35-381 region (Results, 
Figure 3.1) yielded enough protein for extensive studies.
Measurements of dissociation constants for the four p50 construct species with a 
16-mer kB motif oligonucleotide (Results, Figure 3.3) and dissociation rate 
constants in the presence and absence of the polyamine spermidine (Results, 
Figures 3.5, 3.6, Table 3.1) suggested a different DNA binding specificity for the 
aa62 cysteine to serine mutant p50 aa35-381 protein - and hence that cysteine 62 
might be involved in hydrogen bonding contacts with the kB motif DNA. Tliese 
suggestions were strengthened by DNA binding competition analysis of the wild 
type and aa62 cysteine to serine mutant p50 constructs with a range of kB motif
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variants (Results, Figures 4.4 - 4.11, Table 4.1).
As noted before, during these studies a report of the in vitro modulation of 
NF-kB DNA binding activity appeared (Toledano and Leonard, 1991), indicating 
that for both crude sources of kB binding proteins and an in vitro translated p50 
subunit aa l-399 construct, specific kB -binding activity was stimulated by 
treatment with 2-mercaptoethanol. It was also obseived that in the activation of 
cytoplasmic, inhibitor protein-complexed, foims of kB binding activity from 
uninduced T-cell extracts, that there was a synergistic effect of 2-mercaptoethanol 
and the deoxycholate/NP40 detergent treatment previously shown to activate the 
DNA binding activity of IkB -shielded NF-kB (Baeuerle and Baltimore, 1988b). 
Thus raising at least the possibility that oxidised, non DNA-binding fomis of 
kB -binding proteins (not necessarily complexed to ankyrin repeat proteins) could 
exist in the cytoplasm. Further, as seen in the case of the fos-jun heterodimer 
(Abate et al., 1990), the native kB binding proteins and the p50 protein aa l-399 
construct were inactivated by N-ethylmaleimide, and also by the 
sulphydryl-oxidising reagent diamide (Kosower et al., 1969).
Bearing in mind the previously noted hints that cysteine 62 of the p50 protein 
aa35-381 construct is intimately involved in the DNA binding site, and that the 
incubation of the fos-jun heterodimer with an oligonucleotide containing an AP-1 
binding site, prior to treatment with N-ethyhnaleimide protected the protein 
against inactivation (Abate et al., 1990), a similar oligonucleotide protection 
experiment was carried out with the wild type p50 protein aa35-381 construct. 
This demonstrated (Results, Figure 5.1) that the DNA binding activity of the 
preformed DNA-protein complex was essentially unchanged even in the presence
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of 30mM iodoacetate, whereas incubation of the protein with this concentration of 
iodoacetate prior to addition of the radiolabelled 16-mer kB motif oligonucleotide 
resulted in complete inactivation of DNA binding activity - firm evidence for the 
presence of a cysteine residue(s) in the p50 protein aa35-381 construct DNA 
binding site.
Although the above experiment could give no information as to which particular 
cysteine(s) was involved in intimate contacts with the kB motif DNA, the previous 
binding affinity and specificity studies and the results of the titration of the DNA 
binding activity of aU four p50 constmct species (Results, Figure 5.2) with 
iodoacetate all indicate that cysteine 62 is the residue involved in the redox 
modulation of the DNA binding activity of the NF-kB p50 protein aa35-381 
construct. It should be noted that the difference in iodoacetate sensitivities between 
the aa62 mutant and the three other species may well be an underestimate as the 
presence of comparatively large amounts of the carrier protein bovine semm 
albumin, which is rich in cysteine residues, may act as a thiol buffer.
To confiiin the presence of cysteine 62 in the DNA binding site of the NF-kB 
p50 subunit aa35-381 construct, the substrate protection of iodoacetate-reactive 
residues in the DNA binding site (Results, Figure 5.3) was peifonned with 
^^C-iodoacetate. The N-terminal amino acid peptide sequence analysis of HPLC 
fraction number 54 revealed a predominant peptide species (Results, Figure 5.5, 
Panel B) with sequence corresponding to amino acids 60 to 69 of the NF-kB p50 
sequence (Kieran et al., 1990). A repeat of this ^^C-iodoacetate affinity labelling 
experiment with the incorporation of 95% of the theoretical amount of 
recently demonstrated the identity of cysteine 62 as the only radiolabelled cysteine
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- indicating that cysteine 62 is the only cysteine residue in the NF-kB p50 subunit 
aa35-381 constmct DNA binding site.
A recent study of the v-rel oncoprotein identified the homologous cysteine 35 in 
the conseived motif RxxRxRxxC as being essential for v-rel protein-DNA contact 
and suggested that reduction of this conserved cysteine was necessary for optimal 
DNA binding (Kumar et aL, 1992). Making use of an unusual combination of UV 
cross-linking of DNA-protein binding reactions and immunoprécipitation to 
quantitate binding suggested that mutation of all arginine residues in the 
RxxRxRxxC motif resulted in loss of DNA binding activity. It was also proposed 
on the basis of this binding assay that mutation of cysteine 35 to serine resulted in 
a slight increase in binding affinity for a bromodeoxyuridine-labelled palindromic 
kB motif, and that mutation of v-rel cysteine residues 92 and 216 (the homologues 
of p50 cysteine residues 119 and 273) to serine had no effect on DNA binding 
activity.
Wliether these differences in the effects of cysteine to serine mutations are 
inherent between the v-rel oncoprotein and NF-kB p50, or possibly due to the 
truncated nature of the p50 subunit aa35-381 construct is unknown. However, the 
audiors of the above study did identify one significant philosophical problem with 
the proposal that the cysteine 35 to serine mutation increased and deregulated 
DNA-binding activity - that unlike the case with the oncogenic v-jun cysteine to 
serine mutation which both escapes redox control and has increased DNA binding 
activity (Maki et aL, 1987), no such oncogenic mutants are known for 
NF-KB/rel/dorsal family proteins - indeed v-rel itself has a cysteine residue rather 
than serine at this position. It is then necessary to propose that cysteine 35 is also
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involved in some other function such as modulating the interaction of v-rel with 
other cellular proteins.
The demonstration of cysteine 62 as the only cysteine residue in the NF-kB p50 
subunit aa35-381 construct DNA binding site suggested from symmetry arguments 
that its pair, cysteine 62% would occupy a symmetrically related position - 
prompting the question of whether they were close together or widely separated in 
the DNA binding site. Tlie results of diamide treatment of the four NF-kB p50 
aa35-381 constmcts demonstrated that only the aa62 cysteine to serine mutant 
protein failed to be interchain disulphide crosslinked (Results, Figure 5.6). This 
result combined widi the affinity labelling results showed that cysteine 62 and 
62' are close enough in the DNA binding site to form a disulphide bond.
It is becoming clear that arrangements of cysteine sidechains that allow 
interchain and intrachain disulphide bonds to form in cytoplasmic and nuclear 
protein complexes may be quite common - examples include the previously noted 
fos-jun heterodimeric transcription factor (both the fos and jun proteins belong to 
the basic region - leucine zipper (bZIP) class of DNA binding proteins) which is 
converted from an active DNA-binding species to a non-binding species by 
formation of an interchain disulphide bond between the two conserved cysteine 
residues in their basic DNA binding motifs (Bannister et al., 1991), also the 
human glucocorticoid receptor - with evidence for the foimation of inter- and 
intramolecular disulphide bonds and a close link between the reduction of 
intramolecular disulphide bond(s) and the ability of the receptor monomer to bind 
DNA (Silva and Cidlowski, 1989), and tlie human general transcription factor 
TFIIIC (Cromlish and Roeder, 1989). Other examples include other bZIP class
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proteins such as the liver and fat cell specific transcriptional regulator CCAAT / 
enhancer binding protein (C/EBP) (Landschulz et al., 1989; Williams et al., 1991) 
and the Epstein-Barr virus BZLFl transactivator protein (Bannister et al., 1991).
Intruigingly, the bZIP class protein examples mentioned above (fos-jun,
C/EBP, and BZLFl) while all showing the ability to be interchain crosslinked in 
vitro (for C/EBP via a conseived cysteine at the C-temiinus of the leucine zipper) 
by diamide treatment do not all show a significant change in DNA binding activity 
with changes in redox state. Tlius, while the wild type C/EBP dimer did not show 
any difference in DNA binding activity for the reduced and disulphide crosslinked 
forms (Williams et al., 1989), the introduction of a serine to cysteine mutation at 
position 12 of the C/EBP basic motif (tlie equivalent of the conserved 
redox-sensitive cysteine in the core basic DNA binding motifs of the fos, jun , and 
BZLFl DNA binding domains) results in the generation of a redox-sensitive 
protein which can only bind to its recognition site in the presence of DTT 
(Bannister et al., 1991).
This concentration on the bZIP class of transcriptional regulators reflects their 
potential special relevance for the NF-KB/rel/dorsal protein family - with the 
identification of a cDNA encoding the rel B protein (Ryseck et al., 1992) which 
posesses an N-teiminal putative leucine zipper structure between amino acids 22 
and 51. Homodimers of this rel B protein could not bind kB sites with high 
affinity, but heterodimers with the NF-kB p50 subunit could bind with high 
affinity to the kB motif and were transcriptionally active. Given the large number 
of bZIP type transcriptional regulator species within the cell, it seems likely that 
some types of functional heterodimers could be formed between a rel B monomer
156
and another bZIP species - witli the generation of hybrid transcriptional 
regulators with new DNA binding specificities.
An interesting parallel between all of the NF-KB/rel/dorsal family and 
redox-sensitive bZIP proteins such as fos, jun, and BZLFl is that the 
redox-sensitive cysteine is surrounded by a short but well conseived sequence of 
basic residues (different for the two groups of proteins). It has been known for 
some time that such anangements of basic residues near a cysteine can increase 
the cysteines reactivity dramatically - the oxidation equilibrium constant can 
change over several orders of magnitude (Snyder et al., 1981). Thus it may be 
that one function of these basic regions is to make that particular cysteine thiol 
exquisitely sensitive towards changes in the intracellular redox environment - this 
is in addition to any other roles these basic regions may play in contacting the 
DNA of the recognition motif.
4, Implications for the control of gene expression
It is clear that the control of gene expression by trans-acting factors of the 
NF-KB/rel/dorsal protein family binding to KB-like motifs is a highly complex 
problem, and the control of the initial transcriptional activation of the integrated 
HIV-1 provirus significantly more so. However, this study has at least identified 
the redox control of DNA binding activity in the NF-KB/rel/dorsal family as one 
regulatory mechanism with the possibility of therapeutic intervention.
At this point it seems pertinent to explore the possible mechanisms which a cell 
might use to alter its internal redox environment - one seemingly ubiquitous 
activity is the thioredoxin family of dithiol reducing enzymes - originally 
identified as a hydrogen donor for ribonucleotide reductase (Hohngren, 1985).
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The human equivalent of this activity is thought to be the oxido-reducing enzyme 
adult T-cell leukaemia derived factor (ADF) which has been isolated and cloned 
from both the Epstein-Barr Virus (EBV) infected 3B6 B-cell line and the Human 
T-cell Leukaemia Virus type I (HTLV-I) infected adult T-cell leukaemia line 
ATL2 (Tagaya et aL, 1989). Most interestingly, while the niRNA for ADF cannot 
be detected by Northern blotting of resting lymphocytes, it was inducible by 
treating lymphocytes with either the mitogenic lectin phytohaemagglutinin (PHA) 
or the active phorbol ester, phorbol myristyl acetate (PMA) (Tagaya et aL, 1989). 
It has also been demonstrated that high levels of ADF niRNA are present in 
EBV-LCL and HTLV-I positive ATL cells (Wakasugi, 1992). These conditions 
under which ADF mRNA is expressed are also those where transcription from the 
HIV-1 LTR occurs, and which show activation of the DNA binding activity of 
NF-kB.
To investigate the physiological importance of such oxido-reducing enzymes as 
ADF in die control of the DNA binding activity of redox-sensitive transcriptional 
regulators such as the NF-KB/rel/dorsal family we became involved in a 
collaboration with N.Wakasugi and J.-L.Virelizier. Cotransfection of Cos? ceUs 
with an ADF/human thioredoxin expression vector and a luciferase reporter 
construct under the control of a wild type HIV-1 LTR gave a 5-fold increase in 
luciferase activity compared to the absence of the thioredoxin expression plasmid, 
while use of a luciferase constmct with an HIV-1 LTR deleted for the kB sites 
gave no increase in luciferase activity in cotransfections with the thioredoxin 
expression plasmid. In addition in vitro DNA binding assays demonstrated that 
both ADF/liuman thioredoxin and E.coli thioredoxin could directly stimulate
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KB-specific DNA binding activity of the purified wild type NF-kB p50 subunit 
aa35-381 protein constmct, while the aa62 cysteine to serine mutant p50 aa35-381 
protein DNA binding activity could not be stimulated by ADF/human thioredoxin 
(Matthews et aL, 1992). Tlius for NF-kB p50 subunit homodimers at least, there 
seems to be no requirement for an intemediai’y protein such as the Ref-1 nuclear 
protein involved in stimulating (via the reduction of the conseived cysteines in the 
basic DNA binding motifs) the DNA binding activity of the fos-jun heterodimer 
transcription factor (Xanthoudakis and Curran, 1992).
It seems possible that the same may not be true for the p65 subunit of NF-kB 
however, as studies on the overexpressed Ref-1 protein (Xanthoudakis et aL,
1992) have shown that while p65 homo dimer DNA binding activity was 
significantly stimulated by lOniM DTT, it could also be stimulated to a lesser 
degree by treatment with bacterially expressed Ref-1 protein. Transcription factor 
species such as fos-jun and myb were in contrast stimulated to a greater extent by 
the Ref-1 treatment than by DTT. Tlie authors suggested that Ref-1 mediates its 
redox activity through a KCR motif around the redox-active cysteine which is 
absolutely conserved throughout all the fos-related and jun-related proteins 
identified to date, and noted that a similar motif, KICR, occuned in the p65 
sequence at amino acids 195-198 (Nolan et aL, 1991) - with the implication that 
this is the redox-sensitive cysteine of p65 - interestingly enough tliis cysteine is 
conserved among NF-kB p65; dorsal; mouse, human, and turkey c-rel (Nolan et 
aL, 1991) and v-rel proteins (Kieran et aL, 1990), the only exception being the 
NF-kB p50 subunit. However it is also true that around the p65 homologue of the 
completely conseived p50 cysteine 62 is die similar sequence RYKCEGR -
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conserved throughout the rel family which might possibly act as a Ref-1 substrate, 
while the homologous p50 amino acid sequence RYVCEGP may be too distantly 
related for this. Thus the potential relevance of Ref-1 in acting as an intermediary 
in ADF/human thioredoxin-mediated reduction of, and stimulation of the DNA 
binding activity of, the NF-kB p50-p65 heterodimer, and p65 homodimers is as 
yet, unclear.
Up to this point the interior of the cell has been considered solely as a reducing 
environment where the presence of disulphide bonds might not be expected, 
however several suggestions have been made that even under normal metabolic 
conditions the existence of intracellular disulphide bonds is allowed. For example 
studies of 3-hydroxy-3-methylglutaryl-CoA reductase (Cappel and Gilbert, 1988) 
have suggested the regulation of enzyme activity by foimation and reduction of 
disulphide bonds in response to normal changes in the thiol/disulphide oxidation 
state of the cellular glutathione redox buffer.
However, the cell must also face severe challenges such as oxidative stress and 
ultraviolet radiation, in both prokaryotes and eukaryotes such insults can lead to 
the so-called pro-oxidant state - characterised by the build up of reactive oxygen
species of which the major foims are the superoxide anion the hydroperoxy
radical HO2*, singlet oxygen 02^*» the hydroxyl radical H0-, and hydrogen
peroxide (Reviewed in Cemtti, 1985). Prooxidant states can vary depending on 
the target ceU and the type of induction mechanism and cause chromosomal 
damage by indirect action, however such states can be prevented or suppressed by 
a system of cellular antioxidant defense enzymes and low molecular weight 
scavenger molecules.
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The possible involvement of an interplay between the reactive oxygen species 
generated in such situations as the inflammatory response and the intracellular 
antioxidant enzyme/scavenger molecule system was demonstrated in vivo by 
studies showing that treatment of cell cultures with the active phorbol ester PMA 
or tumour necrosis factor a  (TNF-a) resulted in the activation of kB 
DNA-binding activity, in lower levels of intracellular reduced glutathione, and the 
activation of transcription from the HIV-1 LTR. In contrast, treatment of cell 
cultures with N-acetyl-L-cysteine (NAC) prevented the (PMA or TNF-a-induced) 
fall in intracellular reduced glutathione levels, blocked the activation of kB 
DNA-binding species, and blocked the activation of transcription from the HIV-1 
LTR (Staal et al., 1990; Roederer et al., 1990).
Further in vivo studies showed that the activation of NF-kB DNA binding 
activity and of transcription from the HIV-1 LTR in the Jurkat T-cell line could 
be induced by treating cells with micromolar concentrations of hydrogen peroxide 
(Schreck et al., 1991), and that this activation process could be blocked by 
preaddition of NAC. However, if NAC were added at the end of the hydrogen 
peroxide treatment no inhibition was obseiwed, nor could hydrogen peroxide 
alone activate the DNA binding activity of purified NF-kB-IkB complex or the 
complex in cytoplasmic extracts - leading to the suggestion that NAC might be 
reacting with some metabolite of hydrogen peroxide. NAC also blocked the 
activation of NF-kB by agents such as cycloheximide, double stranded RNA, 
calcium ionophore, TNF-a, PMA, interleukin-1, bacterial lipopolysaccharide, and 
lectin - leading to the suggestion that these diverse pathways might aU act via a 
common intermediate involving reactive oxygen species.
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Whether such mechanisms also apply in the case of other inducible transcription 
factors such as die fos-jun heterodimer is unclear - both k B  and AP-1 specific 
DNA binding activities are known to be increased in soluble extracts of 
UV-treated cells (Stein et al., 1989). At present it is also unclear what role 
reactive oxygen species play in the action of the HTLV-1 Tax protein, hepatitis 
virus B X protein, and C-terminally truncated forms of the hepatitis vims B 
middle and large surface antigen proteins which have been shown to transactivate 
several species of inducible transcription factor (including NF-icB) by a process 
which can be inhibited by antioxidants and which presumably involves reactive 
oxygen species (Meyer et al., 1992).
5. Future studies
The evidence presented in these studies suggests that the DNA binding activity 
of the NF-KB/rel/dorsal transcriptional modulator family may be modulated by 
the redox state of a conseiwed cysteine residue (aa62 in p50) in their DNA binding 
and dimérisation regions. Whether the redox mechanism regulating the DNA 
binding activity of the other family members involves the fomiation of an 
interchain disulphide bond as in the p50 protein, or whether it involves some 
other reversible modification such as the generation of a sulfenic acid is a question 
of immediate interest.
It will also be of great interest to determine which other amino acid side chains 
in the DNA binding site are involved in making hydrogen bonds with bases in the 
kB motif. One potentially useful approach would be the use of different specificity 
chemical reagents in substrate protection experiments to attempt to identify side 
chains other than cysteine. Another powerful approach to analysing the
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DNA-protein interaction could lie in detemining the new DNA binding 
specificity of tlie aa62 cysteine to serine mutant by a PCR amplification/random 
oligonucleotide binding site method.
Having identified the role of one conserved cysteine residue (aa62) in the p50 
DNA binding and dimérisation region as a redox state modulator in the DNA 
binding site, an obvious question concerns the function of the other conserved 
cysteine residues (aall9  and aa273). One possibility is a role in protein 
dimérisation - it has been suggested tliat NF-kB may be a zinc-dependent protein, 
thus it could be imagined that the four cysteine residues (aall9 , aa273, aall9 ', 
aa273') might tetrahedrally coordinate a zinc ion. However, it might have been 
expected that a cysteine to serine mutation at either of the 119 or 273 positions 
would then be very detrimental to dimer stability - in contrast to the modest 
effects of these mutations on DNA binding activity in vitro.
Further regulatory possibilities for the NF-icB/rel/dorsal family centre around 
the dramatic increase in on- and off-rates for p50 in the DNA-protein complex in 
the presence of spermidine - it seems likely that effects at least as dramatic are 
seen with native proteins. Given the potential phosphate-shielding activity of 
polyamines such as spermidine, and the tight cell-cycle control of speimidine 
syntliesis, it seems possible that some regulatory interplay between free 
spermidine levels and protein phosphorylation may exist to coordinately regulate 
tlie DNA binding activity of a wide range of factors such as transcriptional 
modulator proteins, DNA replication proteins, and topoisomerases. In vitro 
studies with purified protein kinases and purified members of tlie 
NF-KB/rel/dorsal family would be most useful for understanding this potentially
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important mechanism for regulating DNA binding activity.
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